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Abstract
Epigenetics is the field of biology that investigates heritable factors regulating gene expres-
sion without being directly encoded in the genome of an organism. The human genome is densely
packed inside a cell’s nucleus in the form of chromatin. Certain constituents of chromatin play a
vital role as epigenetic factors in the dynamic regulation of gene expression. Epigenetic changes on
the chromatin level are thus an integral part of the mechanisms governing the development of the
functionally diverse cell types in multicellular species such as human. Studying these mechanisms
is not only important to understand the biology of healthy cells, but also necessary to comprehend
the epigenetic component in the formation of many complex diseases.
Modern wet lab technology enables scientists to probe the epigenome with high throughput and
in extensive detail. The fast generation of epigenetic datasets burdens computational researchers
with the challenge of rapidly performing elaborate analyses without compromising on the scien-
tific reproducibility of the reported findings. To facilitate reproducible computational research
in epigenomics, this thesis proposes a task-oriented metadata model, relying on web technology
and supported by database engineering, that aims at consistent and human-readable documentation
of standardized computational workflows. The suggested approach features, e.g., computational
validation of metadata records, automatic error detection, and progress monitoring of multi-step
analyses, and was successfully field-tested as part of a large epigenome research consortium. This
work leaves aside theoretical considerations, and intentionally emphasizes the realistic need of
providing scientists with tools that assist them in performing reproducible research.
Irrespective of the technological progress, the dynamic and cell-type specific nature of the
epigenome commonly requires restricting the number of analyzed samples due to resource lim-
itations. The second project of this thesis introduces the software tool SCIDDO, which has been
developed for the differential chromatin analysis of cellular samples with potentially limited avail-
ability. By combining statistics, algorithmics, and best practices for robust software development,
SCIDDO can quickly identify biologically meaningful regions of differential chromatin marking
between cell types. We demonstrate SCIDDO’s usefulness in an exemplary study in which we
identify regions that establish a link between chromatin and gene expression changes. SCIDDO’s
quantitative approach to differential chromatin analysis is user-customizable, providing the neces-
sary flexibility to adapt SCIDDO to specific research tasks.
Given the functional diversity of cell types and the dynamics of the epigenome in response to envi-
ronmental changes, it is hardly realistic to map the complete epigenome even for a single organism
vii
like human or mouse. For non-model organisms, e.g., cow, pig, or dog, epigenome data is partic-
ularly scarce. The third project of this thesis investigates to what extent bioinformatics methods
can compensate for the comparatively little effort that is invested in charting the epigenome of
non-model species. This study implements a large integrative analysis pipeline, including state-
of-the-art machine learning, to transfer chromatin data for predictive modeling between 13 species.
The evidence presented here indicates that a partial regulatory epigenetic signal is stably retained
even over millions of years of evolutionary distance between the considered species. This finding
suggests complementary and cost-effective ways for bioinformatics to contribute to comparative
epigenome analysis across species boundaries.
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Kurzfassung
Epigenetik ist das Teilgebiet der Biologie, welches vererbbare Faktoren untersucht, die die
Genexpression regulieren, ohne dabei direkt im Genom eines Organismus kodiert zu sein. Das
menschliche Genom liegt dicht gepackt im Zellkern in der Form von Chromatin vor. Bestimmte
Bestandteile des Chromatin spielen als epigenetische Faktoren eine zentrale Rolle bei der dynam-
ischen Regulation von Genexpression. Epigenetische Veränderungen auf Chromatinebene sind da-
her ein integraler Teil jener Mechanismen, die die Entwicklung von funktionell diversen Zelltypen
in multizellulären Spezies wie Mensch maßgeblich steuern. Diese Mechanismen zu untersuchen
ist nicht nur wichtig, um die Biologie von gesunden Zellen zu erklären, sondern auch, um den
epigenetischen Anteil an der Entstehung von vielen komplexen Krankheiten zu verstehen.
Moderne Labortechnologien erlauben es Wissenschaftlern, Epigenome mit hohem Durchsatz und
sehr detailliert zu erforschen. Ein schneller Aufbau von epigenetischen Datensätzen stellt die com-
puterbasierte Forschung vor die Herausforderung, schnell aufwendige Analysen durchzuführen,
ohne dabei Kompromisse bei der wissenschaftlichen Reproduzierbarkeit der gelieferten Ergebnisse
einzugehen. Um die computerbasierte reproduzierbare Forschung im Bereich der Epigenomik zu
vereinfachen, schlägt diese Dissertation ein aufgabenorientiertes Metadaten-Modell vor, welches,
aufbauend auf Internet- und Datenbanktechnologie, auf eine konsistente und gleichzeitig men-
schenlesbare Dokumentation für standardisierte computerbasierte Arbeitsabläufe abzielt. Das
vorgeschlagene Modell ermöglicht unter anderem eine computergestützte Validierung von Meta-
daten, automatische Fehlererkennung, sowie Fortschrittskontrollen bei mehrstufigen Analysen,
und wurde unter realen Bedingungen in einem epigenetischen Forschungskonsortium erfolgreich
getestet. Die beschriebene Arbeit präsentiert keine theoretischen Betrachtungen, sondern setzt den
Schwerpunkt auf die realistische Notwendigkeit, Forscher mit Werkzeugen auszustatten, die ihnen
bei der Durchführung von reproduzierbarer Arbeit helfen.
Unabhängig vom technologischen Fortschritt, erfordert die zellspezifische und dynamische Natur
des Epigenoms häufig eine Beschränkung bei der Anzahl an zu untersuchenden Proben, um
Ressourcenvorgaben einzuhalten. Das zweite Projekt dieser Arbeit stellt die Software SCIDDO
vor, welche für die differenzielle Analyse von Chromatindaten auch bei geringer Verfügbarkeit von
Zellproben entwickelt wurde. Durch die Kombination von Statistik, Algorithmik, und bewährten
Methoden zur robusten Software-Entwicklung, erlaubt es SCIDDO, schnell biologisch sinnvolle
Regionen zu identifizieren, die ein differenzielles Chromatinprofil zwischen Zelltypen aufzeigen.
Wir demonstrieren SCIDDOs Nutzwert in einer beispielhaften Studie, z.B. durch die Identifika-
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tion von Regionen, die eine Verbindung von Änderungen auf Chromatinebene und Genexpression
herstellen. SCIDDOs quantitativer Ansatz bei der differenziellen Analyse von Chromatindaten
erlaubt eine nutzer- und aufgabenspezifische Anpassung, was Flexibilität bei der Bearbeitung an-
derer Fragestellungen ermöglicht.
Bedingt durch die funktionelle Vielfalt an Zelltypen und die Dynamik des Epigenoms resultierend
aus Umgebungsveränderungen, ist es kaum realistisch, das komplette Epigenom von auch nur
einer einzigen Spezies wie Mensch zu erfassen. Insbesondere für nicht-Modellorganismen wie
Kuh, Schwein, oder Hund sind sehr wenig Epigenomdaten verfügbar. Das dritte Projekt dieser
Dissertation untersucht, inwieweit bioinformatische Methoden dazu verwendet werden könnten,
den vergleichsweise geringen Aufwand, welcher betrieben wird um das Epigenom von nicht-
Modellspezies zu erforschen, zu kompensieren. Diese Studie realisiert eine große, integrative
Computeranalyse, welche basierend auf Methoden des maschinellen Lernens und auf Transfer von
Chromatindaten Modelle zur Genexpressionsvorhersage über Speziesgrenzen hinweg etabliert.
Die gewonnenen Erkenntnisse lassen vermuten, dass ein Teil des regulatorischen epigenetis-
chen Signals auch über Millionen von Jahren an evolutionärer Distanz zwischen den 13 betra-
chteten Spezies stabil erhalten bleibt. Diese Arbeit zeigt dadurch ergänzende und kosteneffektive
Möglichkeiten auf, wie Bioinformatik einen Beitrag zur vergleichenden Epigenomanalyse über
Speziesgrenzen hinweg leisten könnte.
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1CHAPTER 1
Introducࢢon
Lead-in This chapter is written as a gentle introduction into the central topics of this thesis. The
depth of this chapter is thus intentionally limited. The remaining chapters present more detailed
background information, which permits to focus here on selected examples. Readers already famil-
iar with scientific work in biological research can probably skip the first two sections and proceed
directly to the thesis outline without missing vital pieces of information.
1.1 Comparaࢢve Observaࢢon and Reproducibility by Example
Arguably one of the biggest leaps forward in the field of biology was initiated by Charles
Darwin’s “On the Origin of Species” [54]. In his seminal work, Darwin argues that biological
complexity develops gradually over time, and species do not come into existence by independent
creation, but by successively acquiring new traits or losing old ones relative to their ancestral
generation(s). This process, free of any planning or foresight, is driven by natural selection of
advantageous — as opposed to deleterious — variants of biological characteristics, and results
in species that are well-adapted to their ecological niche. Darwin’s elegant model explaining
observed biological variation as an evolutionary process driven by natural selection also builds
on two core concepts of scientific work, both of which are central to the work presented in this
thesis: comparative observation and scientific reproducibility.
Comparative observation, i.e., examining similarities and differences between different
subjects under study, represents a common approach toward viewing the world with a scientific
mindset. Although Darwin was of course not the first naturalist to keenly observe life around him,
he made the important next step of formulating a complete and biologically plausible hypothesis
why certain similarities exist in visibly distinct animal species. A common textbook example for
such an observed similarity is the forelimb of many vertebrate species that all share the same,
so-called tetrapod, bone structure (Figure 1.1) [253]. According to Darwin’s theory of evolution,
these different forms of the same basic layout developed from a common ancestor by natural
selection of those naturally occurring variants that provided an advantage in the struggle for
reproduction. The tetrapod bone structure in the forelimb is called a homologous trait, i.e., a trait
that has developed from a common ancestor in the respective vertebrate species.
Roughly 100 years after Darwin shared his theory of evolution with the public, technological
2advances enabled scientists to explore the molecular aspects of biology and to reason about
the presumed universality of the genetic code [130]. A universal1 genetic code implies, under
Darwin’s theory of evolution, that there should be a last universal common ancestor (LUCA)
from which all living organisms on this planet originated. From that, it immediately follows that
genome sequences can be homologous in nature in the same way as, e.g., the bone structure in
vertebrate forelimbs. This realization gave rise to the field of comparative genomics, i.e., the field
that studies similarities and differences of genomic features across organisms. The experimental
methods in comparative genomics have probably nothing in common with those of Darwin’s era,
yet the concept of learning through comparative studies still applies and is the approach taken in
Chapters 4 and 5 of this thesis.
Figure 1.1: The tetrapod bone structure in vertebrates: similar bone structure in the forelimbs
of several tetrapod vertebrate species exemplifies the evolutionary principle of gradual modifica-
tion of a trait that emerged in a common ancestor. Functional necessity cannot explain the observed
similarities given the different purposes of the forelimbs, e.g., swimming and flying. The tetrapod
bone structure is a homologous trait in the respective vertebrate species (license #4432540824975,
see Table E.1).
The second concept is essential to the “scientific survival” of Darwin’s theory and is implicitly
given in the following statement:
“If it could be demonstrated that any complex organ existed, which could not possibly
have been formed by numerous, successive, slight modifications, my theory would
absolutely break down. But I can find out no such case.”
(cf. Chapter 6 “Difficulties On Theory - Organs of extreme perfection”)
What Darwin is referring to here is the problem that he cannot prove his theory of evolution to
be true, but as long as no contradicting evidence is presented, one can think of the theory as “not
false”. In more general terms, any scientific hypothesis must be independently testable or withstand
a re-examination by third parties. If such independent testing achieves the same (observational)
1A recent publication describes an exception to this universality of the genetic code [168]. For the sake of brevity,
this will not be discussed here.
3conclusions as originally reported, the hypothesis is less likely to be a result of, e.g., chance ob-
servations. This line of thinking is central to the concept of scientific reproducibility that will be
discussed in more detail in Chapter 3. The fact that, to this day, Darwin’s theory of evolution is
considered valid means that not only could Darwin himself not find a counterexample, but also that
nobody else could. In other words, in the approximately 160 years since Darwin published “On
the Origin of Species”, no conclusive evidence could be collected that would allow to refute Dar-
win’s theory. This long-lasting accumulation of evidence in favor of the theory could explain why
Darwin’s theory of evolution is commonly (mis-) represented as an absolute truth in mainstream
media; from an epistemological point of view, this is not correct, but it seems plausible to assume
that any scientist would like to see their hypotheses advance to that level of perceived certainty. In
a broader sense, and as will be argued in Chapter 3, progress in a scientific field requires a repro-
ducible basis of knowledge — first principles perceived as “known to be true” — as starting point
for future studies.
1.2 High-Throughput Biology and Epigeneࢢcs
Jumping forward from the early days of comparative genomics in the second half of the 20th
century to the turn of the millenium, a breakthrough was achieved through the sequencing of the
human genome, with a first draft sequence publicly released almost 20 years ago [50, 136, 247].
This achievement had many implications, of which two shall be mentioned in the context of this
thesis. First, knowing the sequence of the human genome enables scientists to identify genomic
sequence homology relative to other species, thereby illuminating the traces of evolution in our
genome:
“More generally, comparative genomics allows biologists to peruse evolution’s lab-
oratory notebook — to identify conserved functional features and recognize new in-
novations in specific lineages. [...] Plans are also under consideration for sequencing
additional primates and other organisms that will help define key developments along
the vertebrate and non-vertebrate lineages. To realize the full promise of compara-
tive genomics, however, it needs to become simple and inexpensive to sequence the
genome of any organism.”
(Lander et al. [136])
The latter point about economic limitations is no longer a major issue for large-scale sequencing
projects due to the rise of comparatively cheap and scalable technologies collectively referred to
as next–generation sequencing (NGS) or high-throughput sequencing (HTS) technologies [163].
This technological advance also fuels large scientific projects with the objective of sequencing
thousands of different animal species [128]. Hence, scientists in (comparative) genomics are now
at a point where they can create large sequence databases for a multitude of different species. This
recent development has enabled cross-species studies such as the one presented in Chapter 5 of
this thesis.
4The second implication of the completed human genome sequence is much more far-reaching,
but it is also much harder to assess its potential impact on biological and biomedical research:
“In principle, the string of genetic bits (note: the sequenced genome) holds long-
sought secrets of human development, physiology and medicine. [...] Fulfilling the
true promise of the Human Genome Project will be the work of tens of thousands of
scientists around the world, in both academia and industry. [...] The scientific work
will have profound long-term consequences for medicine, leading to the elucidation
of the underlying molecular mechanisms of disease and thereby facilitating the design
in many cases of rational diagnostics and therapeutics targeted at those mechanisms.
[...] We must set realistic expectations that the most important benefits will not be
reaped overnight.”
(Lander et al. [136])
Though it would be an absurd question to ask how long it will take until the above mentioned
benefits, especially in the area of medicine, are realized, it seems safe to say that “20 years” would
not have been the right answer. To illustrate that point, one might consider the exemplary case of
cancer. Substantial progress in diagnosis and treatment has been made for certain types of cancer
also as a consequence of advances in modern genomics, yet cancer is far from being generally
understood and “under control”, i.e., despite increasing survival rates, cancer is still among the
leading causes of death worldwide [93, 94]2. One important aspect to the question why knowing
the human genome is not enough to, e.g., cure diseases such as cancer, is within the reach of
basic biology: the genome exists essentially in form of identical copies in almost every cell of the
body, since, at the beginning of human life, there is only a single fertilized egg. All other cells
in the human body ultimately derive their copy of the genome from this ancestral cell. It seems
compelling that there has to be a process that controls how hundreds of different cell types in the
human body can be created from a single starting point. The field investigating these processes
is called epigenetics. The founding father of epigenetics, Conrad H. Waddington, described it as
“the branch of biology which studies the causal interactions between genes and their products,
which bring the phenotype into being” (quoted after Goldberg et al. [89]). A more contemporary
definition of epigenetics is given by Goldberg et al. as follows: “[...] epigenetics may be defined
as the study of any potentially stable and, ideally, heritable change in gene expression or cellular
phenotype that occurs without changes in Watson-Crick base-pairing of DNA”3. In other words,
epigeneticists study how the information in our genome is turned into functionally different cell
types, and what deviations from normal regulation constitute a disease state, e.g., as observed in
many cancers [74, 114].
Although Conrad H. Waddington coined the term epigenetics decades ago, and its relevance
for the development of the cellular phenotype is no recent discovery, the fact that so many
different and dynamic factors contribute to the epigenome of a cell prohibited larger epigenome
2cancer.gov/about-cancer/understanding/statistics
3This thesis does not elaborate on different standpoints regarding a “precise” definition of epigenetics. Sec-
tion 2.1.1.5 in Chapter 2 is the only part of this thesis where a definition of epigenetics emphasizing the heritability
is relevant. Some literature references discussing issues on the definition and use of the term epigenetics are thus in-
cluded in Section 2.1.1.5.
5studies until the advent of cheap and scalable NGS technologies. In that sense, (high-throughput)
epigenomics is still an emerging field that faces many fundamental challenges, e.g., establishing
experimental protocols, defining data standards, or developing common vocabulary. Such tasks
are rather technical in nature, but they are needed to provide the proper footing for future studies.
Despite technicalities that need to be addressed, research in epigenomics holds great potential for
advancing both basic research and more applied fields such as biomedicine [7, 23, 27, 89, 179, 198].
In the sections above, the anchoring points of this thesis have been introduced with some his-
torical pointers: scientific reproducibility and comparative analyses in the field of (epi-) genomics.
The following section now provides a detailed outline of the remainder of this thesis, and summa-
rizes central points and research directions of each chapter.
1.3 Research Direcࢢons and Outline of this Thesis
In Chapter 2, the biological and computational background is introduced. This background
information focuses on the part of epigenomics and bioinformatic data processing that is required
as basic knowledge for the three methodological chapters 3, 4, and 5. Each of these chapters in
turn includes a section that details chapter-specific data and method information.
Chapter 3 deals with the question of how scientific reproducibility can be practically integrated
into the research routines of large collaborative projects, which are a prevalent organizational form
in modern biological research [56, 106, 136, 202, 233]. Issues with scientific reproducibility are
an area of active debate [4, 73, 171, 172, 192], and large research initiatives, with their substantial
economic and scientific means, hold the role of key players in terms of setting experimental
standards. Hence, research initiatives also carry part of the responsibility to consolidate work in
emerging fields such as epigenomics. Any work supporting efforts of conducting research in a
reproducible way is thus an important contribution to the overall level of quality in a research
project.
Specifically, the approaches presented in Chapter 3 were prototypically developed and field-tested
as part of the German epigenome programme (Deutsches Epigenom Programm [48] (DEEP)).
The work in Chapter 3 starts with a brief introduction on scientific reproducibility and a summary
of several current approaches of how scientific work is conducted in a reproducible way. Based
on this background, the strategies and the software tools combining web technology and databases
that were developed in DEEP are described. The evaluation part of Chapter 3 highlights the
advantages of the implemented approach and discusses several observed shortcomings. Chapter 3
concludes with an empirically motivated attempt to derive some modest principles from the lessons
learned in DEEP that could be implemented in the future to gradually improve reproducibility
rates in computational research.
The next two chapters rely conceptually on the foundations of Chapter 3. Assuming that data
generation and basic data processing are established in reproducible ways, computational research
projects can turn to more biology-oriented questions.
6The central question of Chapter 4 is if it is possible to identify genomic regions that show
a distinct epigenetic profile between different cell types within one species. The type of data
analyzed in Chapter 4 is an abstract representation of an epigenetic signal that has been shown to
provide a rich view on regulatory processes in the cell [29, 72, 119, 205]. In the affirmative case,
the identified regions could thus be specific for the respective cellular phenotype if the regions
could additionally be shown to be biologically plausible and meaningful. The software SCIDDO
has been developed to tackle the question of Chapter 4 by combining statistical evaluation
procedures with fast algorithms in a lightweight command line tool. In the case study presented
in Chapter 4, SCIDDO could identify such regions in a medium-sized real-world dataset within
minutes. The further biological characterization of the identified regions provides evidence
that the epigenetic profile in these regions conforms to the current understanding of epigenetic
regulation in cellular processes, e.g., changes on the chromatin level can be linked to changes in
gene expression patterns. SCIDDO is the first software that implements a score-based approach
for the identification of the genomic regions of interest. This score-based approach provides a
flexible and user-customizable way of emphasizing different aspects of epigenetic regulation.
Biological plausibility of the identified regions, processing speed and flexibility of SCIDDO let
us conclude that SCIDDO is a valid contribution to the bioinformatics toolbox in computational
epigenomics research.
Chapter 5 presents an exploratory study that extends epigenome-based comparative analyses
to non-model vertebrate species. The work in Chapter 5 explores if it is possible to transfer
knowledge acquired in epigenetically well-characterized animals such as human or mouse to other
species that are not canonical model organisms, and hence have a largely uncharted epigenome.
As opposed to the analytical setting in Chapter 4, which builds on abundant epigenome datasets
in human and thus can rely on an abstract representation of biological information, the idea
of Chapter 5 is motivated by the problem that epigenomics is a resource-intensive field of
biology. Consequently, only comparatively few and hardly comprehensive epigenome resources
exist for animal species that are not established model organisms for epigenomics research.
However, factors such as the economic value of species like cow and pig, or the potential
medical value of vertebrate species having an exceptionally low incidence rate of diseases
such as cancer [91, 120, 246] make cross-species studies involving non-model organisms a
worthwhile endeavor. The entire approach in Chapter 5 is performed in silico and sidesteps
any wet lab resource limitations. The results indicate that it is possible to transfer epigenetic
data across species boundaries and still retain sufficient information to perform predictive
modeling on the transferred data using common machine learning tools. In Chapter 5, the
machine learning-based prediction of cellular characteristics across evolutionary distances of
more than 300 million years is demonstrated to be possible with acceptable accuracy. Hence,
this study transcends the idea of comparative observation by testing if observations can, at least
partially, be replaced with computational estimates. The principle validity of this approach rests
on the already described insight that shared ancestry of organisms should result in some discov-
erable similarities; in the context of Chapter 5, these presumed similarities are epigenetic in nature.
7This thesis concludes with Chapter 6, which summarizes and interrelates the three method-
ological chapters outlined above and discusses potential future work. Chapter 6 does not, however,
reiterate the concluding remarks of Chapter 3 (Section 3.6), but highlights some aspects of ongoing
collaborative research efforts in the field of epigenomics that fit the context of Chapter 3.
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Background
Lead-in This chapter provides a general overview of epigenetics with a focus on histone proteins
and their role in regulation of cellular processes. This chapter ends with a description of how the
biological histone signal is translated into computer-readable information, and then processed in
bioinformatics pipelines as implemented by many national and international research consortia.
This standardized way of processing histone data is relevant in the context of Chapter 3. In Chap-
ters 4 and 5, histone data are used as mere input to bioinformatics analyses, and thus the discussion
of potential sources of noise presented in Section 2.3.1 is of implicit importance in these chapters.
2.1 (Epi-) Geneࢢcs and Chromaࢢn
The biological concepts discussed in this chapter require some basic knowledge in genetics
for easy comprehension. The next paragraph introduces these definitions in a non-exhaustive
manner focusing on the aspects relevant for this thesis:
As highlighted in Chapter 1, one of the central questions that is studied in epigenetics is how
fine-tuned epigenetic regulation contributes to the development of the functionally diverse cell
types in multicellular species such as human. “Epigenetic regulation” refers to the processes
that modulate the transcriptional or regulatory state in confined regions of the genome. This
modulation can be thought of as either absolute, e.g., switching from an inactivate to an active
state, or as gradual, e.g., increasing or decreasing local activity levels. Transcription usually refers
to the transcription of deoxyribonucleic acid (DNA) into ribonucleic acid (RNA) in a genomic
region that represents the locus of a protein-coding gene. Since a precise definition of what a
gene is, seems to be elusive [85], a “working definition” of a protein-coding gene is sufficient
here: a gene is a heritable DNA segment that codes for at least one protein and that is associated
with “regulatory regions”. These regulatory regions are important, e.g., for gene activation and
initiation of transcription (“gene promoter”), or for the regulation of the gene’s activity level
(“gene-associated enhancer”). The activity of a gene is usually quantified as the gene expression
level, where expression refers here to the process of transcribing the nucleotide sequence of a
gene into messenger RNA.
9Following the main topics of this thesis, the description of epigenetic factors and their role in
regulation given below focuses on the normal or healthy cellular condition; detailed descriptions
of aberrant patterns of epigenetic regulation, e.g., related to disease phenotypes, are omitted.
RNA-mediated ways of epigenetic transcriptional control and RNA constituents of chromatin are
not covered as they are not relevant for the following chapters.
The name “chromatin” was coined by Walther Flemming in the late 19th century when he re-
alized that the scaffold inside a cell’s nucleus could easily be stained (chroma is Greek for color;
chromatin can thus be translated to “stainable material”) [181]. The related term “chromosome”
was introduced around 10 years later by Heinrich Wilhelm Waldeyer, and translates to “stainable
body”, i.e., a constituent component of chromatin [181]. In more recent literature, chromatin was
described as consisting of DNA, RNA and proteins, and the term refers collectively to all chro-
mosomes [167]. The realization that “[i]n such chromatin, only a portion of the genetic material
is available for transcription by RNA polymerase, and the genes thus accessible are the same ones
that are accessible and transcribed in life” [30] is immediately suggestive of one of the major char-
acteristics of chromatin: while chromatin can be considered a “packaging scaffold” to fit the ap-
proximately two meters of DNA inside the cell’s nucleus, chromatin also has to be locally flexible
enough to expose certain parts of the genome, e.g., to enable proper gene transcription. These two
states of chromatin — open and accessible or closed and inaccessible — are called euchromatin
(open) and heterochromatin (closed). The flexibility to change from heterochromatin to euchro-
matin in confined regions of the genome is possible due to the hierarchical structure of chromatin.
At the basic level, approximately 150 base pairs (bp) of DNA are wrapped around histone proteins
and this complex of DNA and histone proteins is called a nucleosome. The serial arrangement
of nucleosomes along the genome is commonly referred to as the “beads on a string” model (see
Figure 2.1, second row), and more and more stages of twisting and coiling eventually result in the
necessary level of compaction to fit the DNA into the nucleus (Figure 2.1, top to bottom). While
it may appear that the structure of chromatin is highly organized, the recent characterization of
so-called nucleosome clutches by Ricci et al. suggests otherwise [204]. Ricci et al. defined nu-
cleosome clutches as groups of nucleosomes that show variation in size and density in a cell-type
specific manner. This high-level view on chromatin organization hints at an additional layer of
detectable cell-type specificity that, for the sake of brevity, will not be discussed here. Instead, the
following section focuses on the histone proteins.
2.1.1 Histone proteins and nucleosomes
Histone proteins are divided into two super families and five subordinate families: the linker
histone family H1, and the four core histone families H2A, H2B, H3 and H4. Two members of each
core family build the octamer core of a nucleosome (Figure 2.2) [151], whereas the H1 histones
attach to the linker DNA that connects adjacent nucleosomes (cf. Figure 2.1, second row). There
is a considerable number of histone variants in each family, and the occurrence of many of these
variants has been linked to, e.g., specific phases of the cell cycle, to certain eukaryotic lineages, or
to disease phenotypes [159, 234, 235]. In the context of this work, histone variants are not relevant
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Nucleosome
Linker DNA
Figure 2.1: Packaging of DNA in chromatin: chromatin organization inside the cell’s nucleus
has a hierarchical order, starting with individual nucleosomes separated by short stretches of linker
DNA (second row); the linker histone H1 bound to the linker DNA is not shown. Precise chromatin
organization beyond the 11 nanometer (nm) fiber (“beads on a string” model) is still an area of
active research [204] (license #4407631152362, see Table E.1; labels “Nucleosome” and “Linker
DNA” and corresponding arrows were manually edited into the figure).
and it suffices to note that histone variants represent a source of epigenetic variation in addition to
those discussed in this chapter (in particular Section 2.1.1.4).
The four core histones are small proteins (~100 to ~135 amino acids) that have three α-helical
domains and an unstructured N-terminal domain, referred to as histone tail [151]. The individual
amino acids of a histone protein are identified by their position relative to the N-terminus, e.g.,
the first lysine of histone 3 is located at position 4, and hence identified by the shorthand notation
“H3K4”. This shorthand notation is used throughout the remainder of this thesis. When a H3-H4
tetramer and two H2A-H2B dimers are assembled to form the octameric core of a nucleosome, the
histone tails protrude from the center of the nucleosome and are amenable to chemical modifica-
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tions by other enzymes (Figure 2.2); the role of these post-translational modifications is discussed
in Section 2.1.1.4. As pointed out above, the spatial organization of nucleosomes is not necessar-
ily rigid, implying that nucleosome formation, at least at certain genomic locations, has to be a
regulated process with some discernible specificity.
Figure 2.2: Ribbon traces of the nucleosome core particle showing 146 bp of the DNA backbone
and the four core histone proteins (blue: H3; green: H4; yellow: H2A; red: H2B). The histone
tails visibly protrude from the core and are thus accessible for other enzymes that bind or modify
individual residues (see Section 2.1.1.4 below; license #4407621492444, see Table E.1).
2.1.1.1 Histone deposiࢢon and nucleosome formaࢢon
Before some principles of nucleosome formation are introduced, it is helpful to elucidate two
related terms that are often used interchangeably and lack a community-wide accepted standard
definition [223]: nucleosome positioning and nucleosome occupancy. Nucleosome positioning
refers to the position of a nucleosome along the genome sequence. A “highly positioned” or
“strongly positioned” nucleosome could in principle be identified by its “sequence coordinates”,
i.e., the combination of nucleotide position(s) and chromosome number. Instead, relative
nucleosome coordinates are commonly used. For example, the strongly positioned nucleosome
immediately downstream of the transcription start site (TSS) is conventionally identified as the
“+1” nucleosome. The number of strongly positioned nucleosomes has been reported to be around
10%, with many more nucleosomes showing at least a tendency toward consistent genomic
positions [82].
Nucleosome occupancy, on the other hand, refers to the presence or absence of a nucleosome in
specific sequence contexts. For example, when we examine a stretch of DNA that has a strongly
positioned nucleosome and a high occupancy, we would expect to find a nucleosome at exactly
this location every time we examine the same stretch of DNA again. However, if the occupancy
were low, we can only say that, if we find a nucleosome, it will be located at exactly the same
position. This consideration is relevant for the interpretation of the high-throughput assays
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introduced in Section 2.2, where the biological material for an experiment is not just a single cell,
but a large quantity of functionally homogeneous cells.
The process of nucleosome formation requires the stepwise assembly and deposition of the
H3-H4 tetramer or of H2A-H2B dimers onto the DNA, resulting in pre- or immature nucleosomes.
These nucleosome building blocks are delivered by histone chaperones such as CAF1, which are
broadly conserved throughout the eukaryotic lineage, but the process of initial assembly is not
yet understood in all details [158]. Another class of proteins, so-called chromatin remodelers,
are responsible for finalizing histone core assembly and for creating regularly spaced, mature nu-
cleosomes [44]. Nucleosome assembly is a process that directly follows DNA replication (see
also Section 2.1.1.5) and, in this context, it may not seem obvious why nucleosome positioning
would have to be regulated, since the information is essentially just copied. However, given the
observation of strongly and weakly positioned nucleosomes and of nucleosome mobility (Sec-
tion 2.1.1.2), the existence of factors determining nucleosome positions seems compelling. It is
generally assumed that there is some sequence preference, motivated by the fact that the DNA bend-
ing around the histone core favors periodic occurrences of certain dinucleotides for their physical
properties [151]. Moreover, the characterization of sequences — most notably the Widom 601
sequence [148] — exhibiting a strong nucleosome positioning effect (in vitro) similarly suggested
a sequence-dependent positioning process. However, it seems implausible that predicting (all) nu-
cleosome positions from sequence alone would be reasonable for functionally diverse cell types
in multicellular organisms, as the predictions would necessarily be tissue-independent and could
thus not capture the observed flexibility in nucleosome positioning/occupancy. Nevertheless, some
studies suggest that sequence-based (prediction) models could be helpful for better characterizing
the role of sequence effects relative to other factors (e.g., [86, 245]). More comprehensive but
abstract models of nucleosome positioning and occupancy also consider factors like the local reg-
ulatory environment, higher order chromatin structure, and the effect of potentially competitive
binding by transcription factors (TFs) [223]. Under these conditions, nucleosomes may be placed
or moved into sequence contexts with unfavorable physical properties, which is only possible be-
cause other factors compensate for this unfavorable sequence context. Despite the existence of
strongly positioned nucleosomes, it seems reasonable to view nucleosomes as rather dynamic en-
tities, in particular during important cellular processes such as gene transcription.
2.1.1.2 Nucleosome mobility
The passage of the transcriptional machinery along the gene body is occluded by nucleosomes
that are particularly well-positioned in exons [9]. There are at least two obvious solutions to this
problem: the nucleosomes have to be either disassembled (sometimes referred to as disruption
or eviction) and reassembled after the transcriptional machinery has passed, or the tight contact
between the DNA and the histone core has to be relaxed to make the DNA accessible for the tran-
scriptional machinery. The observation that the canonical H3 histone variant is replaced by the
variant H3.3 in transcribed genes provided supporting evidence for the first solution [260]. Since
H3.3 is not produced in the synthesis phase of the cell cycle when DNA is replicated, and thus could
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not have been incorporated into the histone core of the nucleosome as described in Section 2.1.1.1,
it is assumed that some nucleosomes are indeed completely disrupted and reassembled during tran-
scription.
The second way of making the DNA accessible involves only partial disassembly of nucleosomes.
The FACT (for “facilitates chromatin transcription”) complex has been shown to displace H2A-
H2B dimers of the histone core, which destabilizes the nucleosome and makes the DNA accessible
enough for the transcriptional machinery to proceed [16, 17]. Besides this partially disruptive pro-
cess, chromatin remodeling complexes can also “slide” nucleosomes along the DNA following
the so-called “wave-ratchet-wave” model [44, 95, 209]. In this model, a chromatin remodeling
complex binds to the nucleosomal DNA at a specific location, and pulls in DNA from one side of
the nucleosome, locally breaking histone-DNA contacts and forming a small bulge of DNA. The
resulting tension in the DNA is released by propagating the DNA bulge toward the other end of
the nucleosome in a wave-like fashion at a step size of around 1–2 bp.
Whereas the preceding paragraph deals with mechanisms that restore the local chromatin envi-
ronment after a temporary alteration, the next section exemplifies cellular processes that remove
nucleosomes permanently.
2.1.1.3 Nucleosome evicࢢon
In scenarios in which the local chromatin environment is in closed conformation and needs
to be accessible, e.g., when a gene is activated and the promoter region has to be opened to en-
able transcriptional initiation, a complete removal of specific nucleosomes has been observed. In
this case, additional signals are required to trigger the eviction process, e.g., initiated by TF bind-
ing [140, 260]. To give an example, one of those TFs is the acetyl transferase EP300 (p300),
which acetylates lysine 14 of histone H3 (H3K14), leading to subsequent destabilization and evic-
tion of the modified nucleosome by the histone chaperone Nap1 [150]. This process opens some
space in the promoter region and enables transcriptional initiation. A similar destabilizing effect
of histone acetylation has been reported by Chatterjee et al. [40], who observed that nucleosomes
with an acetylated histone H3 (lysines at position 115 and 122) have a higher predisposition of
being disassembled by chromatin remodeling complexes. Another mechanism specifically de-
posits nucleosomes carrying the histone variant H2A.Z in promoters of inactive genes. Whereas
these nucleosomes are rather resistant against chromatin remodeling, they are removed quickly
upon transcriptional activation due to their lower stability compared to nucleosomes with canoni-
cal H2A [140].
It should be pointed out that nucleosome eviction in the context of transcriptional activation does
not lead to promoters that are entirely devoid of nucleosomes. As a consequence, gene promoters
— and other regulatory elements in the genome — are amenable to basic classification schemes
based on histone post-translational modifications that commonly occur in the respective regulatory
contexts.
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2.1.1.4 Histone post-translaࢢonal modiﬁcaࢢons
Histone proteins can be post-translationally modified by chromatin modifying enzymes (not
to be confused with chromatin remodeling enzymes). The two chemical modifications, histone
marks for short, that are important in the context of this work are acetylation and methylation of
lysine residues; other modifications will not be discussed here [132]. The enzymes facilitating
post-translational modification of histone residues, i.e., lysine methyltransferase (KMT), lysine
demethylase (KDM), lysine acetyltransferase (KAT) and histone deacetylase (HDAC) [6], plus
those enzymes that bind to modified residues are often collectively referred to has “readers” and
“writers/erasers” of histone marks, presumably motivated by the notion of a “histone code” [110].
The histone code hypothesis builds on the following line of thought: histone marks, or rather
combinations of them, constitute recognition sites for other chromatin-associated proteins with
potentially synergistic or antagonistic effects. These other chromatin-associated proteins in turn
regulate changes in genomic activity levels, e.g., switching from silent to transcriptionally active
chromatin states. Hence, the histone code hypothesis postulates that the combinatorial space of
all histone marks extends the information encoded by the sequence of nucleotides in the genome.
Large-scale studies of dozens of histone acetylation and methylation marks identified a core
set of 17 histone marks that seem to be more or less ubiquitously present in promoter regions
of transcribed genes, suggesting that there could be a histone signal strictly indicating active
transcription [255]. However, in the same study, approximately 75% of all detected combinations
of histone marks were only present at one gene each. While these numbers cannot be taken
at face value, as Wang et al. also noted, due to noise in the data, they seem to suggest that, if
there is a histone code, it would probably be quite challenging to clearly identify distinct “code
words”. Taking this unresolved state of the histone code into account, and because “reading” and
“writing” histone marks provokes associations of language and interpretation, histone-modifying
enzymes (HMEs) will not be referred to as “readers” and “writers/erasers” in the remainder of
this thesis. Instead, those enzymes that set or remove a chemical modification will be referred to
as HMEs, and those enzymes that have a recognition domain for specific marks will be referred
to as histone-binding domain enzymes (HBDEs).
Current literature lists more than one hundred different histone marks and reports on their
functional role implicating them in a large variety of regulatory processes [123, 132]. To limit
the complexity, it is common to focus on a set of “core marks” that are broadly representative of
many important chromatin activity levels ranging from, e.g., repressed genes, to active enhancers,
or regions of heterochromatin. In the context of the International Human Epigenome Consor-
tium [233] (IHEC), this core set comprises six histone marks that have a canonical functional
interpretation usually restricted to individual marks or to combinations of at most two (Table 2.1).
This set of core marks (or a subset thereof) represents the chromatin marking relevant in all
remaining chapters of this thesis.
While most of the functional annotation of the individual histone marks is straightforward, e.g.,
H3K4me3 marking active promoter regions, others such as so-called “bivalent domains” or
“poised” promoter or enhancer states demand some clarification. Initially, the term “bivalent
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domain” was introduced by Bernstein et al. to describe the observation that genes encoding
developmentally important TFs show a distinct promoter chromatin signature in embryonic stem
cells [22]. This chromatin signature consists of the two marks H3K4me3 and H3K27me3, and
genes in this poised state show a low expression level despite the presence of H3K4me3 at the
promoter region (cf. Table 2.1). Bernstein et al. hypothesized that these genes are kept in a state
that allows for rapid activation upon suitable signaling. The existence of bivalent domains was
also confirmed by Rugg-Gunn et al., who additionally described bivalent domains marked by the
combination H3K4me3 and H3K9me3 [207]. Other studies extended the investigation of similar
patterns of chromatin marking to enhancer elements, which established the notion of poised (or
sometimes also bivalent) enhancers. In the case of poised enhancers, the chromatin signature
is not reported consistently, either only referring to H3K4me1 and no H3K27ac marking [52],
or to both H3K4me1 and H3K27me3 marking without H3K27ac being present at the enhancer
element [197, 265]; in both cases, the presence of H3K27ac was reported to indicate an active
state of the enhancer. Considerations involving two (or more) individual histone marks should
always be taken with a grain of salt since the common way of identifying such bivalent domains
amounts to overlaying the data of the individual histone marks and identifying co-occurrences.
Customized assays that probe the same biological material sequentially for different histone
marks (“reChIP”) showed that the common naïve way of identifying bivalent domains lacks
sensitivity and thus results in an incomplete characterization of bivalent domains [126]. Another
aspect complicating the functional interpretation of histone marks lies in the symmetry of the
histone core. The canonical way of looking at histone marks would suggest that, e.g., lysine 4 is
either mono- or trimethylated (cf. Table 2.1), but not both because it is the same residue. This
view neglects that there are two H3 N-terminal tails per nucleosome that can be asymmetrically
modified [251]. In summary, the canonical functional interpretation of a limited set of core marks
has been shown to be valuable to characterize the histone component of the epigenetic landscape
in many important regulatory contexts.
The above sections summarize the importance of nucleosomes and of histone marks as com-
ponents of various regulatory processes and highlight the flexibility inherent to many of these
processes. It is thus a natural question to ask how this regulatory program is safely transmitted in
its entirety from one generation to the next.
2.1.1.5 Epigeneࢢc inheritance: are histones epigeneࢢc factors?
Classifying (modified) histones as core components of the epigenome can be questioned on
the ground of their unclear heritability. Depending on the emphasis of the heritable factor and its
meaning, e.g., just across cell divisions (“mitotic inheritance”) or between generations (“meiotic
inheritance”), histones may fall short to meet definitions of epigenetics that emphasize the heri-
tability of epigenetic factors (cf. footnote on page 4, Section 1.2) [55, 193, 194]. As exemplified
in Sections 2.1.1.2 and 2.1.1.3, nucleosome positions are not necessarily fixed depending on the
local chromatin context or on cellular processes like DNA replication and transcription. Chromatin
remodeling enzymes may move or disassemble nucleosomes, which already creates the difficulty
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Table 2.1: Core histone marks as defined within IHEC
Histone mark(s) Canonical functional annotation
H3K27ac active enhancer [52], active promoter [255]
H3K27me3 polycomb-mediated silencing [12, 221]
H3K36me3 active transcription, elongation [12]
H3K4me1 (poised) enhancer [52, 101]
H3K4me3 active promoter [12]
H3K9me3 heterochromatin [12]
H3K4me3 &
H3K27me3
bivalent promoters [22, 252]
H3K4me1 &
H3K27me3
bivalent enhancers [197]
of identifying the nucleosome that is assumed to carry the heritable information; a problem that is
essentially absent in the world of DNA methylation1. This consideration also immediately hints
at the other central problem: all histone proteins of the same type or variant are identical from a
biochemical point of view. Hence, it seems compelling that chromatin modifying or remodeling
enzymes need additional information — not represented by the histones themselves — to target
the correct histones in the appropriate genomic context.
A more realistic view could be to consider the local chromatin state as the heritable epigenetic
information, which would only require propagation of a “sufficient” chromatin signal to allow for
re-establishment of the correct regulatory chromatin state. In the case of DNA replication, the
“random model” and the “semi-conservative model” of histone propagation have been developed
to describe this process [156]. Both models assume that nucleosome disassembly prior to DNA
replication is followed by reassembly of new nucleosomes that consist, at least partially, of old
histone H3-H4 components; these components are either distributed randomly or, as dimers or
tetramers, are deposited in roughly equal proportions to the newly synthesized strand. The latter
model may sound attractive in its simplicity, but it would require a process precisely regulating
histone deposition in the wake of DNA replication. In the random model, however, the chromatin
signal may be diluted and the transmission of the epigenetic state would thus be imprecise, but
potentially sufficient. Besides this more or less direct transfer of the chromatin marking, other
reports in the literature describe a propagation of the histone marks H3K4me3 and H3K27me3
during DNA replication via complete de novo marking by the respective HMEs [187]. Though the
study by Petruk et al. [187] was conducted in fly embryos and is not directly applicable to verte-
brate species such as human, it highlights the important role of HMEs as part of the (epigenetic)
1It is common to refer to individual methylation sites either by their genomic position (sequencing-based assays),
or by an identifier that can be mapped back to a genomic position (array-based assays); personal communication with
Michael Scherer.
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inheritance process across cell divisions.
Elucidating the mechanisms that regulate epigenetic inheritance, especially on the chromatin level,
is an ongoing endeavor, but the existing evidence seems to suggest that the combination of his-
tone marks, histone modifying and chromatin remodeling enzymes is essential to stably propagate
the cellular phenotype [38, 156]. Based on this more holistic view, histone marks are considered
epigenetic factors in this thesis.
2.1.2 Non-histone proteins
Besides histone proteins, the protein family of TFs is a key player in gene regulation, which
also includes the already mentioned HMEs, HBDEs and chromatin remodelers. By convention,
TFs are usually not considered epigenetic, but as exemplified in Section 2.1.1.5, strict definitions
of what an epigenetic factor is and is not may be premature given the pace of discoveries in the field
of epigenetics. Upon activation, TFs bind to regulatory elements such as enhancers or promoters,
thereby promoting access to the DNA and facilitating the recruitment of other factors, especially in
the context of transcriptional initiation [125, 178]. It was already pointed out that TFs belonging
to the group of HME can alter the local chromatin state, e.g., the KAT EP300. It is thus not
unexpected that the presence of certain histone marks can be accurately predicted from TF binding
data [21]. This relationship has also led to the realization that, within certain limits, TF binding data
and histone marks are statistically redundant for the predictive modeling of gene expression [34].
Similarly, the identification of regulatory elements is also possible in a tissue-specific manner using
TF binding data, e.g., using EP300 to locate and to measure the activity of enhancer elements [250].
While the notion of master TFs exists (see, e.g., Whyte et al. [256]), there is no consensus on a set
of TFs to be measured routinely in analogy to the core set of histone marks (Table 2.1).
2.1.3 DNA methylaࢢon
If not indicated otherwise, the following information is based on Jones [113].
DNA methylation is the chemical modification of cytosine nucleotides in the DNA via the ad-
dition of a methyl group to the carbon at position 5. This modification is most commonly observed
in the context of CpG dinucleotides. DNA methylation is commonly described as a broadly re-
pressive epigenetic mark. Mammalian genomes usually show a high methylation level, which is
presumed to be a silencing mechanism for genomic regions that must not interfere with regulatory
processes. A notable exception are CpG-dense regions, so-called CpG islands (CGIs), that are
often devoid of methylation and commonly occur close to regulatory regions such as promoters.
Numerous studies have elucidated various patterns of DNA methylation depending on the regula-
tory context. For example, DNA methylation in gene bodies of expressed genes is usually high, low
in CpG-rich promoters of expressed genes and variable in enhancer regions due to, e.g., the inter-
play with TFs. If a promoter region becomes methylated, this is usually a sign of long-term stable
silencing of the respective gene, which represents an epigenetic silencing signal distinct from the
histone-based bivalent domains described in Section 2.1.1.4. As opposed to histone modifications
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(Section 2.1.1.5), the process by which the methylation status is copied after DNA replication is
known in (more) detail [224]. Specialized enzymes, so-called maintenance methyltransferases, re-
establish the methylation status on the newly synthesized DNA strand, which explains how DNA
methylation status can be stably inherited during cell division. The known path of inheritance
combined with the comparatively easy readout of DNA methylation status — cytosines can either
be methylated or not — offer a plausible explanation why methylome analysis is often the central
component of epigenome studies.
2.2 High-Throughput Assays for Chromaࢢn Proﬁling
The following sections summarize a subset of current technologies that afford efficient profil-
ing of the chromatin landscape in a genome-wide manner. The descriptions focus on the first step
of the experiment, i.e., linking the epigenetic information to the local sequence context to enable
localization of the epigenetic signal by subsequent HTS and short–read mapping to the genome
reference. Technical details of sequencing library preparation and the biochemistry of sequencing
will not be discussed (e.g., see the review by Metzker [163]). The selection of technologies is
biased toward protocols that were used within DEEP.
2.2.1 Determining nucleosome posiࢢons
The observation that DNA exists basically in two activity states — open and accessible to the
cellular machinery or closed — is the key to enzyme-based assays such as micrococcal nucle-
ase digestion followed by high-throughput sequencing (MNase-seq) that generate genome-wide
maps of nucleosome positions [12, 219]. During the enzymatic digestion process in MNase-seq,
a micrococcal nuclease cuts DNA only at accessible sites, and with a strong preference for linker
regions between nucleosomes; locations occupied by nucleosomes or by transcription factors are
protected from the enzymatic digestion process. The aim of the digestion process is to generate
predominantly mononucleosomal fragments with a length of around 150 bp. These fragments are
then size selected via gel electrophoresis and prepared for HTS. Although MNase-seq is an es-
tablished protocol for determining nucleosome positions, the reliance on an enzymatic digestion
process bears the risk of introducing a bias if the digestion enzyme does not cleave the DNA in an
unbiased manner [43].
A recently developed protocol, nucleosome occupancy and methylome sequencing (NOMe-
seq) [121], which was also extensively used in DEEP, involves the chemical modification of
DNA via a methyltransferase enzyme. The key point is that this methyltransferase methylates
cytosines in GpC — but not in CpG — sequence contexts, which distinguishes this artificially in-
troduced DNA methylation from “canonical” DNA methylation (see Section 2.1.3). Since the GpC
methyltransferase can only modify accessible nucleotides, i.e., nucleotides that are not blocked by
a nucleosome, NOMe-seq provides information about nucleosome position/occupancy as well as
methylation status for the same DNA molecule. However, because of the sequence-dependence,
regions with low GpC dinucleotide density can hardly be interrogated using this approach.
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2.2.2 Interrogaࢢng histone variants and histone modiﬁcaࢢons
The arguably most widely used method for characterizing chromatin is chromatin immunopre-
cipitation followed by high-throughput sequencing (ChIP-seq) [12, 165]. The ChIP-seq protocol
is usually adapted to cell type, experimental conditions, and other factors. Hence, the following
description is just a generic outline of the procedure [124, 218].
To probe for histone variants in the nucleosome core or for histone marks on the histone tails, the
histone core proteins are chemically cross-linked to the DNA with formaldehyde. Next, the DNA
is fragmented either by means of enzymatic digestion (MNase treatment as above) or by sonica-
tion; the latter was the method of choice in DEEP. The resulting fragments, ideally of the length
of the DNA of one to two nucleosomes, are then immunoprecipitated with an antibody specific for
the target of interest, e.g., the histone mark H3K4me3. This step reduces the set of all DNA frag-
ments to those that are linked to a nucleosome with the chromatin signature of interest. These DNA
fragments are then used for library preparation and undergo HTS, which translates the epigenetic
signal into machine-readable form. It is strongly recommended [138] to also sequence a so-called
Input2 control, which is a sample taken after DNA fragmentation but before immunoprecipitation.
This control is supposed to help correcting for sample-inherent biases and needed to accurately
quantify sites of histone signal enrichment (see Section 2.4).
ChIP-seq is also the technology of choice to determine TF binding sites. For this scenario, there is
an adaptation of the protocol, termed ChIP-exo, that uses an exonuclease enzyme to trim the ends
of the DNA cross-linked to the bound protein, thereby increasing the spatial resolution and thus
enabling a more precise determination of the binding site [203]. Enhancements of the (histone)
ChIP-seq protocol have been reported in terms of lowering customization needs across cell types
and conditions [10], but a substantial amount of effort was — and still is — dedicated to increas-
ing the analytical value of ChIP-seq studies by reducing the necessary amount of DNA starting
material, e.g., to enable the ChIP-seq analysis of rare cell populations.
2.2.3 Toward single-cell analysis: droplet-based assay
The recent trend toward single-cell analysis in the field of NGS and epigenomics [222] has been
difficult to follow for ChIP-seq analysis. The standard laboratory protocol outlined above requires
a population of cells (a “bulk” sample) to collect enough DNA as starting material because certain
sample preparation steps lead to a loss of material. Subsequently, artifacts inherent to ChIP-seq
may render it impossible to distinguish noise from signal in the final dataset if the initial quantity
of DNA was too low (see Section 2.3.1 below). While several attempts have been made to reduce
the number of cells from millions to thousands [10, 33, 88, 218] or to adapt protocols to lower input
requirements [213], no single-cell ChIP-seq assay has been reported in the literature so far. At the
time of writing, the consensus in the ChIP-seq community seems to be that standard protocols for
bulk assays will not allow downscaling of ChIP-seq analysis to the single-cell level [170].
Rotem et al. [206] reported a different approach to single-cell chromatin analysis by adapting the
2To distinguish the Input control experiment from any generic “input”, the capitalized spelling is commonly em-
ployed; this convention is used throughout this thesis.
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technology of droplet-based sequencing (Drop-seq): Drop-seq is a massively parallel single-cell
assay originally developed for transcriptome studies that combines microfluidics and DNA barcod-
ing [153]. In the Drop-seq assay, a single cell (= the biological analyte) is encapsulated together
with a barcoding bead in a droplet. Inside the droplet, the biological analyte is tagged with a
unique sequence barcode via a biochemical reaction. After the barcoding step, the droplets can be
dissolved and the single cells combined for subsequent sequencing; the unique barcode ensures
that the resulting raw reads can be sorted according to their sample of origin. Drop-seq combined
with ChIP enabled Rotem et al. to generate single-cell chromatin profiles for two histone modifi-
cations (H3K4me2, H3K4me3) in several murine cell types. However, the reported read coverage
is sparse (roughly 1,000 unique reads per single cell) and hence necessitated to assay thousands
of individual cells to obtain reliable profiles. This proof of concept study provided evidence that
single-cell variability in the regulatory (chromatin) landscape can offer insights, e.g., into early
priming in embryonic stem cells, which enables scientists to better understand paths of cellular
differentiation. The authors noted nevertheless that the successful application of their method and
meaningful interpretation of their results
“relies on the existence of a coherent chromatin state in a sufficient number of sampled
cells. Power to distinguish such subpopulations thus benefits from sampling large
numbers of cells and from the high throughput of microfluidics systems.”
In summary, current technology does not allow for exploring the chromatin landscape at single-
cell resolution with the same efficiency as for DNA methylation or transcriptome assays [75, 109].
If there is no technological breakthrough in the next few years, it is conceivable that the role of
bioinformatics has to shift to decomposition methods for the bulk ChIP-seq signal, either to char-
acterize cellular subpopulations directly or, at least, to complement other single-cell assays with a
more fine-grained map of the chromatin landscape.
2.3 Sources of Noise and Validaࢢon Strategies
2.3.1 Sources of noise
The potential causes for signal artifacts in histone data are multifaceted and some of the most
prevalent ones are summarized here. A core problem of the ChIP-seq technology is the requirement
for large amounts of DNA as starting material. This implies that each histone dataset is a snapshot
of a whole population of cells and thus shows at least biological variation, e.g., due to differences in
chromatin structure or cellular state. The reliance on antibodies demands for rigorous testing and
quality control, but nevertheless, antibodies have varying binding affinities and specificity, which
can result in fluctuations of the histone signal that are not of biological interest [66, 138]. The
enrichment of genomic loci by means of the immunoprecipitation step also implies that a certain
amount of duplicated reads is to be expected. However, since the ChIP-seq protocol also involves
a sequence amplification step, the source of any duplicated read is potentially ambiguous [42, 98]3.
3The ChIP-seq processing pipeline in DEEP was initially configured to keep all reads, and later changed to remove
all reads marked as duplicates.
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Regions of open chromatin and in particular highly expressed genes, have also been described as
showing biased read counts and thus giving rise to false positive signals; in the context of ChIP-seq
analysis to determine TF binding sites, these regions were denoted as “hyper-ChIP-able” [42, 239].
Besides chromatin characteristics, the underlying genomic sequence can also affect the signal de-
pending on, e.g., local repeat density and thus varying read mapping efficiency; as an example,
this is relevant for the heterochromatin mark H3K9me3 because heterochromatin formation often
occurs in repeat-rich sequence contexts [23]. Genomic regions that are known to attract a large
number of reads during read mapping are commonly referred to as “blacklist regions”, and reads
overlapping these regions should be removed before any downstream processing to obtain a more
realistic histone signal [11].
Since artifacts caused by the underlying biology can either be attenuated or exacerbated by details
of the experimental protocol and of bioinformatic processing pipelines, large epigenome mapping
consortia try to standardize sample handling and processing as far as possible ( [11, 138] and Chap-
ter 3). Despite these efforts, ChIP-seq data still present a substantial challenge for bioinformatics,
in particular when samples from various research consortia should be integrated and analyzed to-
gether, which is the current objective of IHEC’s Integrative Analysis Working Group4. Whether or
not such international initiatives will result in a generally accepted and implemented way of pro-
cessing ChIP-seq data is unclear, but it seems unquestionable that early considerations [12] stating
that
“[s]ince the ChIP-Seq method is analogous to direct counting of the molecules in the
ChIP DNA samples, it requires minimal normalization. The number of tags detected
for a particular nucleosome is directly proportional to the modification level of that
nucleosome.”
turned out to be somewhat optimistic.
2.3.2 Experimental validaࢢon
The above described various sources of technical and biological noise raise the question how
the quality of a ChIP-seq experiment can be assessed. The current gold standard for validating
the result of a ChIP-seq experiment is a quantitative polymerase chain reaction (qPCR) of known
positive and, ideally, negative loci [11, 138]. It seems understandable that limited throughput
and the necessary primer design prevent qPCR from being used to create genome-wide reference
catalogs even for a single histone mark in a single condition. As a consequence, studies that include
experimentally verified validation sites are limited in their scope (e.g., the software benchmark
study by Micsinai et al. [164] reports a total of 297 qPCR validation sites) when compared to the
actual numbers of specifically modified histones in a vertebrate genome (~104 – 105 depending
on measured histone mark and experimental conditions). While bioinformatic methods can never
provide proof of a successful ChIP-seq experiment, it is an accepted standard to gather evidence
of success as follows: (i) if the histone mark has already been measured in a sufficiently similar
biological sample, the enrichment profiles should reflect the biological similarity; (ii) if the histone
4ihec-epigenomes.org/about/workgroups/integrative-analysis
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mark is well-characterized and known to correlate with certain genomic elements like transcription
start sites or enhancers, the histone signal overlaid with the respective annotations should show the
expected enrichment profile [138]. The latter in silico options increase in their value over time as
more and more ChIP-seq experiments become publicly available and can be used for comparative
quality assessment strategies.
2.4 Basic Data Processing
The background information presented so far has introduced chromatin biology as well as
technologies that enable scientists to investigate certain aspects of chromatin in a high-throughput
manner. This section is concerned with modeling and basic in silico analysis of the collected
biological information. Since the connecting step between sequencing and modeling, i.e., short
read mapping, is not specific to chromatin analysis, it will not be detailed here (see, e.g., Fonseca
et al. [79], Trapnell and Salzberg [243] as a starting point). In other words, it is assumed that the
bioinformatics analysis starts with millions of short reads aligned to the reference genome, each
read annotated with its genomic coordinates and a mapping quality score. This mapping quality
score can be thought of as quantifying how unique a given alignment of a read is relative to all
other possible alignments of that read [141]. To provide some frame of reference, the current
IHEC recommendations for ChIP-seq quality control only consider reads with a mapping quality
of at least five5, whereas, e.g., the NIH Roadmap Epigenomics Mapping Consortium (REMC) set
a more conservative threshold of at least 30 for some of their ChIP-seq analyses [205]. It should
be pointed out that there is no commonly accepted minimum mapping quality for reads to be kept
for downstream analysis of ChIP-seq data (besides a mapping quality larger than zero). Hence,
within this thesis and as far as relevant and controllable, any value that at least fulfills the IHEC
recommendations is considered acceptable.
2.4.1 Data reducࢢon: genome-wide histone signal
A standard way of representing aligned reads along the genome is in the form of so-called
signal or coverage tracks. The basic idea is to convert the read alignment information into a read
count per bp or per genomic bin of fixed size, say, 25 bp. There is no common standard for
generating signal tracks, e.g., concerning quality filtering or signal smoothing. An example for
one of the few more widely applied processing steps is the normalization of the read counts to an
average genomic coverage of one by appropriate scaling (“1x coverage normalization”) [226]. The
genomic coverage is computed as
genome coverage = # aligned reads · read lengtheffective genome size (2.1)
The effective size of a genome refers roughly to the part of the genome to which short reads can be
aligned, i.e., it is a parameter dependent on read length and has some other pitfalls that are not of
5github.com/IHEC/ihec-assay-standards
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interest here6. Since signal coverage tracks are usually at least one order of magnitude smaller than
the original alignment file, they are a default output of many epigenome processing pipelines to
facilitate further downstream analyses and data sharing (see Chapter 3). For example, signal tracks
make it straightforward to quickly examine the strength of the individual histone marks in regions
of interest, e.g., by taking the mean of the signal values in gene promoters. For many applications,
this is already a sufficient characterization of the local genomic activity level (cf. Table 2.1, see
Chapter 5).
2.4.2 Data modeling: detecࢢng sites of enrichment
Whereas genome-wide signal tracks provide a convenient abstraction for visualizing and
processing the read information of a ChIP-seq experiment, a substantial part of the biological
information can be captured in a much more compact way. To this end, so-called peak calling
software is used to locate genomic sites (“signal peaks”) that show enrichment of reads relative
to a suitably chosen background model. These sites are then assumed to indicate positions of
nucleosomes that have the histone marking of interest, e.g., H3K4me3 or H3K36me3. Within the
context of this thesis, ChIP-seq background always refers to the read distribution observed in the
Input control experiment. Software tools for the task of peak calling exist in such a large variety
that examples named in the following were selected only for referential purposes and are by no
means exhaustive (for an overview, see, e.g., [164, 242]).
In essence, two modeling decisions are implemented in most peak calling tools: how to define
an appropriate size for the window of enrichment and how to model the read distribution in
order to attribute the notion of significant enrichment relative to the background for the identified
peak. Concerning the first point, there is a plausibility argument that due to the length of the
nucleosomal DNA plus a stretch of linker DNA, the minimal window size should be around
200 bp. In practice, the window size is often estimated from the data and realistic values are in
the range of approximately 140–180 bp. In principle, a strongly positioned nucleosome with high
occupancy, i.e., a nucleosome present in almost all cells in the bulk sample, could be detected
with a signal peak of that size, which is commonly described as a sharp or narrow peak. The
complementary situation of diffuse enrichment covering several neighboring windows with diffi-
cult to detect boundaries is called a broad peak. It is customary to classify histone marks by their
predominant enrichment profile, e.g., H3K4m3 and H3K27ac are canonical narrow marks and
H3K36me3 and H3K27me3 are considered broad marks. This is, however, a somewhat artificial
classification scheme, because such distinctions do not exist in vivo and varying peak shapes for
different histone marks have been observed [18]. The determined window size is then used in a
binning (e.g., histoneHMM [100], specialized for broad marks) or sliding window approach (e.g.,
MACS [268], general purpose) to scan the genome for enriched sites. To determine whether the
local read count is statistically significantly higher than expected, the second modeling decision
of how to model read counts needs to be addressed. Again, given the variety of existing peak
callers, the description of this modeling step is limited here to a common variant (an overview of
other approaches for several peak callers can be found in Thomas et al. [242]). Moreover, peak
6deeptools.readthedocs.io/en/latest/content/feature/effectiveGenomeSize.html
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callers such as MACS [268] offer several different ways of parameterizing the background read
distribution. To simplify matters, it will be assumed that the Input control experiment is used to
globally model the background.
The next paragraph follows Hilbe [104] in argument and notation if not stated otherwise.
A standard way of modeling read counts is to assume that the counts X follow a Poisson
distribution with mean parameter µ: X ∼ Poisson(µ), e.g., in MACS [268]. In that case, the
probability of observing k reads within a window is given as
Pr(X = k) = e−µ · µ
k
k! (2.2)
By estimating the parameter µ from the Input control, i.e., the assumed null distribution of read
counts, it is possible to compute a p-value for the enrichment as
Pr(X ≥ k) = 1− e−µInput
k−1∑
x=0
µxInput
x! (2.3)
The Poisson assumption works reasonably well in practice, in particular for narrow peak calling.
However, there is limited flexibility in the estimation of mean and variance with the single pa-
rameter µ, which leads to a lack of fit for data where the assumed equality of mean and variance
does not hold. This situation is called extradispersion, which is commonly encountered in the form
of overdispersed data, i.e., the parameter µ underestimates the true variance in the data (“excess
variance”). Since overdispersion is frequently observed in ChIP-seq experiments, modeling the
read counts X as a negative binomial is a common alternative strategy: X ∼ NB(µ, α), e.g., in
ZINBA [201] or histoneHMM [100]. Here, the additional parameter α is the dispersion parame-
ter. The effect of the dispersion parameter can be understood by examining the variance σ2 of the
negative binomial distribution
σ2 = µ · (1 + α · µ) (2.4)
The parameter µ is the mean count value as above, and one can see that an increase in the mean
leads to an increase in the variance, and the variance is never smaller than the mean. In the special
case of α = 0, this reduces to the Poisson model with the variance equal to the mean. Under this
parameterization, the probability of observing k reads is given by
Pr(X = k) =
(
k + 1α − 1
1
α − 1
)(
αµ
1 + αµ
)k ( 1
1 + αµ
) 1
α
(2.5)
Since the use of a negative binomial necessitates the introduction of the additional overdispersion
parameter α, the model estimation is more involved compared to the regular Poisson model and
will not be elaborated here (a complete technical description for modeling overdispersed read
counts can be found, e.g., in [147]). Whether or not this additional complexity is actually needed,
is not easy to answer. Count data can appear to be overdispersed but may in fact not be, and a few
simple adjustments, e.g., removing outliers or dealing with non-randomly missing values, could
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result in (transformed) count data that can be fit well with a simple Poisson model (see Tables 2.2
and 2.3 in Hilbe [104]).
The last adaptation of read count modeling presented here attempts to adjust for the following
ambiguity: assume that the ChIP-seq experiment is supposed to detect nucleosomes with
H3K4me3 histone marking. When scanning the genome for sites of enrichment, a peak calling
algorithm inevitably also finds many sites with a read count of zero. Note that the situation
of X = 0 can be captured with both the Poisson and the negative binomial model and is then
expected to be encountered with a certain probability according to the model. A read count
of zero could occur at the location of a nucleosome that does not have the required histone
marking, but the marking could in principle be acquired at some point; here, the zero value has
a biologically meaningful interpretation. If, on the other hand, the zero read count is caused by,
e.g., a technical problem such as insufficient sequencing depth, the zero value is biologically
meaningless. This consideration suggests that the number of zero counts can be excessive relative
to the expectation based on the chosen count model. This situation is referred to as “zero excess”
and can be handled, e.g., by adapting the count model for zero inflation. Under zero inflation,
the read counts are assumed to have been generated by two distinct processes, one just producing
(excess) zeros and the other one producing the full range of counts including “meaningful”
zeros. Zero-inflated models are implemented in only a few peak calling algorithms, e.g., in
ZINBA [201] and Zerone [53]. This may be due to the observation that the largest improvements
in model fit are realized by switching from a Poisson to a negative binomial model for overdis-
persed data, and additional improvements by explicitly modeling excess zeros are only minor [57].
It should be pointed out that despite all considerations about appropriate modeling of (ChIP-
seq) read count data, no community-wide accepted way of modeling ChIP-seq read counts and
performing the subsequent peak calling has been established; a goal that might also be hard to
achieve given the numerous sources of noise (see Section 2.3.1). Consequently, any study that
relies on peak calling as an intermediate step bears the risk of calibrating downstream analyses to
the peak calling software, which could negatively affect reproducibility of the results (see Chap-
ter 3). To illustrate that point by example, Table 2.2 lists genomic coverages for all peak calls
of several peak calling tools applied to a triplicated hepatocyte control sample from DEEP. The
two tools MACS2 [268] and histoneHMM [100] (only broad marks) are part of the official DEEP
processing pipeline for ChIP-seq data. The peak caller Zerone [53] was added for comparison and
produces a single list of peak calls for all replicates combined (the donor number is given as “NN”
in these cases). This exemplary case shows substantial variation in genomic coverage of the called
peaks, suggesting that common downstream analyses that rely, e.g., on assessment of peak over-
laps with other functional annotation data may give different results when switching to another
peak calling algorithm. Although one may argue that different output from different tools employ-
ing different modeling assumptions about the data is no surprising observation, this would miss
the point. Because there is no generally accepted way of combining peak calls across any number
of biological replicates and from any number of different tools, and genome-wide gold standards
of the true biological signal do not exist (see Section 2.3.2), the situation illustrated in Table 2.2
represents one of the persistently challenging problems in ChIP-seq bioinformatics. Hence, any
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Table 2.2: Example of differences in genomic coverage for peak calls produced by different tools.
The three selected samples are biological replicates of hepatocytes (healthy controls) from three
male donors. The samples were sequenced, aligned and analyzed (except for tool Zerone) in the
context of the DEEP consortium.
Donor Mark Profile Coverage (Mbp) Software
Hm09 H3K27ac narrow 173.81 MACS2
Hm16 H3K27ac narrow 260.18 MACS2
Hm25 H3K27ac narrow 169.29 MACS2
HmNN H3K27ac narrow 140.20 Zerone
Hm09 H3K27me3 broad 550.32 MACS2
Hm09 H3K27me3 broad 1430.98 histoneHMM
Hm16 H3K27me3 broad 749.38 MACS2
Hm16 H3K27me3 broad 1525.89 histoneHMM
Hm25 H3K27me3 broad 588.34 MACS2
Hm25 H3K27me3 broad 1457.07 histoneHMM
HmNN H3K27me3 broad 847.94 Zerone
Hm09 H3K36me3 broad 430.94 MACS2
Hm09 H3K36me3 broad 971.12 histoneHMM
Hm16 H3K36me3 broad 456.20 MACS2
Hm16 H3K36me3 broad 980.06 histoneHMM
Hm25 H3K36me3 broad 423.73 MACS2
Hm25 H3K36me3 broad 963.98 histoneHMM
HmNN H3K36me3 broad 307.20 Zerone
Hm09 H3K4me3 narrow 64.84 MACS2
Hm16 H3K4me3 narrow 69.02 MACS2
Hm25 H3K4me3 narrow 64.68 MACS2
HmNN H3K4me3 narrow 42.88 Zerone
study-specific solution to the problem of how to handle peak calls in downstream analysis bears
the risk of not resulting in generalizable conclusions.
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CHAPTER 3
Reproducibility in Computaࢢonal
Research
Lead-in This chapter is concerned with possible solution strategies for the problem of lacking
reproducibility of scientific results — commonly referred to as the “reproducibility crisis”. The
following material represents the state-of-the-art approach toward improving reproducibility in
the context of the collaborative research initiative DEEP. Section 3.1 provides the necessary
background in a broad, i.e., non-DEEP specific sense, whereas the remaining sections are written
from the DEEP perspective. This chapter concludes with Section 3.6 as a detailed outlook on
potential future developments to support reproducible research in computational epigenetics,
which, for reasons of chapter coherence, will not be summarized as part of Chapter 6 (Perspectives).
The work presented in this chapter is an extended version of the manuscript Ebert et al. [64]
(for publication details and author contributions, see Appendix E.1.1).
3.1 Background - What is Science?
A necessary precondition to any discussion on the topic of scientific reproducibility is to define
science itself. The body of work on this subject is vast and the different philosophical considera-
tions are beyond the scope of this work. A possible and concise definition of science is given by
Edward Osborne Wilson [257]:
“Science [...] is the organized, systematic enterprise that gathers knowledge about the
world and condenses the knowledge into testable laws and principles.”
(Chapter 4 “The Natural Sciences”)
It is instructive to also highlight two of the main characteristics of science:
“The diagnostic features of science that distinguish it from pseudoscience are first,
repeatability: The same phenomenon is sought again, preferably by independent in-
vestigation, and the interpretation given to it is confirmed or discarded by means of
novel analysis and experimentation. Second, economy: Scientists attempt to abstract
the information into the form that is both simplest and aesthetically most pleasing —
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the combination called elegance — while yielding the largest amount of information
with the least amount of effort.”
(Chapter 4 “The Natural Sciences”)
Following Wilson’s arguments, creating conditions that support the independent re-investigation
of natural phenomena and the presentation of abstracted information in a simple and accessible
way are two pillars of science. While the latter is open to interpretation, in particular concerning
the question what the “aesthetically most pleasing” form of abstraction is, the importance of inde-
pendent testing has also been discussed in many epistemological treatises. To give an example, in
his work The Logic of Scientific Discovery [190], Karl Popper argues that
“a positive decision can only temporarily support the theory, for subsequent negative
decisions may always overthrow it. So long as theory withstands detailed and severe
tests and is not superseded by another theory in the course of scientific progress, we
may say that it has ’proved its mettle’ or that it is ’corroborated’ by past experience.”
(Section I.1.3 “Deductive Testing of Theories”)
“Only when certain events recur in accordance with rules or regularities, as is the case
with repeatable experiments, can our observations be tested — in principle — by any-
one. We do not take even our own observations quite seriously, or accept them as sci-
entific observations, until we have repeated and tested them. Only by such repetitions
can we convince ourselves that we are not dealing with a mere isolated ‘coincidence’,
but with events which, on account of their regularity and reproducibility, are in prin-
ciple inter-subjectively testable.”
(Section I.1.8 “Scientific Objectivity and Subjective Conviction”)
It is the premise of this chapter that these theoretical considerations are accepted as vital for scien-
tific progress by the majority of scientists. It is, however, not obvious how these principles should
be translated into practical tools assisting researchers in their daily routine. The work presented
here is a proposal of concepts and tools that were developed with the objective of bridging the gap
between theory and daily practice (Section 3.2).
3.1.1 Disentangling replicability, reproducibility and repeatability
In the previous section, different terms are used interchangeably that all refer to the concept
of scientific reproducibility. In the area of computational research, it is of particular importance
to distinguish between these terms to avoid common misconceptions; following the definitions
of Drummond [59], “replicability” will be defined as rerunning code to produce the same output
again. This mere replication naturally includes all potential flaws in the results, e.g., due to
programming errors in the software code. Successful replication thus cannot be seen as evidence
supporting the original claims. In particular, replicability does not imply that the reported results
would hold up in an independent test. On the other hand, lack of replicability implies lack of
reproducibility.
“Reproducibility” refers to an independent test or attempt to reproduce results using a different
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and yet suitable approach that should allow drawing the same conclusions from the same data.
In computational research, the implementation of various distinct algorithms or models all of
which aiming at the same goal represents a setting where reproducibility can be easily tested. Of
course, this example neglects the data generation part, i.e., a noisy input dataset may generally
render any study irreproducible. Since the scope of this chapter is on the computational side,
potential reproducibility issues caused in the wet lab are not addressed. More precisely, compu-
tational reproducibility only supports the original claims about the information contained in and
extractable from a published dataset. Assuming a fully deterministic analysis, one may argue that
a reimplementation of sufficiently similar methods would always result in the same output, which
should not be taken as evidence of reproducibility. Although a formal definition of “sufficiently
similar methods” is probably hard to conceive, such criticism makes nevertheless intuitive sense;
it emphasizes that “reproducibility requires change” [59]: an independent test has to aim at the
same goals, but with different means.
The term “repeatability” appears to be defined with most stringency and usually refers to the
repetition of measurements within the same experimental setup, e.g., to assess the precision and
reliability of one or several detection methods [26]; it is thus not relevant for this chapter.
The notion of reproducibility as defined above will be used throughout the rest of this chapter.
However, there is one caveat due to reasons of practicality: because reproducibility requires an
independent outside perspective, it is difficult for the same individual to truly work reproducibly.
As a consequence, this chapter uses a “working definition” of reproducibility that requires replica-
bility and aims at transparency of workflows. It is assumed that reproducing any computationally
generated result is feasible under these conditions. In essence, transparency requires a thorough
documentation of computational analysis steps and unambiguous ways of identifying the correct
datasets for the analysis; given that, a computational analysis as a whole is testable in the sense
that it should be possible to reach the same conclusions. The exact identification of datasets is a
manageable — if not trivial — task, whereas the concise documentation of an analysis pipeline
can be a challenge that grows with the pipeline’s complexity.
3.1.2 Planning for reproducibility: a tradeoﬀ in granularity
A pivotal question for an environment that fosters reproducible research is what level of detail
— or granularity — can be considered “sufficient” in terms of capturing enough information to
ensure reproducibility of a body of work. In simpler terms, there does not seem to be a universal
standard for reproducible research that defines what information needs to be recorded and to what
level of detail. Computational work in particular presents a challenge to defining the level of
required granularity: numerical simulations should be documented with exact information on the
numerical libraries and, potentially, on the underlying hardware, whereas the description of a data
conversion step in a computational pipeline may arguably not require such an amount of detail. The
assumption in this chapter is that the above question can only be answered in a context-specific
manner. This view is supported by Thain et al. [240] who state that
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“[t]he choice of granularity depends on the overhead of metadata management, stor-
age overhead, the time overhead of submission, storage and reconstruction, and user-
friendliness.”
Assuming user-friendliness as crucial to foster compliant behavior among scientists implies that
the granularity should be governed by ease of accessibility. The information a scientist is asked to
record should be immediately available, e.g., the version of a software tool is usually easy to iden-
tify whereas the versions of all programming libraries the tool relies on may not be discoverable.
The approach of favoring simplicity over completeness1 can be beneficial as it captures less but
more meaningful information. Of course, if attempts to reproduce a study fail due to incomplete
documentation, a previously defined schema has to be revised to record the missing information
in future studies.
Although the unclear requirements regarding record keeping in practice may seem like a potential
candidate that could at least partially explain the reproducibility crisis, Section 3.1.3 summarizes
in the following several recently published articles on the matter that do not seem to motivate the
conclusion that more (comprehensive) guidelines on information recording can solve the repro-
ducibility crisis.
3.1.3 Current issues with scienࢢﬁc reproducibility
The lack of reproducibility in biomedical research has recently been addressed by the editors of
more than 30 major journals [171] and is an issue of active debate [172]. In the published editorials,
the authors report on a common set of Principles and Guidelines in Reporting Preclinical Research2
that should support reproducibility by establishing clear requirements for any manuscript to be
eligible for publication. Although such an initiative driven by the Nature Publishing Group and
by Science is certainly a necessary step to raise overall awareness for the reproducibility crisis,
a closer look at those guidelines reveals that they are still abstract in nature; the following three
examples are an excerpt from the National Institutes of Health (NIH) guidelines:
• “A section outlining the journal’s policies for statistical analysis should be included in the
Information for Authors, and the journal should have a mechanism to check the statistical
accuracy of submissions.”
• “Standards: Encourage the use of community-based standards (such as nomenclature stan-
dards and reporting standards like ARRIVE), where applicable.”
• “Encourage presentation of all other data values in machine readable format in the paper or
its supplementary information. Require materials sharing after publication.”
These guidelines leave room for interpretation: who exactly is supposed to check the statistical
accuracy and to what level of detail? How should the reporting be done if there are no community-
based standards? Who checks that the authors did not overlook or ignore existing standards? What
is a machine-readable format? Does that, e.g., include proprietary binary file formats?
Similar guidelines or best practices were published in numerous other articles (e.g., Peng [184],
1Thain et al. [240] refer to this as “capturing the mess” versus “encouraging cleanliness”.
2nih.gov/research-training/rigor-reproducibility/principles-guidelines-reporting-preclinical-research
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Sandve et al. [212], Schnell [217]) and it is reasonable to assume that constant reminders on the
topic are necessary to avoid a qualitative drop in reproducibility standards. However, there is
presumably a consensus in the scientific community that burdening reviewers with the practical
implementation of all those guidelines is not a viable solution. It is thus an open question how
a practically useful realization of these quality control measures should look like. The lack of
such concrete implementations can lead to presumably widespread and often trivial errors. For
example, Ziemann et al. [272] reported on a substantial number of erroneous gene symbols in the
supplementary material of 704 out of 3,597 studies published in 18 different journals. The source
of the error was identified as automated string format conversion by Microsoft Excel®. It should
be emphasized that depositing lists of gene symbols in the form of spreadsheets is in line with
the above guidelines (use a “machine readable format” and adhere to “nomenclature standards”).
Published “how to work reproducibly” articles and guidelines provide a conceptual framework that
outlines necessary conditions for reproducible work. Yet, these articles commonly lack practical
solution strategies that support scientists in working reproducibly as part of their daily routine.
The multifaceted roles of researchers in the scientific community as authors, reviewers, editors,
etc., may exacerbate a stringent separation of responsibilities. It nevertheless stands to reason
that responsibilities and actions have to be defined and distributed across the scientific commu-
nity to deal with the reproducibility crisis. One could assume that scientists will always work
reproducibly3, because irreproducible work is not publishable — the current reproducibility crisis
proves that wrong. It is probably unrealistic that reproducibility can be guaranteed under all con-
ditions, because this would require to eliminate, e.g., negligence, miscommunication, and human
error. Therefore, practical solutions should presumably aim at managing reproducibility to bring
down the number of irreproducible studies [14, 67, 169, 192].
3.2 Problem Analysis and Project Objecࢢve in the Context of
DEEP
The organizational structure of DEEP is similar to that of other research consortia such as the
Encyclopedia of DNA Elements [49, 231, 241] (ENCODE), REMC or the European Hematopoi-
etic Epigenome Project [1] (BLUEPRINT). The consortium structure reflects the collaborative
nature of large-scale scientific projects that rely on expertise from various groups that are not (nec-
essarily) located on the same research campus. This implies that the consortium-related work in
an institute is usually built on top of existing infrastructure and internal operating procedures. For
example, the DEEP compute cluster at the Data Analysis Center (DAC) is administrated by the
DAC’s Information Services and Technology (IST) department following all in-house policies,
with limited exceptions to allow for access by selected external users. As a consequence, any
attempt to develop and to implement a consortium-wide strategy for recording (computational)
metadata for the purpose of supporting reproducibility has to take into account the existing struc-
tures at all collaborating institutes. The role of each contributing research group in DEEP can be
roughly characterized using one or two of the following tasks:
3The caveat mentioned in Section 3.1.1 should also be taken into account here.
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1) Acquisition: collecting primary samples from donors in clinics or, in case of animal data, in
specialized facilities; cultivating cell lines in the wet lab
2) Translation: running assays such as ChIP-seq to translate the biological information into the
(computer-readable) form of data files containing raw sequencing reads
3) Quantification: performing the low-level of bioinformatics analysis to obtain an easier to
interpret quantitative representation of the biological signal; short read mapping to the ref-
erence genome and generating standard output (e.g., signal coverage tracks, see Section 2.4)
are both subsumed under this point
4) Interpretation and integration: performing the high-level bioinformatics analyses, e.g., dif-
ferential analysis between samples or exploratory analyses guided by specific research ques-
tions
5) Collection and storage: collecting all (digital) results for archival purposes in a form such
that the research community can access and analyze the data; sensitive information that may
be used to identify (human) individuals is excluded from open access portals for ethical
reasons
Each of these tasks comes with a different burden of metadata complexity. For the sample ac-
quisition, there will be one metadata record per sample at the end of the consortium’s life span.
Experiment and translation already result in several metadata records per sample because the min-
imal requirements for an IHEC reference epigenome specify nine assays for each sample4. Of the
three remaining tasks, which are mostly the responsibility of computational research groups, only
the initial quantification of raw data can be documented with a predefined metadata model, because
it merely translates raw data into commonly used standard file and data formats; a task for which it
is comparatively straightforward to design analysis pipelines with a more or less fixed scope. Such
pipelines enable scientists to formulate expectations about reasonable metadata to be recorded for
a pipeline run. As opposed to quantification analyses, downstream interpretation and integration
tasks are commonly guided by research questions and, thus, analysis code may change frequently.
This complicates the a priori definition of milestones for a study that would lend itself to capturing
a coherent metadata record up to that point (with the sole exception of the final publication stage).
Similarly, data collection and storage require a continuous effort within a consortium that lacks a
formal definition of data relevance (“what to record?”) and of data quality (“when to record?”).
One major consequence of the above points is that the development of a practically useful metadata
model for computational analyses should start with an emphasis on the initial quantification step.
This approach has been realized in DEEP and is the primary concern of this chapter.
The requirement of reproducibility predates the era of large-scale computational research and, thus,
numerous concepts and software tools aiming at documenting computational analysis for support-
ing reproducible computational research have been published in the past couple of decades. In
the following section, several of these will be presented with a focus on contemporary software
solutions that were also evaluated in terms of their potential applicability within DEEP.
4Bisulfite-seq, RNA-seq, ChIP-seq Input plus six histone marks; for a list of optional assays, see
ihec-epigenomes.org/research/reference-epigenome-standards
33
3.2.1 Exisࢢng concepts and so[ware soluࢢons to record computaࢢonal
metadata
3.2.1.1 Literate programming and interacࢢve reports
As explained in Section 3.1.1, reproducing a computational analysis requires an independent
reimplementation of its concepts and underlying ideas. For any individual software tool or core
algorithmic component, this suggests that the code itself needs to be described in a manner that
exceeds inline comments or auto-generated documentation of library functions. This style of writ-
ing code has been put forward by Knuth [127] as “Literate Programming” with an emphasis on
“explaining to human beings what we want a computer to do”. The idea of Literate Programming
is at the core of many software packages (e.g., Perez and Granger [186], Xie [262]) that aim at
simplifying the creation of so-called interactive reports. These packages create documents that
mix code, textual documentation and embedded graphics with the ability to rerun the code using
altered parameter settings at the click of a button5. For an isolated analysis with limited scope,
an interactive report presumably contains a complete record of all data transformations plus the
relevant code, hence enabling independent reproduction of the results. However, in a consortium
setting, standardized analyses commonly consist of several chained software tools developed by
different research groups. This suggests that the ideas of Literate Programming and their mod-
ern interpretation in the form of interactive reports may not be directly applicable to documenting
complex analysis processes; from the consortium perspective, the inner workings of each individ-
ual software tool are less relevant than their combined setup. Restricting the documentation to
the overall workflow, i.e., to the series of computational analysis steps, affords a strict separation
between workflow specification and its execution, which avoids redundancy in documentation.
3.2.1.2 So[ware for managing computaࢢonal workﬂows
Popular tools in the bioinformatics community that implement a workflow-centric approach
are Galaxy [2, 87], Taverna [176, 259], and KNIME [24]6. Galaxy provides a rich graphical user
interface tailored to creating “clickable” workflows that do not require any programming skills
to set up, provided that all tasks in the workflow can be accomplished with tools registered in
the Galaxy repositories7. These workflows can be downloaded as textual documents (JavaScript
Object Notation (JSON) serialized) and thus can be shared with collaboration partners. Of
course, taking full advantage of sharing Galaxy workflows requires functional Galaxy instances
at the receiving end. Although the burden of a local Galaxy setup including configuration and
maintenance could be avoided by using off-the-shelf Galaxy cloud instances, analyzing sensitive
patient data is problematic due to the inherent privacy issues in such a scenario. Sharing Galaxy
workflows with the purpose of just informing collaboration partners about a computational
5It is common to refer to such interactive reports as “computable documents”. Despite being an appealing notion,
it should be pointed out that the “Computable Document Format”™ (CDF) is a proprietary document specification by
Wolfram Research.
6KNIME’s desktop application is free of charge, but support for compute clusters requires a paid license. Due to
this restriction, the focus is on Galaxy and Taverna.
7toolshed.g2.bx.psu.edu
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pipeline is similarly cumbersome: Galaxy workflow documents are meant to be imported into
Galaxy and then to be displayed in a human-readable form, i.e., besides the actual workflow steps,
these documents contain additional information pertaining to the layout, to resource identifiers and
to Galaxy-internal attributes (see example in Appendix A.1.1). In summary, Galaxy workflows in
their textual form are not meant to be read by humans and are arguably not ideal for disseminating
descriptions of computational pipelines.
A popular alternative to Galaxy in the bioinformatics community is Taverna. Taverna offers
similar capabilities as Galaxy, e.g., a client software with a graphical interface for creating and
manipulating workflows, or specialized setups targeting cloud computing environments. Tav-
erna’s feature set comes with the same downside regarding limited human readability of workflow
documents. Originally, Taverna workflows were also specified in the form of Extensible Markup
Language (XML) documents, but since the release of Taverna 3, Taverna’s Simple Conceptual
Unified Flow Language (v2) (SCUFL2) specifies entire workflow bundles8. These workflow
bundles are containers that, besides the workflow document, can include various metadata records
such as execution profiles for different computing environments, or annotations for resource
identification and data provenance tracking. Given that Taverna also emphasizes the use of web
services as part of computational pipelines, it is understandable that Taverna offers a variety of
ways to semantically enrich workflow bundles. Although Taverna’s workflow bundles are a
powerful way to develop and to document scientific workflows, they only show their full potential
when imported into Taverna; here, similar considerations concerning consortium-wide setup and
maintenance as for Galaxy apply.
By restricting the view on bioinformaticians, it would be feasible to select software tools
for workflow development and documentation that do not offer a graphical user interface (e.g.,
Snakemake [131], Ruffus [90] or (GNU) Make9). In this scenario, it can be expected that the re-
sulting workflow documents also contain a considerable amount of program code. Consequently,
such workflow documents can only be reasonably shared with third parties that have the right set
of programming skills for understanding the workflow. Of course, using workflow documents
created by any of the aforementioned command line tools leads to a similarly limited usability as
described above for Galaxy and Taverna. A possible way out of this “locked-in”10 situation is
provided by standards for workflow documents that are cross-platform compatible; one currently
emerging standard is the Common Workflow Language (CWL)11. The development of CWL was
initiated with the goal of establishing the de facto standard for specifying complex, cross-platform
compatible computational workflows in data-intensive fields such as bioinformatics. If such
a standard were supported by a large enough number of software tools and found acceptance
8There is no example of a Taverna workflow bundle included in the Appendix since it is not practical to visualize
its structure and content in textual form.
9gnu.org/software/make: presumably the spiritual father of all modern workflow management frameworks.
10The term “(vendor) lock-in” is usually used for commercial or otherwise closed software; in this context, it is simply
referring to the fact that the workflow descriptions of the individual tools are not cross-compatible.
11commonwl.org: Common Workflow Language stable specification v1.0. Recently, other new projects such as
the Broad Institute’s Workflow Description Language (WDL) (software.broadinstitute.org/wdl) have emerged, which
indicates that several modern workflow languages are competing for becoming the standard in bioinformatics.
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throughout the scientific community, this would indeed lower the need for human readable work-
flow documents if workflow visualization capabilities are built into commonly used software tools.
In summary, existing software solutions emphasize usability and ease of developing new work-
flows and, due to the lack of standards, can only ensure proper documentation of computational
analysis within the boundaries of their own ecosystem. As explained in Section 3.2, existing soft-
ware infrastructure has to be taken into account in a collaborative project. It is therefore ques-
tionable whether current workflow management tools offer the right set of features to fulfill the
needs of several computational research groups working under the same umbrella. The obvious
alternative to software that assists in developing and executing workflows, is to focus just on doc-
umenting computational workflows and to leave the implementation details at the discretion of the
respective computational research group.
3.2.1.3 Code-free reporࢢng standards
In biology and biomedicine, code-free reporting standards exist for numerous purposes, e.g., as
part of the Minimum Reporting Guidelines for Biological and Biomedical Investigations (MIBBI)
project [238]. At the time of writing, none of the available standards explicitly addresses in silico
workflows, though they cover current experimental setups for high-throughput assays12. A related
initiative called ISA-tab13 focuses on decomposing large projects, e.g., DEEP as a whole, into
smaller studies that collect and process data by running various assays. The ISA-tab framework
offers templates and different tools that help generating the necessary documentation by providing
convenience functions such as the incorporation of controlled vocabularies via ontologies. Since
the ISA-tab framework is generic by design, it is not impossible to document computational work-
flows, yet the examples provided by ISA Commons strongly suggest that this is not the intended
usecase for ISA-tab. Moreover, rationality dictates that metadata records following the ISA-tab
specification should be used throughout the entire consortium, i.e., from wet lab to dry lab, to
achieve the highest benefit from implementing such a structured approach.
3.2.2 Documenࢢng research projects: a maer of culture
A possible conclusion resulting from the comments on software-based and code-free solutions
for workflow specification and documentation is that they reflect two fundamentally different
approaches toward the same goal: computational scientists aim at offloading the tedious task
of record keeping onto the computer. Contemporary workflow management systems easily
scale with the growing amount of data and, at least as long as best practices concerning data
backup are followed, no information about analysis runs is lost. Accessing computer-generated
documentation and automatically created metadata records within a heterogeneous consortium
is nevertheless still a challenge, presumably due to the lack of a predominant data exchange
12Examples: Functional Annotation of Animal Genomes (FAANG) experiment and sample metadata specification or
the Minimum Information about a high-throughput Nucleotide Sequencing Experiment (MINSEQE) reporting guide-
lines.
13isacommons.org: data model for “Investigation-Study-Assay” tab-separated data.
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standard. In other words, there seems to be an emphasis on record completeness at the expense of
record accessibility by collaboration partners.
At the other extreme of the spectrum are manually created documents, which seem to be more
commonly used in “non-computational” research settings. These range from handwritten notes in
lab notebooks14 to more sophisticated approaches relying on supportive software and templates as
exemplified above for the ISA-tab initiative. Of course, manual work does not scale and is prone
to missing information due to, e.g., human error. However, the manually recorded information
is more accessible by third parties15, especially if the information exchange happens exclusively
among humans.
When limiting the view to the existing software solutions, an important observation can be
made: solving the problem of ensuring replicability of a body of work seems to be feasible16.
Replicability is already a central step toward reproducibility (Section 3.1.1). However, the limi-
tations of existing software solutions in terms of difficult deployment throughout a heterogeneous
consortium, potentially restricted handling of data and metadata and unclear support for newly
developed tools sparked reasonable doubt that any off-the-shelf method would be suitable to gen-
erally capture computational metadata within DEEP. Hence, when designing the computational
metadata model for DEEP, the objective was to create a modest solution that would enable replica-
tion — and ideally reproduction — of all computational analysis in DEEP while striking a balance
between manual documentation and automated information recording.
3.3 Soluࢢon Strategy Developed for DEEP
Taking into account the central issues identified in the problem analysis and the perceived short-
comings of existing off-the-shelf solutions for workflow documentation, the goals for the DEEP
computational metadata model can be characterized with the following conceptual requirements:
1. Modesty: the computational metadata model should serve its purpose with only a limited
amount of (manual) work required by computational scientists in the consortium (exceptions
apply for members of the team who developed the specification). Modesty helps focusing
on central problems and increases the chances of acceptance as the necessary mental effort
to understand and to use the metadata model is low.
2. Iterative refinement: the different roles of the collaboration partners (Section 3.2) in a con-
sortium are clear from the start, but the data or information contributed by them may change
over time. As a consequence, the metadata model and related tracking systems need to be
designed flexibly enough to allow for updates or extensions without a restart of the whole
system.
14As done in DEEP — personal communication with members of the AG Walter, Saarland University.
15Ease of sharing considered as orthogonal problem here.
16Substantial improvements in facilitating replicability of computational analyses have been made in the past couple
of years due to the steep increase in popularity of tools such as Bioconda that aim at standardizing software environment
setups and also support the packaging of entire workflows as containers [92].
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3. Human communication: access to the tracked information must be easy enough to allow for
fluent communication and information exchange by all researchers involved in the project,
with different levels of granularity depending on their scientific background. Although not
optimal in terms of transparency and accessibility, disseminating information via e-mail is
still common and it is thus desirable to have metadata available in a form that supports
making use of that medium if necessary.
4. Computer communication: a research setup distributed across several institutes implies a
diverse software landscape that requires simple text- or API-based data exchange if no sin-
gle de facto data standard exists. In particular, application-specific binary data formats or
popular yet proprietary file formats like Microsoft Excel® spreadsheets are not suitable for
hassle-free interoperability.
5. Controlled collection: if possible, any metadata record should be validated before entering
the DEEP ecosystem and erroneous data should trigger immediate feedback to the submitting
user to ensure timely correction. Besides checking for errors, controlled metadata collection
encompasses the task of avoiding redundancy in the records, which can be a prime source
of confusion for users when querying the system for information.
6. Centralized collection: a single authority has to collect the complete body of metadata to
avoid synchronization issues between collaborating institutes and to offer the same coherent
information to all scientists in the consortium and in the scientific community.
All concepts developed at the DAC to record metadata of computational analyses within DEEP
implement one or more of these points. However, since these concepts were designed and tested
as part of DEEP itself, it was not possible to realize the last point of a single source of information,
which naturally would have been hosted and maintained by the Data Collection Center (DCC) in
Heidelberg. The following paragraphs provide an overview of the metadata model developed as
part of DEEP. The technical implementation details are presented in Section 3.4.
3.3.1 Concept digest: process and analysis metadata
DEEP metadata for a computational analysis pipeline consist of two core components, a generic
“process document” and an “analysis metadata file” (Figure 3.1). A process document provides
a template-like specification of a computational analysis run, listing required input, output and
reference data plus the individual command line calls to execute. The process document itself is
versioned and includes version information for all programs, thus providing a static description
of the software environment that should be used to transform input into output files. A process
document contains the general layout of a specific type of analysis and has to be created manually
by the bioinformatician in charge.
The metadata of an actual execution of the pipeline is captured in the analysis metadata file, i.e.,
there is a one-to-many relationship between a process document and the corresponding analysis
metadata files. Records in an analysis metadata file contain concrete values for all parameters
specified as placeholders form in the process document. In conjunction, a process document and
a corresponding analysis metadata file represent both the complete set of information necessary to
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repeat an analysis, and the full documentation of how a specific type of data file is processed in
the DEEP consortium to obtain the desired result.
Figure 3.1: Documenting pipeline runs with a DEEP process document and analysis meta-
data files: a DEEP process document (upper left) contains the abstract specification of a standard-
ized computational pipeline. Executing this pipeline with different input data generates distinct
output files and metadata records per run (green and orange arrows, top to bottom). The complete
metadata record of a run includes the information of input and reference file names (top and right)
and is stored in an analysis metadata file (bottom, large icons) .
3.3.2 Concept digest: ﬁle tracking database
Every pair of process document and analysis metadata file can be seen as an isolated metadata
record that ties the given information to the point in time when the record was created, i.e., when
the analysis metadata file was created after a successful run of the pipeline. To ensure a consistent
state of this metadata record, it is necessary to link this record to the actual data files in a dynamic
manner. We therefore developed a DAC-internal Oracle® database (in the following: file tracking
database) that registers DEEP analysis runs and monitors the associated files for changes based on
timestamps and data checksums. As long as all data and metadata files do not change, we know
that the information captured is still correct at any point in time after the initial registration of the
metadata record.
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3.3.3 Data exchange between DAC and DCC
As stated in the beginning of this section, the proof of concept status of the DEEP metadata
model prohibited a deployment beyond the DAC infrastructure. As a consequence, no error check-
ing system was put into place to avoid the automatic transfer of potentially large amounts of erro-
neous data from the DCC to the DAC. The download of alignment data from the DCC to the DAC
for standardized analysis, and the re-upload of the results from the DAC to the DCC were thus
critical points with the potential of introducing errors into the local software environment at the
receiving end. Hence, for practical reasons, the consistency of the computational metadata records
was only monitored between the time of arrival of new data at the DAC up to the time of the upload
of analysis results to the DCC.
3.4 Implementaࢢon in DEEP
The specification of the DEEP computational process documents and analysis metadata files
was published in Ebert et al. [64]. The description given below includes more technical details
compared to the published specification. Furthermore, the description of the file tracking database
that establishes the dynamic link between a metadata record and the files on the file system is
largely absent from the published manuscript; more details about the file tracking database are
also given in the following.
3.4.1 Process and analysis metadata
A process document standardizes one type of computational analysis and contains eight sec-
tions (see Table 3.1), which are specified in form and content in an XML Schema Definition (XSD)
document. Relying on the well-established XSD/XML formats has the advantage that suitable
libraries are available for many programming languages popular in bioinformatics, e.g., R and
Python. A crucial point in the decision for the XSD/XML formats was the desired functionality
that a DEEP process file can be computationally validated to be compliant with the specification
as set in the XSD document. A prototype validation script was published together with the specifi-
cation in Ebert et al. [64]; for an example usecase, see Listing 3.1. Additionally, the small file size
of XML-based process documents — they are just structured text files — facilitates sharing pro-
cess documents, e.g., by sending them via e-mail to collaboration partners. To improve (human)
readability of DEEP process documents, a link to a Cascading Style Sheets (CSS) file is included
in each process file. When viewing the process document in a web browser, the CSS document
is automatically loaded and the DEEP process document is rendered into a human readable form
(Figure 3.2); no special software besides any common web browser and an active internet connec-
tion is required.
The sections in the process document are organized into three different categories: metadata about
the process file itself (name, version, author, and description; Figure 3.2), a listing of data files
(inputs, references, and outputs; Figures 3.3 and 3.4) and a listing of step-by-step instructions de-
tailing the individual computational steps of the process (software; Figure 3.5). Listing reference
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data as an item separate from input files reflects what we have identified to be a common way
of thinking among scientists, i.e., reference data are not subject to data transformations as part of
the computational analysis and are thus semantically different from input data. All file listings
use generic identifiers (placeholders) to fulfill the requirement of having a single process XML
document for all computational analyses of a certain type with run-specific details limited to the
analysis metadata file. These placeholders are also used as in the respective command lines in
the software section of the process. The computational tools listed in the software section have
to be specified with version information to enable other researchers to setup an identical software
environment on their infrastructure. Concerning custom scripts, this version information may be
stated in form of a repository revision number or commit tag. Beside generic file identifiers, each
command line may contain any number of additional placeholders pertaining to parameters whose
values depend on the input data. Due to the necessity of using generic file identifiers, the “loop”
field explicitly states if all input files are processed together or not, i.e., whether or not the com-
mand can be executed in parallel for a set of input files (see Figure 3.5).
The complementary analysis metadata file is automatically produced at the end of a successful anal-
ysis run and contains at least the sections description, inputs, references, outputs, and parameters.
These sections consist of textual “key-value” mappings that do not require dedicated programming
libraries to be created. This lenient format specification is reasonable because all computational
researchers in the consortium have to be able to produce analysis metadata files using their pre-
ferred programming language in their own software environment. Despite this flexibility, the strict
specification of a process document together with the possibility of validating process and analysis
metadata together can be used to avoid the collection of unstructured metadata for an analysis run.
Table 3.1: The structure of a DEEP process document. The example name “CHP” is the 3-letter
identifier for the DEEP ChIP-seq pipeline.
Section Content
name Name of process, e.g., CHP
version Version of process, e.g., 4
author Name and e-mail address of process author(s)
description Free-text description of the purpose of the process
inputs Listing of all required input files
references Listing of all required reference files, e.g., genome assembly
outputs Listing of all generated output files
software Listing of all analysis steps with details about software
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Listing 3.1: Example run of the prototype script validating the process document CHPv5 and the
analysis metadata files for several analysis runs. The validation fails for the analysis metadata file
that was generated with the previous version of the same process (CHPv4).
1 py thon3 mdva l id . py \ \
2 −−schema d ee p _ p r o ce s s _s c h em a . xsd \ \
3 −−p r o c e s s CHPv5 . xml \ \
4 −−a n a l y s i s \ \
5 43 _Hm03_BlMa_TO_Hist_F_1 . CHPv5 . 2 0 1 7 0 9 1 6 . hg38 . amd . t s v \ \
6 44_Mm03_WEAd_C2_Hist_F_1 . CHPv4 . 2 0 1 5 0 6 1 9 . m38 . amd . t s v \ \
7 51 _Hf01_BlCM_Ct_Hist_B_1 . CHPv5 . 2 0 1 7 0 9 1 6 . hg38 . amd . t s v
8
9 [ INFO ] Checking :
10 [XML] CHPv5 . xml
11 [AMD] 43 _Hm03_BlMa_TO_Hist_F_1 . CHPv5 . 2 0 1 7 0 9 1 6 . hg38 . amd . t s v
12 [ INFO ] OK:
13 [XML] CHPv5 . xml
14 [AMD] 43 _Hm03_BlMa_TO_Hist_F_1 . CHPv5 . 2 0 1 7 0 9 1 6 . hg38 . amd . t s v
15 =====
16 [ INFO ] Checking :
17 [XML] CHPv5 . xml
18 [AMD] 44_Mm03_WEAd_C2_Hist_F_1 . CHPv4 . 2 0 1 5 0 6 1 9 . m38 . amd . t s v
19 [ERROR] Cannot f i n d p r o c e s s name CHPv5
20 i n a n a l y s i s m e t a d a t a s e c t i o n ” d e s c r i p t i o n ”
21 [ERROR] AMD f i l e
22 44_Mm03_WEAd_C2_Hist_F_1 . CHPv4 . 2 0 1 5 0 6 1 9 . m38 . amd . t s v
23 does n o t v a l i d a t e a g a i n s t p r o c e s s XML
24 [ INFO ] FAIL :
25 [XML] CHPv5 . xml
26 [AMD] 44_Mm03_WEAd_C2_Hist_F_1 . CHPv4 . 2 0 1 5 0 6 1 9 . m38 . amd . t s v
27 =====
28 [ INFO ] Checking :
29 [XML] CHPv5 . xml
30 [AMD] 51 _Hf01_BlCM_Ct_Hist_B_1 . CHPv5 . 2 0 1 7 0 9 1 6 . hg38 . amd . t s v
31 [ INFO ] OK:
32 [XML] CHPv5 . xml
33 [AMD] 51 _Hf01_BlCM_Ct_Hist_B_1 . CHPv5 . 2 0 1 7 0 9 1 6 . hg38 . amd . t s v
3.4.2 File tracking database
The file tracking database was designed and implemented in winter 2013/2014 and went online
in spring 2014. The database is running on a DAC-internal Oracle® server and all server-side
functionality has been implemented in PL/SQL. Programmatic access to the database is realized
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(a) Textual XML view (b) CSS–rendered view
Figure 3.2: Text and CSS–rendered version of a DEEP process document: excerpt of a DEEP
process document in its textual XML form (a) and in its CSS–rendered form (b). The XML docu-
ment can be opened and read in any text editor, whereas the more human–friendly version requires
any common web browser and an active internet connection (rendered here with Mozilla Firefox
61.0.1).
Figure 3.3: Input file listing of a DEEP process document: excerpt of the input file listing in
the DEEP process CHPv5. Throughout the process document, files are referenced using a generic
identifier. The quantity value “collection” indicates that the process has been designed to handle
several files of this type. In this example, the input file identifiers contain a reference to another
DEEP process (short read mapping for genomic libraries, GAL), indicating that process CHPv5 is
designed for output files of the GAL process.
either directly via a server-side SOAP17 service, via a custom Python client interfacing with said
SOAP service or via a custom Extensible Markup Language Remote Procedure Call (XML-RPC)
server that mediates between XML-RPC clients and Oracle’s® SOAP service.
17SOAP used to be an acronym for “Simple Object Access Protocol”, but current specifications of SOAP allow more
than just object access, hence, SOAP is just a name and no longer an acronym/abbreviation.
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Figure 3.4: Output file listing of a DEEP process document: excerpt of the output file listing
in the DEEP process CHPv5. This example illustrates how identifiers for output files should be
derived: DEEPID.PROC.DATE.ASSM.raw.bamcov is the concatenation of the DEEP sample identifier,
the process identifier (here: CHPv5), the date and genome assembly (ASSM) plus a meaningful
suffix (here: raw.bamcov) that makes the resulting file name unique.
Figure 3.5: Single step of a DEEP process command line listing: excerpt of the software list-
ing in the DEEP process CHPv5. This example illustrates the use of file identifiers as part of the
command line specification. The wildcard symbol “*” is used in its common meaning of match-
ing all identifiers with the prefix GALvX_, i.e., the histone BAM files GALvX_Histone and the Input
control GALvX_Input are all matched by this expression (Figure 3.3). Parameters in curly braces
(deeptools_parallel and genomesize) may change with each execution of this process and their
concrete value has to be specified in the respective analysis metadata file to produce a valid meta-
data record.
The core components of the database are outlined in Figure 3.6. The database has two main
tasks: first, linking files that belong to the same analysis and, second, detecting and reporting file
changes after said link has been established. For the first task, the user creates a new record in the
database representing an analysis run (table DEEP.ANALYSISRUN). This new analysis run is linked
to the respective process (table DEEP.PROCESS) provided that it already exists. Otherwise, the
user is required to create the new process entry. This strict requirement exists because a process
serves mainly a documentary purpose in DEEP, and this enforced sequence of steps guarantees
that no undocumented analysis can be stored in the database. In a second step, the user supplies
lists of input and output file paths that are linked to the metadata record of the analysis run. Here,
reference files are subsumed under input files since both file types have to exist before the analysis
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starts and are, from the database point of view, conceptually identical. The necessary input
information to complete these two or three steps has to be supplied manually (see Listing 3.2), but
it is of course possible to automate run registration and to add this as the final task of an analysis
pipeline; in other words, the system is designed such that human interaction can be reduced to a
minimum if desired. After successful analysis run registration, no more manual interaction with
the database is required to monitor the coherence of the metadata records.
It is important to realize that this coherence cannot be guaranteed by saving the database
entries alone, e.g., in the form of backups. Metadata coherence has to be actively and continuously
monitored to safeguard against data corruption. To this end, a daily synchronization between the
file tracking database and the DAC file systems scans for changed file modification times. If the
timestamp differs between database and file system, the MD5 checksum stored in the database
is compared to the MD5 checksum calculated from the file to reliably18 detect changes of the
file’s content. Because there are plausible scenarios that do not affect the overall coherence of
the analysis metadata records, but yet may result in a different file checksum, e.g., correcting a
typographical error, there is currently no automated resolution for confirmed file changes; the
emphasis of this setup is that no modification should be unnoticed. Keeping file metadata in a
separate location has the additional benefit that, for the duration of the project, recovery after
data corruption on the file system level is simplified19. Since the database stores filenames and
file paths, restoring this information based on a matching checksum is straightforward and faster
than complete recovery from — potentially outdated — tape backups. A long-term benefit is
that the metadata of a file are kept beyond the file’s lifetime on the file system, i.e., if the file is
eventually deleted, the database record is set to inactive but otherwise left intact. In case of data
inconsistencies detected at any later point in time, this eases the search for the error source as it
permits to narrow down the time window when the corruption happened.
The implementation and active use of the file tracking database resulted in other advantageous
applications that extended the central tasks described above. The most important ones from the
consortium perspective are the automated progress reporting and e-mail notification system, and
the possibility to download quality control plots and to annotate samples with quality labels20.
These services can be regarded as evidence that a system primarily intended to collect and to
monitor metadata records can serve various useful purposes in a consortium.
18While MD5 is known to be vulnerable and considered insecure for cryptographic uses (see, e.g., the blog
post schneier.com/blog/archives/2005/06/more_md5_collis.html by Bruce Schneier), its use to detect data corruption
is generally uncontested. At the time of writing, no MD5 collision detected by the file tracking database was due to
MD5’s known collision vulnerabilities.
19Personal communication with IST: despite all redundancies on the hardware and on the software level, there is a
non-zero probability that a chain of severe failures results in lost file system metadata, i.e., files still exist, but only as
blocks of data with no folder hierarchy, filenames or attributes.
20See deep.mpi-inf.mpg.de/status (DAC status page) sections Reporting and Service
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Listing 3.2: Example code of using the Python3 SOAP client to store a DEEP process and an asso-
ciated analysis run of a computational pipeline in the file tracking database. Mandatory parameters
are printed all upper case. The complete output of each client call is omitted for visual clarity.
1 $ py thon3
2
3 >>> i m p o r t d e e p t r a c k d b as d t d
4
5 # i n i t i a l i z e c l i e n t − pre−c o n f i g u r e d
6 # f o r DAC i n f r a s t r u c t u r e
7
8 >>> c l i e n t = d t d . DEEPTrackDB ( )
9
10 # s t o r e new p r o c e s s i n d a t a b a s e
11
12 >>> c l i e n t . s t o r e _ p r o c e s s (PROCESS_NAME,
13 PROCESS_FILE ,
14 d a t a f r e e z e =None ,
15 f r e e z e d a t e =None )
16
17 # c r e a t e new a n a l y s i s run
18 # f o r e x i s t i n g p r o c e s s
19 # −> r e t u r n s DB_RUN_ID
20
21 >>> c l i e n t . s t o r e _ a n a l y s i s _ r u n (USER_RUN_ID ,
22 PROCESS_NAME,
23 USERNAME,
24 machine=None ,
25 cpus =None ,
26 r u n t i m e _ h r s =None ,
27 memory_gb=None )
28
29 # add f i l e s t o a n a l y s i s run
30
31 >>> c l i e n t . s t o r e _ f u l l _ a n a l y s i s (DB_RUN_ID ,
32 INPUT_FILES ,
33 OUTPUT_FILES ,
34 check =True )
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3.5 Evaluaࢢon of the Computaࢢonal Metadata Model
The evaluation of the DEEP metadata concept together with the file tracking database focuses
on four major aspects: (i) comprehensiveness of the recorded information, (ii) error detection, (iii)
future uses of the system and (iv) discovered shortcomings.
3.5.1 Comprehensiveness of the metadata records
The basic documentation of all DEEP pipelines in the form of process specifications has been
continuously updated throughout the lifetime of DEEP. Processes describing pipelines that are
not executed by the DAC, e.g., short read alignment or RNA quantification, may not necessarily
be in line with current software setups at the respective analysis centers, as this cannot be ensured
by the DAC. For all assays routinely analyzed at the DAC21, the process documents are updated
together with the computational pipelines to ensure consistency. At the time of writing, the file
tracking database contained metadata records for more than 280,000 individual files and more
than 1,000 analysis runs that were registered with an analysis metadata file. For certain types of
automatically registered analysis runs, e.g., data down- and uploads between DAC and DCC, no
analysis metadata file is created. For these cases, the registration of the analysis run in the file
tracking database serves only the purpose of marking the time point when files enter or leave the
DAC compute infrastructure. In total, the database records document computational analyses for
approximately 250 biological samples22. Because the file tracking database did not experience
any data loss, the total of all entries can be considered complete from the DAC perspective,
and under the constraint that only standardized pipelines are taken into account. The proper
documentation of any project-specific analysis of DEEP data is at the discretion of the responsible
bioinformatician. However, the database also tracks files not linked to standardized analysis
pipelines, so data consistency can be monitored also for data files resulting from custom analyses.
When considering also opportunistic uses of the file tracking database such as the central-
ized collection of quality labels for individual experiments, it becomes apparent that automation
seems key to achieve completeness: the number of manually assigned quality labels is below what
would be required to provide a comprehensive picture of the sample quality in DEEP. This gap
between mostly automatic data recording and manual effort seems not surprising and highlights
the need for research environments that record metadata autonomously and then summarize it in a
human-accessible way. Notwithstanding the incomplete sample quality annotation, it seems justi-
fied to conclude that the DEEP computational metadata model in conjunction with the file tracking
database represents a comprehensive documentation resource that has proven useful in detecting
errors and in supporting the global IHEC initiative (see following sections). As such, this project
has been a valuable contribution to the overall scientific quality of the DEEP project.
21WGBS, RRBS, NOMe, DNase and histone ChIP
22This number includes all official DEEP samples plus cell lines and external data that were processed using the
DEEP pipelines upon request.
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3.5.2 Error detecࢢon and consistency checking
Checking the adherence of computational analysis metadata files to the respective process doc-
ument can be realized using the validation script introduced above (see Listing 3.1). Apart from
that, bioinformaticians can rely on the file tracking database for continuous monitoring of the
recorded metadata. Since the file tracking database can detect potential errors or data corruptions
by itself, an e-mail notification system was implemented that attracts human attention to the file
tracking database only when needed. Several examples of these notifications are listed in Table 3.2
with detailed explanations given in Listing 3.5.2.
1. The manual recovery attempt after a failed pipeline run resulted in a misconfiguration spec-
ifying the wrong species reference data. The listed binary alignment map (BAM) files have
identical checksums despite belonging to human (file 1) and mouse (file 2).
2. File 1 is a pipeline error log, file 2 is a DEEP process document. The error was caused by
registering a mock file as DEEP process document in the file tracking database. Both the
error log file and the mock process document were empty, i.e., the MD5 checksum is that of
an empty file.
3. An error in sample naming and subsequent sorting into wrong folders resulted in data dupli-
cation at the DCC. The error was automatically synchronized to the DAC file system.
4. Inconsistent file naming (comma-separated value (CSV) versus tab–separated value (TSV)
filename extension) resulted in data duplication at the DCC. The error was automatically
synchronized to the DAC file system.
5. An error in sample naming and subsequent sorting into wrong folders resulted in data dupli-
cation at the DCC. The error was automatically synchronized to the DAC file system.
6. Both experiment metadata files have the same content, but file 1 belongs to a male subject
(“Hm”) and file 2 belongs to a female subject (“Hf”). It should be noted that both filenames
are syntactically correct, i.e., there is no direct way to spot this as an error for a human
investigator.
7. Despite a difference in the reference assembly used (human GRCh38 and GRCh37), both
result files have identical contents. However, this is an example of a “false alarm”: the data
files correspond to a microRNA experiment, and microRNAs are not directly mapped against
a reference genome assembly, but against a library of potential targets. Hence, a change in
the reference assembly may not affect the output files as long as these do not contain actual
sequence locations.
8. The contents of the analysis metadata files are identical despite belonging to a steatotic pa-
tient (file 1) and a normal control (file 2), respectively. Since analysis metadata files also
contain information on the input data files, their contents must not be identical.
9. A case similar to item 6 above, but the two files listed are quality control metadata files
produced at the end of a short-read mapping pipeline. That indicates that, due to a wrong
sample name, a “new” sample was introduced into the DEEP environment and processed
using the default pipelines (again, both sample names are syntactically correct). The corre-
sponding BAM files have likewise been flagged by the file tracking database (not included
in Table 3.2).
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10. An example of a file change notification after an update of several sample and experiment
metadata files at the DCC. The changed file modification time triggered the comparison
of the MD5 checksum stored in the file tracking database to the newly calculated MD5
checksum of the file; since the two checksums differed, the notification was sent to indicate
a potential data corruption.
An instructive example of a case where the existing software solutions could not have de-
tected a problem occurred in May 2015 as follows: after a routine update of the DEEP ChIP-seq
pipeline for basic signal quantification and peak calling, one of the quality control plots depicting
a correlation heatmap between all histone marks showed a substantial deviation from the previ-
ous version. Figure 3.7a shows the original heatmap created in May 2014, and Figure 3.7b shows
the updated version created in May 2015. The two heatmaps clearly show differences suggesting
that the original results cannot be reproduced (or rather replicated) with the updated computational
pipeline. Due to the extensive metadata records at the DAC, it was possible to conclude beyond
reasonable doubt that this anomaly did not result from an error in the DAC processing pipelines.
The source of the problem was traced back to a change in deepTools [199], where a previously
implemented stringent strategy of outlier removal was changed without documenting this in the
release change logs (see Figure A.1). It is a matter of personal experience whether one considers
a minor negligence like missing documentation of changed program behavior a common situation
in computational research or not. Irrespective of personal experiences, though, without the meta-
data records kept at the DAC, it would not have been possible to quickly isolate the source of the
problem with reasonable certainty, which would have put all previous results into question.
3.5.3 Post-DEEP use of the metadata records
The funding period of the DEEP consortium ended in October 2017 and the file tracking
database can be archived at the DCC in Heidelberg as soon as all remaining DEEP analyses have
been completed. Since all records can be dumped as SQL or textual tables, it will still be possible
to retrieve all information without the need for the complete programmatic environment described
in section 3.4.2. The documentation resource created at doi.org/10.17617/1.2W is linked via the
IHEC data portal [36]23 and provides open access to the complete description of the computational
pipelines developed and applied in DEEP. It follows that full documentation and metadata records
will be available to the scientific community beyond the lifetime of the DEEP project.
3.5.4 Idenࢢﬁed shortcomings in design and implementaࢢon
The routine use of the DEEP metadata model revealed several weaknesses of the setup. The
requirement of straightforward, iterative updates of the process documents and of the associated
pipelines turned out not to be in line with realistic needs. Empirically, process documents and
the respective computational pipelines were usually only updated when reference data changed,
e.g., after switching to a new version of a genome reference assembly. This raised the question
23Documentation linked under “Methods” for the DEEP consortium.
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(a) CHPv1: deepTools v1.5.7
(b) CHPv3: deepTools v1.5.9.1
Figure 3.7: CHPv1 and CHPv3 quality control heatmaps: (a) histone mark Pearson correlation
heatmap for mouse sample 44_Mm01_WEAd_C2 created with deepTools v1.5.7 as part of DEEP
process CHPv1 in May 2014. (b) the same data were analyzed with deepTools 1.5.9.1 as part of
the updated CHPv3 process in May 2015. Rows and columns of both heatmaps are labeled with
the respective histone mark name, “Input” refers to the Input control dataset.
whether the flexibility of specifying reference data was actually necessary; tying a fixed set of
reference datasets (per species) to one process version may be sufficient to fulfill the needs of
a large-scale consortium with a predefined research scope. Of course, a solution that also ties
specific reference data to process versions requires consortium-wide agreements which references
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to use for every single reference annotation file.
A stricter handling of user-submitted data was also discussed as a potential enhancement of
the file tracking database with the objective of improving metadata consistency. For example, the
file tracking database could have canceled the registration of analysis runs if process document
and analysis metadata failed to validate. The downside of such restrictive approaches is that
usability usually suffers, which in turn can be expected to lower user compliance. However, since
the metadata model was developed as part of DEEP, its use in daily operations can be considered
a field test to detect deficits; to that end, a lenient system potentially offers more insights into
what features users actually expect, want or use.
One of the design principles behind the DEEP metadata model is the reliance on rather simple
data formats to facilitate data exchange between all collaborating institutes. Consequently, DEEP
process documents are text files and not, e.g., executable pipeline scripts. Nevertheless, it would
have been possible to extend the tooling support for the computational metadata beyond the
validation script. For example, it would likely be feasible to implement a tool that extracts the
command lines from the process documents to provide bioinformaticians with a rudimentary
(Linux) shell script. Although such auto-generated basic shell scripts are presumably not out-of-
the-box portable across the infrastructure of all partner institutes, they could have been useful
for small-scale testing of updated (parts of) pipelines or for running a DEEP pipeline on selected
non-public/non-consortium datasets.
The last potential deficiency concerns the better integration of additional metadata related to
individual samples and experiments. The file tracking database extracted information about DEEP
samples exclusively from the filenames and file system folder structures. An explicit inclusion of
sample and experiment metadata in the file tracking database could have helped to identify miss-
ing data files and missing metadata records (see Section 3.6.3 below). It could be argued that
this would turn the file tracking into a sample tracking database, which is out of scope for the
DEEP computational metadata model. In particular, the computational validation of sample and
experiment metadata can be cumbersome — if not impossible — without strict specifications of
controlled vocabularies or biological ontologies. It follows that, as a prerequisite to the explicit
inclusion of additional metadata in the file tracking database, collection and validation strategies
have to be defined in more systematic ways. Given that groundwork, augmenting the file track-
ing database with sample and experiment metadata would be feasible and, as will be argued in
Section 3.6, would also represent an important building block for reproducible research24.
24The IHEC Data Ecosystem working group is developing strategies to validate experiment and sample meta-
data using JSON and XSD/XML based templates similar to the DEEP computational metadata model; see
github.com/IHEC/ihec-ecosystems/tree/master/version_metadata/examples
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3.6 Discussion and Perspecࢢves
The final section condenses the central aspects of this chapter into a tentative outlook on future
strategies for reproducible (computational) research. Some points made in this discussion may
be perceived as optimistic, but the practical suggestions that could be — and partially were —
implemented in a research consortium such as DEEP only require comparatively little changes to
established operating procedures. It is the premise of this discussion that gradual improvements
in reproducibility should be preferred over absolute — but hard to achieve — “quantum leap”
solutions.
3.6.1 Is the concept of reproducibility outdated?
The reproducibility crisis and the apparent lack of a self-evident way out of it motivate
the question if scientific reproducibility is still an appropriate quality measure for data-driven,
high-throughput biomedical research in the 21st century. The consensus in the current literature
seems to be that only reproducible research is reliable research [4, 19, 47, 61, 103, 108, 137, 228].
The generally accepted answer to the question why that is the case is that testing a new hypothesis
requires a framework of previously established theories that are assumed to hold (until proven
otherwise, see Section 3.1); science can only advance in a systematic manner under that condition.
However, accepting the above answer to the question why reproducibility is still fundamental
to (modern) scientific progress does not provide an immediate answer to the question what that
entails; two parts seem to be relevant here: (i) what studies need to be independently tested and (ii)
to what extent must the results be concordant to call the original study reproducible? Concerning
the first part of the question, an observable pattern is that controversial or groundbreaking studies
are often reproduced by independent groups out of scientific interest; see, e.g., the case of Obokata
et al. [175], where the results could not be reproduced and the publication was retracted25, or the
so-called “Schön scandal”26. It thus seems reasonable to assume that the majority of published
research is left untested, and the published claims or findings are, from a theoretical point of view,
in an unclear state of reliability. A conceivable reason behind this is a lack of broad scientific
interest, which justifies not to raise the necessary resources to reproduce any published body of
work.
The second part of the above question concerning concordance of reproduced and original results
can be assumed to be (even) more elusive, because the required (minimal) agreement between an
original study and its successful reproduction is presumably context-dependent [244]27.
In summary, it seems difficult to find a precise answer to the question what the importance of
reproducibility — if anything at all — implies for modern high-throughput research. Reality offers
at least a practical answer, because science is advancing despite a lack of independent testing for
most studies; some even argue that most published research findings are false [107]. However, it
25Nature retraction notice: doi.org/10.1038/nature13598
26Nature News: doi.org/10.1038/news020923-9
27A failed or succeeded attempt to reproduce a study is presumably often a case of “I know it when I see it”.
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may be that speed and resource-efficiency of the current scientific progress are perceived as less
than adequate [152]. In conclusion, reproducibility as a condition for scientific progress seems not
to have lost its importance for modern research, but the concept of scientific reproducibility may
be in need of a “theory of sufficiency” [80] to keep pace with changing trends in science (e.g., from
hypothesis-driven to data-driven science). A theory of sufficiency28 for scientific reproducibility
should define sufficient conditions under which a scientific field can advance without aiming for
potentially wanted but hard to achieve ideals such as reproducibility rates of 100%. Defining
a theory of sufficiency for scientific reproducibility is of course not the objective of this thesis.
Hence, the following paragraphs focus on more practically oriented suggestions for modernizing
some aspects of scientific work with a potentially positive effect on reproducibility.
3.6.2 Suﬃciency in reproducibility as a community-driven project
The driving force behind any change in the contemporary implementation of the scientific
method has to come from within the scientific community, which includes all involved parties,
from journal editors and reviewers to principal investigators, staff scientists, and data curators. As
pointed out in Section 3.1.3, formulating demands on how to improve reproducibility that address
the scientific community as a whole seems not to be the right way of solving the reproducibil-
ity crisis. A reasonable alternative would be to tackle the problem at smaller scale on the level
of subcommunities. Subcommunities of comparatively narrow research fields, e.g., ChIP-seq,
regulatory network analysis or short read mapping could regularly assemble to host Quo Vadis
events. During these gatherings, experts and proficient users could jointly identify core issues in
their niche: what published work is of general interest and should be reproduced? What open
questions should be addressed to move the field forward? What databases or data resources are
widely used and need curation, better interfaces or sustained maintenance? What data standards
are needed, or need an update, or are obsolete altogether? The answers to these questions could
then be summarized in a white paper29 that serves multiple purposes: first, it highlights problem
areas relevant to the community, which may help to acquire funding for low-profile and yet impor-
tant work such as infrastructure or maintenance projects. Second, it identifies research problems
that are of broad interest to the community, which may provide guidance to make better decisions
at crucial points during a research project30. Third, the research community outlines what pub-
lished research needs to be independently tested to provide proper footing for future work. The
actual reproduction work could then be carried out by volunteering labs that receive earmarked
funds for each reproducibility study. Although this community-driven process does not by itself
constitute a “theory of sufficiency” for modern reproducibility, it yet accomplishes three things in
this regard: first, it locates concrete responsibility and action within a small group of researchers
28The cited source by Harry G. Frankfurt deals with sufficiency in economics, which is of course not relevant here.
However, using the term and the concept of a “theory of sufficiency” was motivated by this source.
29The Computational Pan-Genomics Consortium has published a white paper along those lines [157]. The purpose of
this white paper was to provide an overview of this emerging field, and thus the manuscript does not address potential
reproducibility issues; this could of course change as soon as the field is more established.
30An obvious objection against such an approach would be that it could limit diversity of research or amass to much
resources on a narrow scope. Although theoretically this could happen, it should be noted that, by complementation,
such a white paper also points into directions of high-risk/high-gain research.
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instead of addressing the scientific community as a whole (Section 3.1.3). Second, as an imme-
diate consequence, the scientific community anchors reproducibility studies as an integral part of
the scientific work routine, which attributes more value it. Third, instead of considering (the lack
of) reproducibility as an absolute problem, an iterative and adaptive strategy sets short-term goals
of what is needed for any particular field to advance “in good faith” — the scientific endeavor as
a whole would then benefit from these growing fields of “sufficient reproducibility” established at
the level of subcommunities.
3.6.3 Reproducibility by design in large-scale research projects
Under the assumption that a notion of sufficiency in reproducibility is a practical necessity
given the current pace of research, it seems pertinent to examine potential implications for large-
scale research projects such as DEEP. It seems indisputable that the main objective of research
consortia would not be altered by a more contemporary view on reproducibility: the expertise of
all collaborating groups is combined to tackle difficult or even high-risk research problems that are
beyond the reach of any individual group. Hence, the studies published by the research initiative
are the central output. As argued in Section 3.6.1, if the published results are groundbreaking or
controversial (enough), it can be expected that the results will be independently tested by groups
outside of the consortium. For work with lower impact, the realization of Quo Vadis events in-
cluding reproducibility studies by volunteering labs would offer another route to gaining higher
confidence in results published by research consortia. However, it does not seem reasonable to
assume that the majority of the works published in a consortium context would be independently
tested for their reproducibility. It follows that some of the findings reported by a research consor-
tium are of unclear value to the scientific community (Section 3.6.1). This does not by any means
diminish the individual achievement; yet it suggests that large research consortia may need to
modernize their role as providers of comprehensive datasets to support (sufficient) reproducibility
by design. The common practice of depositing raw data at an International Nucleotide Sequence
Database Collaboration (INSDC) [211] database may ensure long-term availability of the data, but
this is not per se a useful resource. Although a certain amount of annotation or metadata is required
before a raw dataset can be deposited at an INSDC database, consortium-internal rules on sample
naming, recorded sample information or trivialities like units of measurement may complicate the
creation of a coherent data resource at an INSDC archive.
A possible improvement over the current situation could be achieved by collecting sample, ex-
periment and computational analysis metadata in a consortium-internal database that allows for
controlled access by external experts for “virtual reproducibility audits”. During such an audit,
external experts would examine the coherence of the metadata records with the objective of “vir-
tually” reproducing all analysis steps. In other words, the external experts would try to evaluate if
the metadata recorded for a specific analysis task are presumably sufficient to independently repro-
duce the results given suitable primary data. Due to their experience, experts can spot missing but
relevant metadata, or identify potential low quality samples, e.g., based on quality control metrics
without having to repeat the analysis. These audits could be conducted as part of standard report-
ing procedures, and potentially more often upon request. Furthermore, they would have several
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beneficial properties: first, the burden on the infrastructure is low as the data volume is limited
— metadata have usually the form of textual information — and the necessary technology, i.e.,
databases with simple and access-controlled interfaces is well-established. Second, the consortium
does not suffer from a competitive disadvantage because no access to the primary data is required.
Third, the outside perspective prevents the effect of “organizational blindness” when evaluating
comprehensiveness and usefulness of the metadata records. Fourth, potential missing information
would be discovered before data submissions to INSDC databases have to be prepared, which may
increase the chances of collecting the missing information before data submission. Fifth, in emerg-
ing fields with no consensus on the reporting standards, this transparency may help to identify a
core set of sample, experiment or computational analysis metadata that need to be recorded irre-
spective of the study context. Sixth, if the medium- to long-term preservation and accessibility
of the consortium metadata records cannot be ensured by any of the collaborating groups, saving
the records at a dedicated service such as Zenodo31 could solve the issue. In summary, planning
for “virtual reproducibility audits” when devising resource requirements for large-scale research
projects may offer a practical way for “sufficient reproducibility” by design within the sphere of
influence of a consortium.
3.6.4 A building block for reproducible research in DEEP
The DEEP metadata model for computational analysis is the realization of one of the central
building blocks that are required for preparing a consortium for “virtual reproducibility audits”.
The proof of concept status of the metadata model, including metadata validation and the file track-
ing database, prevented a more strictly enforced — instead of just encouraged — use throughout the
DEEP consortium. Due to this proof of concept status, the last objective formulated in Section 3.3,
i.e., the continuous and centralized collection of all metadata at the DCC in Heidelberg, has not been
realized. Nevertheless, the remaining objectives outlined in Section 3.3 have been achieved: the
metadata model described in this chapter is a task-oriented approach for recording computational
metadata in a large-scale research consortium. This model requires only limited manual work, i.e.,
specifying process documents, but captures a substantial amount of information when consider-
ing the combination of process documents and analysis metadata files. Validating these metadata
records (Listing 3.1) and continuously checking their consistency via the file tracking database en-
sures that this body of information provides a reliable resource for future queries about the DEEP
data. Specifically, this setup ensures that hypotheses about the data can be tested with certainty
about data processing steps, which can provide important hints for elucidating the nature of spu-
rious observations. The DEEP computational metadata model abstracts implementation-specific
intricacies of analysis pipelines into a human- and machine-readable form without compromising
on the comprehensiveness of the metadata records. To that end, the model is designed to require
only limited resources while overall capturing a sufficient amount of information such that repro-
ducing (computational) results is a practically achievable goal. It is self-evident that the DEEP
computational metadata model cannot prevent human error (but it can detect it, see Section 3.5)
31Zenodo is a general purpose, “catch-all” repository for scientific data funded by the European Commission and
hosted by the CERN.
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or negligence, and, consequently, cannot provide guarantees on the reproducibility of a study. It
does, however, provide reliable information on the “what and how” for individual results. It is this
combination of lowering error rates and providing reliable information that harbors the potential
of substantially improving reproducibility.
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CHAPTER 4
Fast Detecࢢon of Diﬀerenࢢal
Chromaࢢn Domains with SCIDDO
Lead-in This chapter is concerned with the problem of systematically identifying regions of
differential chromatin between cellular phenotypes of interest within one species. Section 4.1
provides a short motivation and an overview of existing methods that tackle the same problem.
As detailed in Section 4.1, these existing methods have several methodological limitations that
motivated developing our tool SCIDDO as a more broadly applicable and more flexible approach
toward differential chromatin analysis. Section 4.2 presents the methodological and theoretical
foundations of SCIDDO, followed by the results of an exemplary study that illustrate potential
use cases for SCIDDO (Section 4.3). The results are discussed in Section 4.4 and some pointers
for future work on SCIDDO are included in Chapter 6 of this thesis.
The work presented in this chapter is an extended version of the manuscript Ebert and Schulz
[63] (for details and author contributions, see Appendix E.1.2).
4.1 Background
Large epigenome mapping consortia such as DEEP, BLUEPRINT or ENCODE produce an
ever-increasing amount of reference epigenomes for a multitude of different cell types. With the
ultimate goal of compiling a publicly available catalog of 1,000 reference epigenomes released
under the IHEC umbrella, comparative analyses of epigenomes present a formidable challenge for
bioinformatics. However, as explained in Chapter 2, the cell-type specific and dynamic nature of
the epigenome adds substantial complexity to the problem of characterizing cellular similarities
and differences on the epigenetic level. Moreover, limited resources commonly force scientists to
investigate only a small number of biological replicates per condition of interest. Despite these
challenges, the discoveries in the field of epigenomics have greatly enhanced our understand-
ing of transcriptional regulation, cellular identity and disease development [23, 102, 114, 135, 149].
Following the main topic of this thesis, this chapter focuses on the histone chromatin
component of the epigenome. The interpretation of histone mark data is particularly intricate
as the interplay between different histone marks results in a combinatorial complexity that is
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largely absent for other epigenetic modifications such as DNA methylation (see, e.g., bivalent
domains described in Chapter 2, Section 2.1.1.4 and Table 2.1). The realization that histone
mark combinations can be interpreted as local activity states of the genome, so-called chromatin
states, led to the widespread use of probabilistic graphical models for discovering these “hidden
states” [70, 72, 105, 154, 230]. Popular tools such as ChromHMM [70] or EpiCSeg [154]
have tremendously simplified the analysis of histone data as they summarize the combined
effect of histone mark co-occurrences in a manageable number of discrete chromatin states. After
functional characterization, the discovered chromatin states are commonly augmented with textual
labels to ease interpretation, e.g., identifying regions as active or poised promoters (see Chapter 2,
Section 2.1.1.4 and Table 2.1), or distinguishing between weak and strong transcriptional activity.
However, in our experience, the generated chromatin state maps are often manually inspected
in only a limited number of loci or simply serve as additional genomic annotation data. Given
that chromatin state maps provide a neat abstraction of the various histone mark combinations,
it stands to reason that a more comprehensive view on them may offer valuable guidance in
exploratory studies.
So far, there are only few tools available that use chromatin state maps to identify regions
of differential chromatin marking. ChromDet [39] can be applied in a genome-wide manner
and uses Multiple Correspondence Analysis (an analog to Principal Component Analysis for
categorical data) followed by an iterative clustering approach to identify regions that partition the
samples into cell-type or lineage specific groups (so-called chromatin determinant regions). The
computational burden of a ChromDet analysis is lowered by various filtering steps to remove,
e.g., uninformative or outlier regions, which renders ChromDet analyses prohibitive for small
sample numbers1. This preprocessing also requires enough insight into the nature of the samples
at hand to manually set appropriate filtering thresholds.
Other available tools for the differential analysis of chromatin state maps enable only the analysis
of a predefined set of genomic regions. The ChromDiff [264] tool first computes the percent
coverage of all chromatin states in each user-specified region of interest, e.g., the bodies of all
coding genes. Next, after correcting for batch effects using a regression model, ChromDiff uses
the non-parametric Mann-Whitney-Wilcoxon2 test [155] to identify differential chromatin states
between sample groups, e.g., contrasting all male and female samples. Since ChromDiff relies
on standard statistical tests for its analysis, sufficient statistical power in terms of number of
available samples per group is mandatory to find any significant differences between the groups.
The recently published Chromswitch package [111] similarly identifies differential chromatin
states only in preselected regions of interest. Chromswitch can only analyze a single chromatin
state at a time and uses a binary “presence/absence” encoding to construct feature vectors that
are subsequently clustered. The cluster assignments resulting from the hierarchical clustering
1Personal communication with the developer in March 2018 via GitHub: the minimum number of samples required
for an analysis presumed reliable is three biological replicates for three different cell types. Ideally, the dataset should
consist of 5–10 biological replicates for four or more cell types. For datasets with lower numbers of replicates per group,
ChromDet may finish the analysis with the status “not enough group diversity” and not return any output.
2The test name stated here is as given in the publication by Yen and Kellis [264]. This is the same test as the
Mann-Whitney-U test that is used several times in this thesis.
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are then scored by their agreement with the known biological labels of the samples and manual
thresholding on these scores is required to select the final set of differential chromatin regions.
A common denominator of all surveyed methods is that they consider chromatin state similarity
as a binary variable, i.e., any chromatin state is (dis-) similar to any other chromatin state to
exactly the same extent. We think that this is an unnecessary simplification that does not fit the
commonly encountered interpretation of chromatin states as representing different activity levels
of the genome. For example, it seems counterintuitive that chromatin states representing strong
and weak enhancer activity should be as dissimilar to each other as they are to a state representing
heterochromatin.
In summary, current methods are limited to region-based analysis, focus on individual chromatin
states, require a comparatively large number of biological replicates for their statistical analysis,
and use a quite basic representation of chromatin state similarity, which hinders general applica-
bility of existing methods.
We devised a new method for the score-based identification of differential chromatin domains
(SCIDDO) with the goal of providing a generally applicable tool for the fast identification of dif-
ferential chromatin marking. One of SCIDDO’s main features is its capability of identifying po-
tentially large and heterogeneous regions of differential chromatin marking, which we refer to as
differential chromatin domains (DCDs). The statistical evaluation of the identified domains relies
on well-established theory borrowed from score-based biological sequence analysis. This enables
an interpretable presentation of SCIDDO’s results and facilitates downstream analysis. Moreover,
SCIDDO enables users to use custom scoring schemes for an analysis, offering a flexible way
of defining task-oriented and quantitative notions of differential chromatin. In the following, we
present results obtained by analyzing four groups of replicated human samples with SCIDDO. In
this analysis, we assessed the robustness of our method by comparing DCDs between individ-
ual replicates and characterized the identified domains by overlapping them with differentially
expressed genes (DEGs) and various regulatory annotation datasets. We compared SCIDDO to
other methods for the differential analysis of histone data and collected evidence that highlights
SCIDDO’s usefulness in identifying regions of dynamic chromatin changes, e.g., enhancers switch-
ing from an “on” to an “off” state between cell types.
4.2 Materials and Methods
4.2.1 Experimental data overview
All analyses were carried out using the official IHEC human hg38/GRCh38 assembly. We
selected the following high quality DEEP samples to include both closely related as well as more
distantly related cell types in our analysis: two replicates of HepG2 (HG 1 and 2; Table B.4: Online
Table S1), two replicates of hepatocytes (He 2 and 3; Table B.4: Online Table S1), three replicates
of monocytes (Mo 1, 3, and 5 [254]) and two replicates of macrophages (Ma 3 and 5 [254]). All
primary cell types were isolated from healthy, adult donors. For each replicate, we downloaded the
DEEP reference alignments for six histone marks (H3K4me1, H3K4me3, H3K27ac, H3K27me3,
61
H3K36me3, H3K9me3) and the corresponding Input3 control as BAM files (Table B.4: Online
Table S1). Additionally, we downloaded DEEP mRNA expression data for all samples as raw read
FASTQ files (Table B.4: Online Table S2). The hg38 genome reference was restricted to fully
assembled auto- and gonosomes for all data preprocessing steps. The differential analysis with
SCIDDO was then limited to autosomes and chromosome X to alleviate any effects arising from
the uneven distribution of sexes in our dataset. Annotation data were likewise limited to the same
set of chromosomes. The GeneHancer [78] enhancer annotation was licensed for academic use
on 2017-05-30. The GeneHancer annotation was reduced to gene-enhancer pairs that could be
mapped to gene identifiers in the GENCODE v21 annotation [96].
4.2.2 Generaࢢon of chromaࢢn state maps
Following IHEC recommendations, all histone BAM files were filtered using Sambamba
v0.6.6 [237] to exclude low quality reads (mapping quality ≥ 5; no duplicated, unmapped or non–
primary reads/alignments). These filtered BAM files were used as input to generate chromatin
state segmentation maps for all samples. We used a pre-trained ChromHMM model provided by
the REMC. This model was trained to segment the genome into 18 chromatin states, hence we refer
to this model as CMM18. We decided to use the pre-trained CMM18 model because it has been
carefully designed using the large compendium of epigenomes generated by the REMC. We thus
assumed that CMM18 robustly captures chromatin states irrespective of the biological source of
the samples at hand (we examined this assumption using a newly trained ChromHMM model, see
Section 4.2.3). As an additional benefit, the chromatin states of the CMM18 model were function-
ally characterized and labeled by the REMC to facilitate interpretation of the state segmentation
maps (for state descriptions and colors, see Figure B.1 and Table B.1). We executed version 1.12 of
ChromHMM with commands “BinarizeBam -b 200” and “MakeSegmentation -b 200” and oth-
erwise default parameters to create the state segmentation maps.
4.2.3 Applicability of the pre-trained CMM18 model
We used ChromHMM version 1.12 to train a new 18-state model on our dataset with the com-
mand “LearnModel -b 200” and otherwise default modeling parameters. We then compared the
chromatin state emission probabilities of the newly trained model (NEW18) to the state emission
probabilities of the pre-trained model (CMM18) provided by the REMC. The task of matching
the chromatin states between the NEW18 and the CMM18 model was modeled as a “minimum
weight perfect bipartite matching” (in the following: “assignment”) problem and solved using lin-
ear programming. This assignment problem can be conceptualized via a bipartite graph consisting
of the vertex sets A and B, where each of the 18 nodes in A and B represents one chromatin state
of the NEW18 and of the CMM18 model, respectively. The edges E in this bipartite graph are
given as E = A× B. For each edge eab connecting vertex a ∈ A to vertex b ∈ B, we computed
the edge weight wab as the Kullback-Leibler divergence (KLD) [143] between the state emission
3Reminder: the capitalized Input designates the ChIP-seq Input control sample as introduced in Chapter 2, Sec-
tion 2.2.2.
62
probability distributions of a and b. The KLD can be interpreted as the increase in entropy if, in
our case, the chromatin state predicted by the NEW18 model is approximated by the predefined
chromatin state from the CMM18 model. A weight wab was then computed as
wab := KLD(a, b) =
∑
i
ai · log
(
ai
bi
)
(4.1)
with i referring to the individual components of the emission probability distribution, i.e., in our
case, the observed six histone marks that were used as input data to generate the chromatin state
segmentation maps (Section 4.2.2). The assignment problem can now be formulated as the fol-
lowing constrained minimization problem:
minimize:
∑
a∈A
∑
b∈B
wab · eab
subject to: ∑
b∈B
eab = 1 for a ∈ A∑
a∈A
eab = 1 for b ∈ B
eab ≥ 0 for a ∈ A and b ∈ B
Solving this problem amounts to selecting 18 edges that match each chromatin state of the NEW18
model to exactly one state of the CMM18 model such that the sum over all edge weights is minimal
and no two edges are incident to the same vertex b ∈ B. The problem was implemented and
solved with default configuration in the Python PuLP package4. As comparison, we also solved
this problem in a greedy way by iteratively selecting the edge eab with minimum weight wab if no
previously selected edge was already incident to a or b.
4.2.4 Diﬀerenࢢal gene expression analysis
Gene expression estimates per replicate were computed with Salmon v0.9.1 [180] using the
GENCODE v21 [96] annotation for protein coding genes. For each gene in the GENCODE ref-
erence, we extracted genomic coordinates for the gene body (5’ to 3’ end) and for the promoter
(-2500 bp to +500 bp around the 5’ end) using custom scripts. After expression quantification,
we used DESeq2 v1.18.1 [147, 229] to obtain differential expression estimates for all six possible
pairs of sample replicate groups in our dataset. We split the DESeq2 results into groups of DEGs
and non-differentially expressed genes (stable genes) based on an absolute log2 fold change in
expression of at least 2 and a multiple-testing corrected p-value of less than 0.01 (DESeq2 p-value
correction method: Benjamini-Hochberg [20]).
4PuLP v1.6.8: github.com/coin-or/pulp
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4.2.5 Diﬀerenࢢal histone peak calling
We selected PePr [267] as a current state-of-the-art tool for differential chromatin analysis
as reference to compare to. We executed PePr v1.1.18 to perform differential analysis including
postprocessing for all six possible pairs of sample replicate groups in our dataset. All available
replicates were processed in a single run of PePr for each comparison. PePr was executed with
the parameter histone “peaktype” set to “broad” for the mark H3K36me3, and otherwise default
parameters (see Chapter 2, Section 2.4.2 for histone peak types). The resulting histone peak sets
were reduced to those peaks with a multiple-testing corrected p-value of less than 0.01 using custom
scripts (PePr p-value correction method: Benjamini-Hochberg [20]). In the comparison between
SCIDDO and PePr, the method performance in detecting DEGs is evaluated using accuracy and F1
score, the latter being the harmonic mean of precision and recall. The following definitions [183]
use the common shorthand notation P to denote all positive samples, N to denote all negative
samples, and TP, TN, FP, FN to denote true positives, true negatives, false positives, and false
negatives:
Accuracy =TP + TN
P +N
Precision = TP
TP + FP
Recall = TP
TP + FN
F1 =2 · Recall · Precision
Recall + Precision
4.2.6 Chromaࢢn dynamics at EP300 peaks
SCIDDO implements an optional postprocessing step for restricting the set of DCDs to those
subregions that show a specific chromatin state change between the sample groups, a feature we
refer to as “chromatin dynamics filtering”. To exemplify SCIDDO’s capabilities of identifying
user-specified chromatin state changes, we designed a use case examining enhancers switching
from an active to an inactive state (Section 4.3.8). To that end, EP300 peak datasets for HepG2 were
downloaded from ENCODE (ENCFF674QCU and ENCFF806JJS) and merged using bedtools
v2.26.0 [196]. To illustSCIDDO’s feature of “chromatin dynamics filtering”, chromatin states
7–11 (genic, active and weak enhancers) were considered as enhancer “on” states, and chromatin
states 13, and 15–17 (heterochromatin, bivalent enhancer, and states of polycomb repression) were
considered as enhancer “off” states.
4.2.7 Staࢢsࢢcal background for SCIDDO
The theory behind the statistical evaluation available in SCIDDO has been developed in the
context of biological sequence analysis, e.g., to identify runs of hydrophobic amino acids in protein
sequences [117, 118]. Since the theory was left unaltered, we give only a compact overview to
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introduce the necessary concepts and nomenclature. The chromatin state map of each sample in
the SCIDDO dataset can be represented as a sequence X = {x1 . . . xp . . . xn}. Here, the xp are
assumed to be random variables over an alphabetA andn is the length of the sequence (more details
are given in the listing below). In our case,
∣∣A∣∣ = 18 representing the 18 different chromatin
states of the CMM18 model. Each pair of states (ai, aj) is assigned a score sij where sij < 0
indicates state similarity (regions with putatively consistent activity) and sij > 0 indicates state
dissimilarity (regions with putatively differential activity; see below for derivation of the sij). We
omit the superscript ij in the following to improve readability. When comparing two chromatin
state maps X,Y , each state pairing (xp, yp) is assigned the respective score s as defined above.
This results in a sequence of scores S = {s1 . . . sn} that is scanned for subsegments of highest
cumulative score. This approach is called local score computation and can be done efficiently
with a linear time algorithm [208]. The set of all maximal scoring disjoint segments returned
by this algorithm represents the set of candidate regions for the respective chromatin state map
comparison. The (unnormalized) raw score R of a candidate region is simply defined as the sum
over all scores in the candidate region R = ∑k≤p≤l sp where k and l indicate the position of the
leftmost and of the rightmost genomic bin included in the candidate region. These cumulative
scores have to be normalized to account for the fact that higher scores have a higher chance of
occurring with increasing sequence length. This normalization step requires the estimation of two
statistical parameters λ and K (for detailed derivation of these parameters, see [118]). Since both
λ and K lack a biologically meaningful interpretation, they can be simply thought of as scaling
parameters for the scoring system and the search space. For this parameter estimation, SCIDDO
relies on the routines implemented in BLAST v2.7.1 [8]. Additionally, four assumptions are needed
for the theory to be applicable, which then allows for modeling the limiting behavior of the score
distribution as Gumbel-type extreme value distribution (see [118]):
1. The sequences are infinitely long
2. The xp are independent and identically distributed (i.i.d.) random variables
3. A positive score must be possible
4. The expected score is negative
Assumptions 1. and 2. of course do not apply to any biological sequence, but are needed for
reasons of mathematical tractability beyond the scope of this thesis [118]. Assumptions 3. and
4. are tested by SCIDDO before starting the actual analysis, safeguarding against errors in the
statistical evaluation. Under these conditions, the Expect value (E) for a DCD with raw score R is
then calculated as
E = K · L · e−λR (4.2)
where the factor L is the length of the chromosomal sequence adapted for replicate variation.
Because SCIDDO has been designed to compare (small) groups of replicates against each other, we
adapted the calculation of the total length of the sequence. For the sake of the argument, consider
the ideal but unrealistic scenario of identical biological replicates in both sample groups. In this
case, a SCIDDO analysis would always result in the same output, irrespective of the two samples
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being compared. Hence, intuitively, the number of (identical) replicates per group should not
increase the statistical stringency, i.e., adding a perfect replicate to a group should not increase
the sequence length factor L. Under more realistic conditions of imperfect but still high-quality
biological replicates, SCIDDO only adds those positions to the total sequence length L that show
a new chromatin state compared to all other replicates already in the group. A pseudocode for this
computation is given as Algorithm 1 below:
Algorithm 1: Compute length normalization factor L
Input: Chromatin state maps for 2 sample groups (GROUPS), each consisting of at least
one replicate r
Output: Length normalization factor Lc per chromosome c
for c ∈ CHROMOSOMES do
Lc = 0
n = |c|
for G ∈ GROUPS do
states1...n = ∅
for r ∈ G do
Lc = Lc +
∑n
p=1 1(rp ̸∈ statesp)
for p = 1 to n do
statesp = statesp ∪ sp
end
end
end
Lc = Lc − n
end
4.2.8 Fit of random scores to Gumbel-type extreme value distribuࢢon
The calculation of the E-value as described above assumes a null model of random sequences.
According to the theory (see Theorem 1 in [118] and examples in [116]) the normalized maximal
scores should follow a Gumbel-type extreme value distribution when comparing random state se-
quences, in the limit of the sequence length n. Because SCIDDO supports the use of customized
scoring schemes, it also supports the user in assessing if the chosen scoring scheme adheres to this
theoretical assumption. To that end, SCIDDO scans the randomly shuffled chromatin state maps of
all sample pairs for high scoring subsegments and retains only the maximally scoring subsegment
per chromosome comparison; if several segments with identical scores emerge, only the first one
is kept. This process is iterated until a pre-specified number of these “random” scores have been
found. The user can then use these “random” scores and, e.g., assess their fit to a Gumbel-type
extreme value distribution following our example (see Section 4.3.2).
4.2.9 Derivaࢢon of pairwise chromaࢢn state similarity scores
The theoretical considerations presented in the previous sections do not require the use of so-
phisticated scoring schemes that are well-grounded in theory, e.g., rather simple “match/mismatch”
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or empirically derived scoring schemes can be used if considered appropriate [117]. We thus de-
cided to use the emission probability vectors of the 18 chromatin states (= the hidden states of
the ChromHMM Hidden Markov Model) to compute pairwise similarity scores. The state emis-
sions Ei =
(
ehi . . . e
h
i
)
for state ai represent a probability distribution over the observed outputs,
i.e., over the observed six histone modifications h. Divergence measures are commonly employed
to quantify the difference between probability distributions (see also Section 4.2.3), and in our
case, it seems plausible that a symmetric measure should be used to compute the pairwise differ-
ence between chromatin states. This motivated using the symmetric Jensen-Shannon divergence
(JSD) [143] to compute chromatin state similarities
JSD(Ei, Ej) = 2 ·H
(
Ei + Ej
2
)
−H (Ei)−H (Ej) (4.3)
where H is the Shannon entropy
H(Ei) = −
6∑
h=1
ehi · log(ehi ) (4.4)
Because the JSD has a lower bound of 0, the pairwise similarities for each state were shifted by
subtracting the mean JSD5. This resulted in negative scores for similar states (JSD near zero) and
positive scores for dissimilar states. Scores are commonly represented by integer values, which
we realized by multiplying the real-valued scores by a factor of 10 and rounding them to integers
afterwards. Before starting the differential analysis, SCIDDO checks the adherence to assumptions
3. and 4. (Section 4.2.7) for any custom scoring scheme such as our JSD-derived one to ensure
applicability of the statistics introduced in Section 4.2.7.
A peculiarity of chromatin state maps is the so-called background state (state 18 labeled as “qui-
escent” in the CMM18 model). This state represents the lack of any detectable signal in the input
data. As it is a priori impossible to identify the true source for this lack of a signal, i.e., it could
be a technical artifact or biologically meaningful, the background state needs to be handled with
special care in the interpretation of chromatin state maps. We decided to implement a conservative
strategy and replaced all pairwise state similarities involving the background state with the mini-
mal score generated with our JSD-based approach. In other words, the background state is similar,
i.e., not differential relative to all other chromatin states. We opted for this strategy to avoid find-
ing differential chromatin domains that are dominated by the background state and could thus be
challenging to interpret.
4.2.10 Code availability and study replicaࢢon
The full source code of the SCIDDO command line tool is available under a GPLv3 license at
github.com/ptrebert/sciddo.
The code for replicating all results presented in this chapter is publicly accessible under
doi.org/10.17617/1.6K. All data preprocessing and analysis pipelines have been implemented in
5The decision to use the mean JSD for discriminating between similar and dissimilar chromatin states was driven
by practical considerations. In the future, a more comprehensive understanding of chromatin differences between cell
types may allow for a systematic approach based on, e.g., known regions of differential chromatin.
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Python/Ruffus [90]. All figures except for Figure 4.1 can be recreated using the respective Jupyter
Notebooks6 available in the aforementioned repository.
4.3 Results
4.3.1 Score-based idenࢢﬁcaࢢon of diﬀerenࢢal chromaࢢn domains
The differential analysis with SCIDDO consists of two major parts, data preparation and the
actual analysis run (see Figure 4.1 for an overview). In the data preparation step (Figure 4.1
step (A)), SCIDDO creates a single coherent dataset storing all data and metadata relevant for
the analysis to support later reproducibility of the results. As part of the data preparation, the
state emission probabilities of the chromatin state segmentation model are used to compute
pairwise chromatin state dissimilarities (see Section 4.2.9). Starting from this dataset, SCIDDO
then performs the differential analysis as follows: for each comparison contrasting sample group
X versus group Y, SCIDDO first compares individual replicates against each other, say, X-2
versus Y-1 (Figure 4.1 step (B)). In this process, each observed chromatin state pair in the two
chromatin state maps is assigned a score that quantifies the dissimilarity of the two states: positive
scores indicate state dissimilarity, and negative scores indicate state similarity (Figure 4.1 step
(C) and Section 4.2.7). Candidate regions showing differential chromatin marking are identified
on this level of replicate comparisons by searching for chromosomal segments that show a high
cumulative score. The magnitude of these cumulative scores can be taken as an indicator of the
chromatin state dissimilarity in the chromosomal segment; hence, we refer to this cumulative
score as the differential chromatin score (DCS) of the segment (Figure 4.1 step (C) to (D)). It
should be pointed out that extracting segments based on (locally) maximal DCSs implies also a
maximization of the segment length, and no (predefined) minimum or maximum length has to be
specified. To proceed from candidate regions identified in individual replicate comparisons (e.g.,
X-2 versus Y-1) to candidate regions that are assumed to be representative of all samples X versus
Y, overlapping candidate regions are merged by averaging their DCSs and taking the union of
their genomic coverages (Figure 4.1 step (E)). As the final step in the analysis, the segment DCSs
are turned into an Expect (E) value, which allows for filtering the resulting candidate regions
for their statistical significance (Figure 4.1 step (F)). The E-value (see Section 4.2.7) has the
interpretation of indicating how many candidate regions with at least a similarly high DCS could
arise simply due to chance when comparing random sequences of the same length. In other words,
when filtering the candidate regions for a default E-value of less than 1 to call DCDs, SCIDDO
restricts the results to those chromosomal regions where the chromatin states are so different
between the samples that one would not expect to find such a difference simply due to chance.
To simplify visualizations, we report E-values after a negative log10 transform in the remainder
of this study. The aforementioned threshold of 1 is thus transformed to 0 and larger E-values
indicate higher statistical stringency.
6http://jupyter.org
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Figure 4.1: Overview of SCIDDO’s workflow for identifying differential chromatin domains:
(A) Data preparation: chromatin state maps can be generated using common tools (blue shaded
area). The chromatin state maps for all replicates of sample groups X and Y are stored together with
the chromatin state emission probabilities in a SCIDDO dataset to ensure later reproducibility of
the analysis. The state emission probabilities are used to compute chromatin state similarity scores.
For the analysis presented in this chapter, the CMM18 model was exclusively used to produce the
input data. (B)–(F) Workflow: (B) the differential analysis starts by comparing all replicate pairs in
the dataset, here exemplified as X-2 vs. Y-1. (C) All observed chromatin state pairs are scored with
their respective dissimilarity score. (D) The resulting score sequences are scanned for high-scoring
candidate regions. (E) Overlapping candidate regions of all replicate pairs are then merged and (F)
filtered after statistical evaluation to generate the final set of differential chromatin domains.
We performed a differential analysis for all six possible pairings of sample groups in our
dataset, i.e., (i) HepG2 vs. hepatocytes; (ii) HepG2 vs. monocytes; (iii) HepG2 vs. macrophages;
(iv) hepatocytes vs. monocytes; (v) hepatocytes vs. macrophages, and (vi) monocytes vs.
macrophages. Before executing the SCIDDO workflow, we confirmed that the generated chro-
matin state segmentation maps reflect the assumed relationships among all cell types by determin-
ing the fraction of identically assigned chromatin states between sample pairs (Figure B.2). This
analysis result conforms to the expectation that monocytes and macrophages are considerably sim-
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ilar on the chromatin state level, whereas primary hepatocytes and HepG2 are not as similar (but
still closer to each other than to the hematopoietic cell types).
Additionally, we tested our assumption that the predefined chromatin states of the CMM18 model
capture relevant regulatory biology in our data despite the fact that these chromatin states were orig-
inally defined based on the REMC dataset. We trained and applied a new 18-state ChromHMM
model (NEW18) on our dataset and found an acceptable agreement between the predefined
CMM18 and the NEW18 chromatin states (Figure B.3, see Section 4.2.3 for details). Hence, we
decided to take advantage of the complete annotation available for the REMC CMM18 model and
limited our analyses to the CMM18 chromatin state maps.
The subsequent SCIDDO analysis including data preparation completed within minutes on a mod-
erately powerful compute server (Table B.2). The results presented for this analysis are structured
as follows: first, we provide some evidence that our data follow the theoretical assumptions nec-
essary for the statistical evaluation. Next, we highlight the robustness of SCIDDO’s results across
replicates and then provide a more biology-oriented characterization of the identified DCDs.
4.3.2 Diﬀerenࢢal chromaࢢn scores follow extreme value distribuࢢon
The last step in the SCIDDO workflow described above consists of turning the DCSs into an
E-value that is used for filtering the set of candidate regions to obtain the final set of DCDs. This
step relies on theory developed for biological sequence analysis (see Materials and Methods) and
requires first a normalization of the raw cumulative DCSs to account for the fact that comparing
longer chromosomal sequences increases the chances of observing higher cumulative DCSs. This
normalization uses two estimated statistical parameters, λ and K that lack a biological interpre-
tation, but can be thought of as scaling factors for the scoring system and the sequence length,
respectively. Second, the theory assumes a null model of random sequences, and under this null
model, the distribution of the scores should in the limit converge in distribution to a Gumbel-type
extreme value distribution (Section 4.2.8). We confirmed that this is indeed the case in our analy-
sis by comparing randomized chromatin state maps with each other and fitting all maximal DCSs
identified during this sampling procedure to a Gumbel distribution (Figure 4.2 left panel). We also
plotted the per-chromosome estimates of the statistical parameters λ and K that are needed for
the score normalization (Figure 4.2 right panel), and could confirm that the estimates are within
reasonable bounds given examples from literature [116]. The observed agreement with theory thus
supports the last step in the SCIDDO analysis (Figure 4.1 step (F)) of filtering candidate regions
based on their E-value.
4.3.3 SCIDDO robustly idenࢢﬁes diﬀerenࢢal chromaࢢn domains
Histone ChIP-seq data is known to be affected by various sources of noise ranging from arti-
facts introduced during library preparation, to irregularities caused by varying mappability in the
reference genome, or to spurious signal due to unspecific antibody binding (see Chapter 2, Sec-
tion 2.3.1 for more details). In combination, biological and technical variation can render any
differential analysis pointless if the results are dominated by noise, and not by the biological signal
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Figure 4.2: Observed maximal scores and parameter estimates follow theoretical assump-
tions (A) Probability plot of all normalized maximal scores derived from comparing random se-
quences (y-axis; see Section 4.2.8 for details) fit to the theoretical quantiles of a Gumbel-type
extreme value distribution (x-axis). Here, we jointly fitted all “random” scores of all chromo-
somes to simplify the visualization. (B) Chromosomes are sorted by increasing size (in genomic
bins) from left to right (x-axis) and the per-chromosome estimates of the two statistical parameters
λ (gray points) and K (black triangles) are plotted on the same scale (y–axis). R2: coefficient of
determination
of interest. To test if the identified candidate regions were indeed representative and not replicate-
specific, we computed the Spearman correlation of the E-values between all overlapping candidate
regions. We visualized an exemplary case selected based on the mean of all comparisons. This
exemplary case shows a Spearman correlation of 0.72 between the candidate regions (Figure 4.3).
The red bars in the lower left corner indicate candidate regions that are unique to the respective
replicate comparison. It can be observed that unique candidate regions tend to have comparatively
lower E-values whereas those candidate regions found in both replicate comparisons tend to have
higher E-values. In general, the average Spearman correlations across all replicate comparisons
are consistently in high range from 0.67 (HepG2 vs. hepatocytes) to 0.73 (HepG2 vs. monocytes;
see Table B.3).
4.3.4 Diﬀerenࢢal chromaࢢn domains occur in various regulatory contexts
Since it is well-established that histone marks occur in various regulatory contexts, e.g., ranging
from promoters and enhancers to gene bodies, it stands to reason that bona fide DCDs should pre-
dominantly occur in similar regulatory contexts. To test this hypothesis, we intersected the DCDs
identified by SCIDDO with various annotation datasets and observed that, in general, around 80
to 90% of all DCDs overlap with at least one type of genomic annotation (Figure 4.4). Since there
is no theory that would enable us to formulate an a priori expectation about the extent to which
differences on the chromatin level should occur between any two cell types, we cannot assess the
plausibility of the absolute numbers of identified domains. Nevertheless, it can be observed that
the lowest number of domains is detected in the comparison of monocytes to macrophages (Fig-
ure 4.4F), i.e., when comparing the two most closely related cell types in our dataset. For all other
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Figure 4.3: Candidate regions are robustly identified across individual replicates: exemplified
agreement of candidate regions identified in replicate comparisons. E-values of candidate regions
identified for He-3 vs. Mo-3 (x-axis) are plotted against E–values of overlapping candidate regions
identified for He-3 vs. Mo-5 (y-axis). The red area indicates E-values of those candidate regions
that are unique to the respective replicate comparison. ρ: Spearman correlation of E-values
comparisons, the number of identified chromatin domains is approximately four- to more than five-
fold higher, but yet shows a similar tendency of a smaller number of identified chromatin domains
for more closely related cell types.
These results also illustrate that the distribution of overlaps seems not to be affected by the number
of DCDs identified. In all comparisons, at least approximately 70% of the DCDs overlap with
at least one regulatory region annotated in the Ensembl Regulatory Build [266]. The Regulatory
Build comprises different types of regulatory regions and has extensive genome coverage. Hence,
the Regulatory Build enables us to interpret the relevance of DCDs in light of various functional
categories. Since the distribution of genomic locations of the DCDs seems fairly similar across
all comparisons, and analogous observations can be made when examining the length distribu-
tion of the DCDs (Figure B.4), we examined if there is a difference in DCD E-values aggregated
over all comparisons (Figure 4.5). DCDs overlapping any regulatory region show higher E-values
compared to those DCDs that have no overlaps (Figure 4.5, bottom panel). This effect is most
pronounced for annotated promoters and transcription factor binding sites (TFBS), and this seems
not to be an effect of regulatory region size (Figure 4.5, top panel). The average number of distinct
regulatory region overlaps per DCD shows that a DCD often spans several of the shorter regulatory
regions, with the exception of TFBS, which is the least abundant region type with a median size
< 1 kbp in the Regulatory Build. At the other end of the size spectrum are promoters, which also
show hardly any variation around a median of one DCD overlap per promoter.
4.3.5 Formaࢢon of diﬀerenࢢal chromaࢢn domains aﬀects gene expression
The results presented in the previous section indicate that DCDs largely overlap with a variety
of regulatory regions, and thus it seems plausible that the formation of a DCD should have func-
tional consequences, e.g., by modulating gene expression levels. Apart from basic considerations
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Figure 4.4: Differential chromatin domains overlap with annotated regulatory regions: (A)–
(F) bar heights indicate percentage of identified differential chromatin domains that overlap with
different genomic annotations for all six sample group comparisons. HG: HepG2; He: hepatocytes;
Ma: macrophages; Mo: monocytes; N: total number of identified DCDs; coding genes: Gencode
v21 protein-coding genes; lincRNA genes: Gencode v21 lincRNA genes; Reg. Build: Ensembl
Regulatory Build v78; GeneHancer: GeneHancer annotated enhancers limited to Gencode v21
gene set; Refseq elem.: RefSeq functional elements
about the magnitude of the observed E-values, we also hypothesized that DCDs covering larger
parts of the gene body could indicate stronger changes in gene expression. To give a canonical
example, a gene that is entirely repressed by means of polycomb-mediated silencing should be
enriched for the histone mark H3K27me3, and this marking should be replaced by H3K36me3
as soon as the gene is activated and actively transcribed (see Chapter 2, Section 2.1.1.4). On the
other hand, if the gene expression is modulated, e.g., by changing transcription factor binding in
enhancer regions, the effect on the chromatin marking in the gene body could arguably be less
pronounced. To investigate this hypothesis, we stratified all genes by the fraction of their gene
body length being covered by a DCD (no overlap in gene body or enhancers, less or more than
50% gene body overlap). Next, we computed gene expression fold changes using DESeq2 [147]
(Section 4.2.4) for the six sample group comparisons and visualized the fold change for all genes
in the three DCD overlap groups as a cumulative distribution (Figures 4.6 and B.5). The curves
indicate that genes covered by more than 50% of their body length with a DCD indeed exhibit
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Figure 4.5: E-value distribution of DCDs overlapping regulatory regions: (bottom) box plots
show distribution of E-values of all differential chromatin domains overlapping regulatory region
types as annotated in the Ensembl Regulatory Build (v78) aggregated over all sample comparisons.
As an example, differences in magnitude of E-values between the groups “tfbs vs. no overlap” and
“promoter vs. no overlap” were assessed with a two-sided Mann-Whitney-U test and considered
significant “*” at p < 0.01. (middle) box plots show distinct overlaps per DCD, i.e., the number of
regulatory regions of that type overlapping the same DCD. (top) box plots show size distribution
of the Ensembl regulatory regions. Dashed line indicates a size of 1,000 bp. Regulatory region
types: ctcf: CTCF binding sites; tfbs: transcription factor binding sites; open: regions of open
chromatin; enhancer: enhancer; flanking: promoter-flanking regions; promoter: promoter
stronger changes in their expression level (orange lines). A similar albeit weaker effect can be
observed for genes having less than 50% of their body or their promoter covered by a DCD (blue
lines). In many cases, the difference in fold change relative to the group of genes that does not
overlap a DCD is significant. Additionally, we applied the same method to test if the number of
gene-associated enhancers that overlap a DCD had a similar bearing on gene expression (Figure 4.6
and B.5, middle and right panels). This enhancer-centric view shows a stable pattern across most
sample comparisons that indicates that stronger changes in gene expression occur if more gene-
associated enhancers overlap a DCD. This observation is particularly intriguing when restricting
the view on intergenic enhancers, where, as opposed to intragenic enhancers, there is lower chance
of a coincidental overlap with a DCD. In general, a small but noticeable difference compared to
the no-DCD overlap group (gray dashed line) can be expected as soon as 2–3 enhancers show a
DCD (magenta curve).
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Figure 4.6: DCDs overlapping gene bodies and enhancers affect gene expression: (left) genes
were stratified by the amount of DCD overlap either covering more than 50% of the body (body;
orange curve) or less than 50% of the body or the promoter region (partial; blue curve). Expression
fold change of the genes in the respective groups is plotted along the x-axis within a restricted
window for improved readability. Statistical significance of the difference in mean fold change of
the groups relative to the no overlap group (“none”, gray dashed line) was computed separately for
negative and positive fold change genes using a two-sided Mann-Whitney-U test (“*” significant
at p < 0.01, “-” not significant otherwise). (middle and right) the same analysis as for the gene
body was performed, but here counting the number of intra- and intergenic enhancers (anywhere,
middle) or only intergenic enhancers (right) per gene that overlap a DCD. Expression fold changes
plotted within a restricted window for improved readability. Statistical significance assessed as
before.
4.3.6 SCIDDO detects chromaࢢn changes in diﬀerenࢢally expressed genes
By design, SCIDDO does not impose any restrictions on the regions of interest that can be
interrogated in a differential analysis. Since there is no general model of chromatin variation
that would enable us to assess the plausibility of the identified differential chromatin domains
irrespective of their genomic context, we decided to focus on a small-scale case study that is
arguably of broad biological interest.
We investigated to what extent DCDs can be used to specifically identify DEGs. As ground truth
for this analysis, we used the same DESeq2 results as above, but applied a threshold to split the
genes into differentially expressed and stable ones (Section 4.2.4). As a first step, we checked
what percentage of DEGs could be recovered using the DCDs identified by SCIDDO (Figure 4.7).
For four out of the six sample comparisons, more than 90% of all DEGs could be recovered
with DCDs either overlapping the gene body, the gene promoter or at least one gene-associated
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enhancer. For the comparison of HepG2 to primary hepatocytes (Figure 4.7A), approximately
81% of DEGs could be recovered, and for the comparison of monocytes to macrophages, 54%
of all DEGs were recoverable by using DCDs (Figure 4.7F). The comparatively lower rate of
DEG recovery for the monocyte to macrophage analysis seems to be in line with the already
observed trend of fewer differences on the chromatin level with increasing cellular relatedness
(e.g, see Figure 4.4). We present a more in-depth analysis of this observation in Section 4.3.7.
Next, we tested if it was possible to broadly distinguish between DEGs and stably expressed
genes by thresholding on the E-values of the DCDs that overlap gene bodies. To that end, we
stratified the set of DEGs based on their fold change into three groups (top 20%, middle and
bottom 40%) and plotted the E-value distribution of the DCDs for these three groups and for
all other chromatin domains (Figure 4.8, bottom panel). We find that the top 20% of all DEGs
overlap DCDs that have a significantly higher E-value on average relative to DCDs overlapping
the remaining DEGs. Furthermore, it is interesting to observe that the E-value distribution of the
DCDs overlapping stable genes is similar to those that do not overlap any gene (but could, e.g.,
overlap with intergenic enhancers). The number of distinct DCDs that overlap any given gene
shows no notable variation across all groups (Figure 4.8, middle panel). The distribution of the
gene body lengths in the respective groups appears to be fairly balanced (Figure 4.8, top panel)
and thus does not suggest that the number of DCD overlaps or the observed difference in E-value
distribution is a simple effect of gene body length. We explicitly confirmed this by repeating
the analysis, but this time stratifying DEGs by gene body length (Figure B.6). The E-values of
the DCDs overlapping the longest genes are comparatively lower, and this suggests that larger
E-values are probably not a result of increasing gene body length.
4.3.7 Methodological and biological limitaࢢons for chromaࢢn–based
detecࢢon of diﬀerenࢢally expressed genes
The theory borrowed from local scoring and implemented in SCIDDO is used to assign a
measure of statistical stringency — the E-value — to each discovered DCD. Yet, the theory does
not offer a way to decide what threshold on the E-value best separates genuine from chance
observations. The necessary normalization to account for the length of the sequences being
compared immediately suggests that short but biologically meaningful differential regions will be
assigned an (untransformed) E-value above SCIDDO’s default threshold of 1.
We checked the extent to which the default E-value threshold of 1 could limit SCIDDO’s ability
to identify — especially short — DEGs. We binned all DEGs by their gene body length and
plotted the amount of genes with a DCD overlapping their gene body at E-value thresholds of 1
and 100 (Figure 4.9). The histogram shows the expected behavior of SCIDDO to predominantly
recover longer DEGs by means of identifying a DCD in their gene body. However, relaxing
the E-value threshold seems not to affect this general trend as the additional DEGs also show a
tendency toward longer gene bodies. We thus wondered if other technical or biological artifacts
might exacerbate the detection of DEGs on the chromatin level. We focused specifically on the
comparison of monocytes to macrophages where approximately only 54% of all DEGs could be
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Figure 4.7: Differential chromatin domains recover differentially expressed genes: (A)–(F)
bar heights indicate percentage of recovered differentially expressed genes by counting overlaps
with differential chromatin domains in gene bodies, in gene promoters (but not in gene bodies)
or in gene-associated enhancers (but not in gene bodies or gene promoters). The leftmost bar is
annotated with the total number of recovered genes. N: total number of differentially expressed
genes per comparison.
recovered using DCDs (see Figure 4.7F).
We examined if artifacts in the data could be the reason for the low DEG recovery rate. Be-
sides chromatin states with annotated function, chromatin state maps usually include a so-called
background state that represents regions of no detectable signal (state number 18 labeled as
“quiescent” in the CMM18 model). It is important to realize, though, that the interpretation of
this background state is difficult. It is conceivable that technical problems caused this lack of a
signal in certain regions of the genome, but the lacking signal may be biologically meaningful in
other regions. Moreover, the six canonical histone marks included in this study certainly cover a
wide range of functionally important chromatin signals (Chapter 2, Section 2.1.1.4), but they do
not represent the entire regulatory chromatin landscape. For example, the recently characterized
H3K122ac histone modification is also found at active enhancers that lack the canonical H3K27ac
marking [191]. Given these uncertainties, we opted for a conservative approach and considered
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Figure 4.8: E-value distribution of DCDs overlapping gene bodies: genes were stratified into
four groups based on their expression fold change (stable/no change, lowest 40% [lo], middle 40%
[mi], and top 20% [hi] of DEGs according to expression fold change). (bottom) box plots show
distribution of E-values of all DCDs overlapping gene bodies in the respective groups aggregated
over all sample comparisons. The no overlap group (no ovl.) contains all E-values of DCDs not
overlapping any gene. Differences in magnitude of E-values for the two comparisons “lo vs. hi”
and “mi vs. hi” were assessed with a two-sided Mann-Whitney-U test and considered significant
“*” at p < 0.01. (middle) box plots show number of distinct DCD overlaps per gene. (top) box
plots show gene body length distribution of all genes in the respective group.
the background state as not differential relative to all other chromatin states (see Section 4.2.9).
We evaluated how many DEGs might not be recoverable under these conditions for the monocyte
to macrophage comparison. For each of the 1,110 DEGs that could not be recovered, we computed
the percentage of the gene body length covered with the background state (averaged over all
replicates in the respective groups). We found that close to a hundred genes that are covered to
at least 60% with the background state are shared between the monocyte and the macrophage
group (Figure 4.10A). At a higher threshold of 80% body coverage, this number drops to 35
genes. Given that this considers genes that are in the same uninformative chromatin state to
roughly the same extent in all samples — and being differentially expressed at the same time — it
seems justifiable to assume that the non-detection of these genes is not a limitation of SCIDDO.
When focusing on the genes that are covered with the background state in either monocytes or
macrophages, the numbers rise considerably (Figure 4.10B). For the lower threshold of at least
60% coverage, 164 genes show the uninformative chromatin state in their gene body, and when
raising the threshold to at least 80% coverage, 72 genes are still affected. In this scenario, the
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Figure 4.9: Relaxing E-value threshold does not improve detection of short DEGs: all DEGs
for all six comparisons were binned based on their gene body size (x-axis) and classified based
on overlapping DCDs in their gene body (y-axis). DCDs were called with the default threshold of
E < 1 (blue) and with a relaxed threshold of E < 100 (orange).
non-detection of the DEGs is hence largely driven by the lack of a signal in one of the two sample
groups.
Considerations involving the background state might explain a few hundred cases of DEGs
that could not be recovered by SCIDDO. This implies, however, that a considerable amount of
DEGs were assigned biologically meaningful chromatin states and yet were not detectable by
SCIDDO.
We hypothesized that a plausible cause for this could be a comparatively weak change in gene
expression for non-detectable genes. When a gene is switched from “off” to “on”, a substantial
change in the histone marking can be expected. However, if the gene is already actively
transcribed and then simply upregulated, e.g., by activating additional enhancer elements (see
Figures 4.6 and B.5), it is not obvious why this change in expression should lead to differential
chromatin marking in the gene body. We tested this hypothesis by plotting the mean difference
in expression, plus the minimal and maximal expression level in any sample, for all DEGs in
the monocyte to macrophage comparison (Figure 4.10 (C)–(E)). We split the genes into three
groups based on DCD overlap in their gene body, in any associated enhancers but not in the body,
and no DCD overlap at all, i.e., the non-detectable genes. The mean change in gene expression
is significantly higher in genes overlapping with a DCD compared to those genes that have no
differential chromatin marking. Interestingly, the minimal expression level (Figure 4.10D) is still
relatively high for those genes that show differential chromatin marking only in their enhancers.
When relating the minimal to the maximal expression level (Figure 4.10D/E), the change in
expression can be characterized as follows: genes with a DCD in their gene body jump from a
low to a high expression level; genes with no DCD in their body but in their enhancer(s) show
increased expression relative to an already high level, and genes with no DCD at all remain at a
low to mildly elevated expression level. It should be pointed out that the implied directionality
is supported by the observed expression changes for the monocyte to macrophage comparison
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Figure 4.10: Uninformative chromatin state in gene bodies and moderate changes in ex-
pression complicate DEG recovery: (top) bar charts show DEGs binned according to the frac-
tion of their gene body covered with the background “quiescent” chromatin state (x-axis). (A)
height of bars depicts number of genes in intersection between monocyte (Mo) and macrophage
(Ma) samples. (B) height of bars depicts maximal number of genes either from monocyte or
from macrophage samples. (bottom) DEGs were stratified according to DCD overlap in gene
body/promoter (Body), or in at least one enhancer (Enh.) or no DCD overlap (None). (C) box
plots show distribution of gene expression values for absolute mean differences between mono-
cyte and macrophage samples, and (D) for minimal expression, and (E) for maximal expression in
any sample. Differences in magnitude were assessed using a two-sided Mann-Whitney-U test and
considered significant “*” at p < 0.01 and not significant (n.s.) otherwise.
(Figure B.5a).
There is a multitude of mechanisms beyond the chromatin level that can fine-tune gene expres-
sion [51, 125, 178]. Given that the DEGs lacking any sign of differential chromatin marking show
also limited dynamics in their expression changes, we wondered whether there was any evidence
of post-transcriptional control of these genes. As control group, we selected all genes that were not
classified as differentially expressed but nevertheless showed signs of differential chromatin mark-
ing in their gene body (N=760 for the monocyte to macrophage comparison). We then plotted the
number of annotated micro RNA targets using the TargetScan v7.2 [3] annotation for both groups
of genes (Figure B.7, bottom panel). There is indeed a small but statistically significant difference
in the number of annotated micro RNA targets per gene between the two groups. This difference
seems not to be caused by a difference in 3’-UTR length, where it is the group of DEGs without
an overlapping DCD that has the larger 3’-UTR regions on average (Figure B.7, top panel).
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4.3.8 SCIDDO aﬀords direct interrogaࢢon of chromaࢢn dynamics
A noteworthy feature of SCIDDO is the possibility to restrict the set of all DCDs to certain
subregions based on the observed chromatin dynamics (see Section 4.3.8). Given that chromatin
states generated by the CMM18 model have been assigned meaningful labels (Figure B.1 and
Table B.1), users can exploit this easily interpretable annotation to perform this postprocessing
step. We used this feature in combination with external validation data to investigate if it is possible
to identify enhancers that switch from an “on” to an “off” state between two cell types. To this
end, we selected two sets of chromatin state labels as representing active and inactive enhancer
states (see Section 4.3.8). SCIDDO then uses these state labels to identify those subregions of a
DCD where the chromatin change of interest can be observed between the selected cell types. It
should be emphasized that, while the chromatin dynamics filtering is based on the identified DCDs,
the individual subregions returned by SCIDDO cannot be statistically evaluated by computing
an E-value. Subregions of a DCD can be as short as one or two genomic bins and, thus, the
computed E-value of a subregion is unlikely to indicate statistical significance. For comparison,
we downloaded several ENCODE peak datasets of the transcriptional co-activator EP300 (p300)
for the cell line HepG2 (Section 4.3.8). Although EP300 is known to be highly predictive of
tissue-specific enhancer activity [250], it cannot be assumed that all downloaded EP300 peaks
mark active enhancers that are unique to HepG2, and are hence inactive in any other cell type. As
a consequence, an exhaustive overlap between EP300 peaks and (switching) enhancer regions in
DCDs cannot be expected. Instead, we hypothesized that it is more realistic to assume that any
biologically meaningful enhancer switch within a DCD subregion should likely also show a change
in EP300 occupancy. We investigated this hypothesis by plotting the count of EP300 peaks and
their signal strength for all peaks generally overlapping DCDs, and for all peaks overlapping with
DCD subregions showing enhancer switches from “on” to “off” and vice versa from “off” to “on”
for the comparison of HepG2 to monocytes (Figure 4.11). There is a prominent difference both
in absolute number of peaks and in signal strength for the two directions of enhancer switching.
This example illustrates that SCIDDO can also offer support in downstream analysis by quickly
identifying regions of specific and directed changes on the chromatin level.
4.3.9 Diﬀerenࢢal chromaࢢn domains recover diﬀerenࢢally expressed
genes with increased stability compared to individual histone marks
The number of available tools that use chromatin state maps as input for a differential analysis
is limited. ChromDet [39] is designed for group comparisons with at least 5 to 10 replicates each
(personal communication between Marcel H. Schulz and Alfonso Valencia, ECCB 2018; see also
footnote 1 on page 59), and thus did not give results on our dataset. Similarly, ChromDiff [264]
could not identify any differential chromatin marking (in genes), presumably due to lacking statis-
tical power given the limited number of replicates in our dataset. The Chromswitch package [111]
can only process one chromatin state at a time, which complicates direct and fair comparisons with
the DCDs identified by SCIDDO.
We thus decided to compare SCIDDO to PePr [267], an established tool for the differential analysis
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Figure 4.11: Chromatin dynamics at HepG2 enhancer elements: height of the bars depicts total
number of peaks overlapping DCDs (left y-axis) and box plots show distribution of the signal of the
overlapping EP300 peaks (right y-axis). The three groups represent (left) EP300 peaks overlapping
with DCDs in general; (middle) with DCDs restricted to genomic locations showing an enhancer
“on” state in HepG2; (right) with DCDs restricted to genomic locations showing an enhancer “off”
state in HepG2. For all three groups, the DCDs identified in the HepG2 to monocyte comparison
were used.
of individual histone marks that can process replicated samples. This strategy has the advantage of
reflecting the canonical “rule-based” approach of interpreting histone marks in well-characterized
regulatory contexts, e.g., by determining enhancer activity based on the presence of H3K27ac peaks
(see Chapter 2, Section 2.1.1.4). Specifically, we used PePr to perform a differential analysis for
the same six sample group comparisons and evaluated PePr’s and SCIDDO’s performance for the
task of detecting DEGs based on differential chromatin marking (Section 4.2.5). To this end, we
considered two different scenarios: first, genes overlapping at least one differential chromatin do-
main (SCIDDO) or having at least one H3K36me3 peak in one cell type but none in the other cell
type (PePr) were labeled as differentially expressed. This strategy could be applied to all 20,091
genes in our gene annotation (gene set G1). In the second scenario, differential chromatin in gene
bodies was taken into account in the same way, but as an additional requirement, at least three an-
notated enhancers of a gene had to show differential chromatin marking (H3K27ac peaks for PePr)
to label the gene as differentially expressed. This reduced the number of genes in the evaluation
set to 17,735 (88.3%; gene set G2), i.e., all genes that had at least three enhancers annotated. We
compared the chromatin-based labeling of genes in sets G1 and G2 with the ground truth DEG
labeling derived with DESeq2 [147] (Section 4.2.4). Although we settled for a fixed threshold on
gene expression fold change (> 2) and p-value (< 0.01) to identify DEGs throughout this study,
we varied these values for the comparison between SCIDDO and PePr to examine the stability of
their performance for different levels of differential expression stringency. We calculated accuracy
and F1 score for all sample comparisons and the gene expression fold changes 0.5, 1, 2 and 4 and
p-values 0.1, 0.05, 0.01 and 0.001 for the two gene sets G1 and G2 (Figures 4.12 and B.8). In
summary, SCIDDO’s performance is superior to PePr. Averaged over all comparisons, SCIDDO
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shows an accuracy of 64.6% (G1) and 69.2% (G2) and a F1 score of 57.5% (G1) and 59.1% (G2)
for the two different strategies of labeling a gene as differentially expressed. For PePr, the average
performance scores are 57.6% (G1) and 57.7% (G2) accuracy and 54.6% (G1) and 54.7% (G2) F1
score.
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Figure 4.12: SCIDDO shows more stable performance at detecting DEGs (G1): box plots
depict SCIDDO’s and PePr’s (light grey) performance of detecting DEGs quantified as F1 score
(left) and as accuracy (right). Performance values are summarized over all sample group compar-
isons and for different thresholds on gene expression fold change (0.5, 1, 2 and 4) and on adjusted
p-values (0.1, 0.05, 0.01 and 0.001) computed with DESeq2 to call DEGs. At least one DCD/differ-
ential H3K36me3 peak (PePr) was required in the gene body of a DEG to be considered detected on
the chromatin level. Differences in performance were assessed with a one-sided Mann-Whitney-U
test and considered significant “*” at p < 0.01.
4.4 Discussion
The use of chromatin state segmentation maps for large-scale annotation and interpretation
of reference epigenomes is well-established in the field of computational epigenomics (see,
e.g., [71, 72]). Nevertheless, comparatively little effort has been invested in the development of
generally applicable software that assists researchers in exploiting these resources. To fill that gap,
we developed SCIDDO, a new tool that implements a score-based approach for the fast detection
of differential chromatin domains between potentially small groups of replicated samples.
The results presented above indicate that SCIDDO is able to robustly identify consistent sets
of differential chromatin candidate regions across individual biological replicate comparisons.
This observation suggests that SCIDDO is well-equipped for the commonly encountered situation
of limited replicate availability while still offering a statistically sound evaluation of the detected
DCDs. Although the statistics implemented in SCIDDO do not afford a theory-driven evaluation
of the detected DCDs, e.g., no suitable E-value threshold is motivated by the theory, we could
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validate our findings in several biologically meaningful ways. The considerable overlap between
the detected DCDs and various regulatory annotation datasets (Figure 4.4) suggests a functional
role for the identified DCDs that is in line with published studies [12, 101, 165]. By relating
gene-expression fold changes to DCD formation in gene bodies and gene-associated enhancers,
we could show that this presumed functional role seems to have a measurable effect on gene
expression behavior (Figures 4.6 and B.5). Our findings conform to the established view
that extensive chromatin changes in gene bodies and in gene-associated enhancers are good
indicators of the expected gene-expression fold change [115, 132, 188]. It should be emphasized
that SCIDDO realizes this view on the interplay between chromatin changes and altered gene
expression without directly quantifying differences on, e.g., the read count level. Nevertheless,
SCIDDO is able to detect most DEGs (Figure 4.7), and shows a performance in such tasks that is
on average superior and more stable compared to competing approaches, which implement more
time-intensive strategies to differential chromatin analysis (Figure 4.12).
An observable trend in the dataset we analyzed is the limited variation on the chromatin level
with increasing cellular relatedness, e.g., what we have detailed for the monocyte to macrophage
comparison. Although this inverse relationship is plausible, it implies that there is a natural limit
in “resolution” of differential chromatin state analyses that governs SCIDDO’s applicability in
discerning cellular phenotypes or characterizing differentiation pathways. Although we did not
investigate these potential limitations in depth, we collected multiple lines of evidence that illus-
trate various ways of how gene expression changes, and thus different cellular phenotypes, could
be realized without necessarily leaving a detectable trace on the chromatin level (Figures 4.10
and B.7). One of these blind spots in chromatin state maps is the “quiescent” background state,
i.e., the chromatin state without any detectable signal. If possible, a more fine-grained character-
ization of the background state would be a promising way of extending score-based differential
chromatin analyses to cover even more regions of the (epi-) genome. For example, a widespread
background state in gene bodies in only one sample group might be interpreted as biologically
meaningful (Figure 4.10B), and thus, an adapted scoring for the background state in this context
could plausibly increase DEG recovery rates via DCD overlap.
In total, the evidence supports the conclusion that SCIDDO’s score-based approach to differential
chromatin analysis discovers biologically meaningful and interpretable DCDs. SCIDDO could
thus become a useful software for chromatin bioinformatics and complement existing tools in anal-
ysis settings as described in this chapter.
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CHAPTER 5
Epigenome-based Predicࢢon of
Gene Expression across Species
Lead-in This chapter is concerned with the following question: can bioinformatics bridge
the data gap between model and non-model organisms in epigenomics? Section 5.1 provides a
short motivation and an overview of relevant observations in previous cross-species epigenome
studies. Based on these reports, we developed a bioinformatics pipeline tailored to perform an
exploratory analysis across species boundaries. In Section 5.3, we present evidence indicating
that there is indeed a case to be made for pure in silico approaches in data-scarce settings such
as cross-species epigenomics involving non-model organisms. This chapter concludes with a
discussion of the results presented in Section 5.4, and ideas for future work are included in
Chapter 6.
The work presented in this chapter is an extended version of the manuscript Ebert et al. [65]
(for details and author contributions, see Appendix E.1.3).
5.1 Background
Cross-species genome analysis is widely used for investigating evolutionary processes,
identifying regulatory elements, improving genomic annotations, and studying the mechanisms
underlying human diseases [28, 32, 129, 139, 161, 248, 258]. Recent progress with epigenome pro-
filing technology has added a new dimension to genome comparisons. Cross-species comparisons
that incorporate epigenomics and functional genomics data have opened up new ways of exam-
ining evolutionary processes, looking beyond genomic sequence conservation [249, 261, 263].
However, due to the high cost of generating epigenome data, as well as the cell-type specific and
dynamic nature of epigenomic marks (Chapter 2), current reference epigenome datasets have
been limited to a handful of species, most notably human and mouse [1, 48, 231, 241]. Genome
sequencing efforts for other vertebrate species rarely include epigenome profiling [68, 128]. This
has hampered the investigation of epigenome regulation in non-model organisms and precluded
systematic cross-species epigenome analyses, with a few notable exceptions [146, 214, 249, 261].
There are several noteworthy observations in the aforementioned exceptions that bear some
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relevance in the context of this chapter. Long et al. [146] investigated why computational
predictions of CGIs in cold-blooded vertebrates (e.g., in zebrafish and frog) often do not overlap
with gene promoters, whereas the inverse is the common case in (warm-blooded) mammals (e.g.,
in human and mouse). After experimentally determining non-methylated islands (NMIs)1 in seven
diverse vertebrate species, Long et al. discovered that the computational predictions of CGIs —
taken as proxy for NMIs — were in strong disagreement with the experimentally determined
NMIs. The experimentally determined NMIs showed the expected location pattern in or around
gene promoters. After examining the nucleotide compositions of all seven species, Long et al.
concluded that differences in CpG and G+C sequence content complicate the computational
identification of NMIs in other (non-model) species. In other words, computational approaches
to cross-species DNA methylome analysis should be carefully evaluated for their applicability if
non-model species are included in the study.
Similar species-specific differences were reported by Schmidt et al. [214], who investigated TF
binding of two liver-specific factors using ChIP-seq in five vertebrate species. The central findings
by Schmidt et al. can be summarized as follows: most TF binding events are species-specific,
and ultraconserved binding events, i.e., binding events shared among all five vertebrates, are
rarely observed in vivo. Moreover, Schmidt et al. found that approximately only 50% of binding
events lost in one species but present in at least two others could potentially be recovered by
nearby TF turnover2 events, suggesting substantial species-specific changes in the local regulatory
environment. Schmidt et al. also made the important observation that there is no cross-species
correlation between TFBS motif and binding event conservation, or between TF binding strength
and binding event conservation. Given that Schmidt et al. selected liver because it is a functionally
conserved organ in the five investigated species, their results seem to suggest that the regulatory
landscape molded by TF binding is too highly dynamic to be amenable for accurate computational
predictions across species if there is no explicit model available to account for the rapid TF
turnover.
On the (histone) chromatin level, previous reports in the literature suggest a rather complex
relation between the genome and the epigenome over evolutionary timescales. For example,
Xiao et al. [261] examined several histone marks in cells from human, mouse and pig. Xiao
et al. reported a notable tendency for epigenetic variation to be larger across species (interspecies
comparison) than within a species (intraspecies comparison). Despite this tendency, Xiao et al.
could also identify several examples of conserved patterns of histone marking across species. By
comparing histone mark co-occurrences between species and by fitting histone-based regression
models to gene expression levels, Xiao et al. could provide evidence for the regulatory signal
1Long et al. [146] use the neutral term of non-methylated islands instead of CGIs, because sequence-based definitions
of CGIs may not be directly applicable to all the examined vertebrates.
2In the context of transcription factors, “turnover” can be defined as “nucleotide substitution that leads to a transcrip-
tion factor binding site (TFBS) motif ’moving’ along the DNA sequence in a locus, or ’transforming’ into a different
TFBS motif” [149]. Specifically in the context of the work by Schmidt et al., the consequence of a turnover event can
be that, e.g., no TF binding motif conservation is detectable between two species, but the local regulatory state may
be functionally conserved because nearby (newly formed) TF binding sites could potentially compensate for the lost
binding site. Here, it is important to keep in mind that Schmidt et al. examined binding events, and not just binding
motifs, which facilitates a more functional interpretation of their results.
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Figure 5.1: Patterns of epigenome conservation: partial reproduction of Figure 3B in Xiao et al.
[261]. Schematic illustration of observed patterns of epigenome conservation for the three histone
marks relevant in this chapter. Genomic sequence conservation is depicted along the x-axis and
(scale-free) epigenome conservation ranging from “low” to “high” is depicted along the y-axis.
represented by certain histone marks seeming to be evolutionarily conserved. A closer inspec-
tion of epigenome and genome sequence conservation revealed several patterns of epigenome
conservation (Figure 5.1). One of these patterns shows a U-shaped correlation between genome
and epigenome conservation, which motivated Xiao et al. to hypothesize that the epigenome
could buffer against otherwise deleterious changes on the sequence level (Figure 5.1, left panel).
This U-shaped correlation was detected for two of the histone marks relevant in this chapter
(H3K27ac, H3K36me3). For the third histone mark used in this chapter (H3K4me3), Xiao et al.
observed a different pattern of weak to moderate epigenome conservation in most sequence
contexts, but showing a spike in epigenome conservation for highly conserved sequences. The
results presented by Xiao et al. seem to suggest that epigenome conservation is not a general
consequence of genomic conservation; it is, however, also supported by their evidence that taking
sequence conservation as a proxy for epigenome conservation is not an unreasonable starting
point to explore epigenome conservation across species.
The conclusions by Xiao et al. [261] seem to be supported by a more recent study of
cross-species epigenome evolution. Villar et al. [249] profiled the two histone marks H3K4me3
and H3K27ac to investigate epigenetic changes in enhancer and promoter elements in the liver of
20 mammals. Villar et al. showed that epigenome conservation seems to depend on the regulatory
context, similar to what was reported by Xiao et al. [261]. The central result by Villar et al.
was stated as follows: epigenome evolution is fast at enhancer elements (H3K27ac) and slow
at promoter elements (H3K4me3 and H3K27ac). Restricting the analysis to the 10 species
with the highest quality genome assemblies, with human used as reference species, enabled the
identification of approximately 300 highly conserved enhancers (of roughly 29,000 in total),
and of around 1,800 highly conserved promoters (of roughly 12,000 in total). For these highly
conserved regulatory elements, Villar et al. detected a moderate selective constraint on the
respective genomic sequences, i.e., these sequences contained fewer nucleotide substitutions than
expected under neutral evolution. Nevertheless, Villar et al. characterized the enhancer repertoire
in each species as mostly recently evolved and thus largely species-specific.
In summary, the status quo of cross-species epigenomics research that looks beyond canonical
model animals suggests that there is detectable epigenome conservation on the (histone) chromatin
87
level, with a more or less pronounced bias toward sequence-conserved regions depending on the
histone mark. Furthermore, it seems that species-specific changes in the (epigenetic) regulatory
landscape are often driven by turnover of TF binding events, and gain or loss of regulatory
elements (of course, these events are likely to reciprocally affect each other, or to be just two sides
of the same coin). It thus stands to reason that bioinformatics could enable cross-species analyses
by harvesting existing epigenome resources, and, consequently, avoid or delay the laborious task
of mapping the epigenome in non-model species.
The objective of the work presented in this chapter was to explore and evaluate cross-species
extrapolation of epigenome data, and epigenome-based inference of gene expression in a range of
target species, based only on existing reference epigenome maps for human and mouse. To that end,
we established computational epigenome transfer and prediction of gene expression (Figure 5.2)
for twelve mammalian and one avian species (Figure C.1). We transferred epigenome data from
our reference species (human or mouse) to the target species using whole-genome alignments. We
used the transferred epigenome data to predict tissue-specific gene expression in the target species
using machine learning models trained and cross validated on data from the reference species.
To validate our approach, we compared our predictions with measured tissue-specific expression
profiles of the target species, confirming that such cross-species predictions can be useful and
informative.
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Figure 5.2: Conceptual outline of the cross-species pipeline: (1) top to middle: epigenome data
from the reference species are transferred to the target species using pairwise whole-genome align-
ments. (2) Top to right: epigenome data in the reference species are used to train machine learning
classifiers that predict gene expression status (blue cross: on/high; orange minus: off/low; red “no”
sign: unlabeled data). The strength of the epigenetic signal in gene loci (here illustrated ranging
from blue/low to red/high) is used as model feature. (3) Bottom: prediction of gene expression
in the target species using the transferred epigenome data (yellow box) and the trained machine
learning classifier (red box).
5.2 Materials and Methods
5.2.1 Included species, genome assemblies, and gene models
We included 12 mammalian species (human [hg19], rhesus [rheMac2], mouse [mm9], rat [rn5],
rabbit [oryCun2], pig [susScr2], cow [bosTau7], sheep [oviAri3], horse [equCab2], dog [can-
Fam3], cat [felCat5], opossum [monDom5]), and one avian species (chicken [galGal3]), based on
the following selection criteria: (i) complete genome assemblies and whole-genome alignments
with at least one of the two reference species (human, mouse) were available from the UCSC
Genome Browser [271]; (ii) gene models for the relevant assemblies were available from one of
three sources (GENCODE [96]: human v19, mouse vM1; The Bovine Genome Database [69]:
cow Ensembl v75; UCSC Genome Browser tables ensGene, ensemblSource and ensemblToGe-
neName: all other species); (iii) epigenome profiles including histone H3K4me3, H3K27ac, and
H3K36me3 as well as transcriptome data were available for defined tissues/cell types in the refer-
ence species (Appendix C.1, Table S1); and (iv) transcriptome data were available for at least some
of these tissues/cell types in the target species. An overview of the evolutionary relationships for
all species included in this study is provided as a phylogenetic tree generated using the TimeTree
service [99] C.1. To alleviate the effect of differences in annotation quality, all gene models were
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reduced to protein-coding transcripts/genes. Additionally, only transcripts tagged as “Consensus
CDS (CCDS)” were selected in the GENCODE annotations. All analyses were restricted to genes
located on the autosomes. Promoter regions were defined as 1.5 kilobase windows around the TSS
(-1,000 bp to +500 bp), and genes with a gene body length of less than 750 bp were discarded.
5.2.2 Whole-genome alignments, gene orthologs, and evoluࢢonary
conservaࢢon
Whole-genome alignments between the reference species (human, mouse) and target species
were downloaded from the UCSC Genome Browser in the form of chain files [122]. Following
the instructions in the UCSC Genome Wiki3, the downloaded chain files were processed to derive
so-called reciprocal best chains, which represent a reduced (high-quality) alignment relative to the
complete alignment information stored in the chain files. The reciprocal best chains were further
processed using CrossMap [269] and custom scripts to build pairwise symmetric alignment blocks.
Genes with less than 100 aligned bases in their promoter and in their body were considered weakly
aligned. Information on gene orthologs was downloaded from OrthoDB [133], and lists of 1-to-1
orthologs for each pair of species and, separately, for all 13 species combined were extracted from
the annotation data using custom scripts.
5.2.3 Epigenome and transcriptome data preprocessing
Publicly available reference epigenomes for the reference species (human, mouse) were ob-
tained from ENCODE, DEEP, and BLUEPRINT (Appendix C.1, Table S1). The resulting dataset
included three histone marks (H3K4me3, H3K27ac, H3K36me3), three cell types (embryonic
stem cells, naïve CD4+ T cells and hepatocytes), and a total of nine epigenome profiles for hu-
man. For mouse, the dataset included three histone marks (H3K4me3, H3K27ac, H3K36me3),
five cell/tissue types (embryonic stem cells, naïve CD4+ T cells, whole liver, kidney and heart),
and a total of 17 epigenome profiles. Tissue-specific transcriptome profiles were obtained from
ENCODE, DEEP, and public repositories (Sequence Read Archive (SRA)/European Nucleotide
Archive (ENA)). Where available, epigenome profiles were downloaded in the form of histone
signal tracks (bigWig format; see Chapter 2, Section 2.4 for details). For the BLUEPRINT mouse
data, which were not available in preprocessed form, reads were mapped using bowtie2 v2.3.3.1
with the preset “–sensitive”, and signal tracks were generated using bamCoverage v2.5.3 from
the deepTools software suite [199, 200]. To prepare the epigenome profiles for the analysis, biolog-
ical replicates from the same laboratory were merged by taking the mean. All resulting epigenome
signal tracks were quantile normalized per project and clipped at the 99.95 percentile to allevi-
ate the effect of outliers. For validation purposes, the liver epigenome data by Villar et al. [249]
(ENA study accession PRJEB6906) were downloaded and histone signal tracks for H3K4me3 and
H3K27ac were generated following the same procedure as for the BLUEPRINT mouse reference
epigenomes.
3genomewiki.ucsc.edu/index.php/HowTo:_Syntenic_Net_or_Reciprocal_Best
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To evaluate the predictions of our machine learning models (Section 5.2.4) with experimentally de-
termined gene expression levels, we obtained transcriptome data from various public sources: em-
bryonic stem cells for human and mouse [231, 241]; CD4+ T cells for human and mouse [46, 60];
hepatocytes for human [48]; whole-organ samples of liver, kidney and heart for all species except
human [81, 112, 162]; and a blood sample for opossum (Appendix C.1, Table S1). Transcriptome
data were processed with Salmon v0.8.2 using the following parameters: “–forgettingFactor
0.8 –useVBOpt –seqBias –gcBias –geneMap”, aggregating transcript-level abundance estimates
into gene-level estimates. Finally, the gene expression values were subjected to quantile normal-
ization, and the normalized transcript per million (TPM) values were used for further analysis.
5.2.4 Epigenome-based predicࢢon of gene expression
The formal description of the machine learning procedure follows Hastie et al. [97] in
argument and notation if not stated otherwise
All prediction models were implemented in Python3, using libraries from the SciPy ecosys-
tem for scientific computing [160, 166, 177, 183]. Histone signal tracks were masked to exclude
non-conserved regions according to pairwise genome alignments between the reference and target
species. Prediction attributes were derived from these masked signal tracks by averaging the sig-
nal across each gene promoter (H3K4me3, H3K27ac) and gene body (H3K36me3). The machine
learning part of our pipeline was realized by training gradient boosting classifiers from the scikit-
learn library [183]. The general idea of boosting is to combine many weak learners into a more
capable and robust ensemble method; here, a weak learner is any (simple) base model that has a
performance only slightly better than random guessing. The most popular choice for selecting the
base model are decision trees (cf. Hastie et al. [97], Section 10.7), which is also the base model
used in the scikit-learn implementation. The fitting of a gradient tree boosted model is a forward
stagewise process, i.e., an iterative procedure that adds one base model at a time without changing
the already existing models in the ensemble. Formally, given a training dataset ofN samples, with
feature matrix X and class labels Y , this can be expressed as follows using decision tree models
T as base learners:
T (x; Θ) =
J∑
j=1
γj1 [x ∈ Rj ] (5.1)
where Θ = {Rj , γj}J1 . A tree T partitions the feature space into J disjoint regions Rj that are
represented as terminal nodes of the tree. In the case of J = 2, such a tree model is called a
“decision stump” that makes only a single split. For each region, there is a constant γj and the
predictive rule is
x ∈ Rj ⇒ f(x) = γj (5.2)
In classification scenarios, an intuitive way to choose γj would be, e.g., to use the label of the
modal class in region Rj . Details on how to find the Rj , i.e., a “good” partitioning of the space
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into disjoint regions are omitted here (see Hastie et al. [97], Section 9.2). The boosted tree model
fM is then a sum over a total of M trees T :
fM (x) =
M∑
m=1
T (x; Θm) (5.3)
where each step of the forward stagewise fitting amounts to solving
Θˆ = argmin
Θm
N∑
i=1
L(yi, fm−1(xi) + T (xi; Θm)) (5.4)
The loss function L is the deviance/cross-entropy in our implementation (cf. Hastie et al. [97],
formula 9.17)
K classes : −
K∑
k=1
pk · log(pk) (5.5)
K = 2 : −p · log(p)− (1− p) · log(1− p) (5.6)
where p and 1 − p are, in our setting of binary classification, the class proportions in a tree node
representing a regionRj . An important property of gradient boosting is that each subsequent stage
in the fitting process is guided by previous “mistakes”. This is realized by fitting the m-th model
fm to the negative gradient of the loss function evaluated at fm−1. Let gim be the gradient for
sample i in iteration m and squared error used to measure the closeness of fit of the m-th model to
the negative gradient, this leads to4
gim =
[∂L(yi, f(xi)
∂f(xi)
]
f=fm−1 (5.7)
Θˆm = argmin
Θ
N∑
i=1
(−gim − T (xi; Θ))2 (5.8)
A pseudocode version of the complete fitting procedure can be found in Hastie et al. [97] (Algo-
rithm 10.3), of which we just repeat the update rule completing iteration m:
fm(x) = fm−1(x) +
J∑
j=1
γim1 [x ∈ Rj ] (5.9)
A common regularization parameter used for gradient tree boosting is the so-called learning rate
ν. Introducing this parameter into the algorithm changes the update rule 5.9 to
fm(x) = fm−1(x) + ν ·
J∑
j=1
γim1 [x ∈ Rj ] (5.10)
4Equation 5.8 omits a technical detail related to the (inexact) approximation to the negative gradient. Since this
chapter only describes an application of the gradient tree boosting procedure, and more elaborate technical considerations
are beyond the scope of this thesis, this minor simplification from Hastie et al. [97] seems to be a reasonable compromise.
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For values smaller than one, ν limits the contribution of each individual base learner. Limiting
the contribution of the base learners leads to a larger value of M to achieve the same error rate
during model training. Despite this trade-off between ν andM , empirical evidence suggests that it
is usually beneficial to tune ν as an additional hyperparameter during cross validation (see Hastie
et al. [97], Section 10.12.1). We followed this advice in the model building part of our pipeline.
Gradient boosting classifiers were trained using histone signal intensities as prediction attributes
and the gene expression status (on/high: TPM ≥ 1; off/low: TPM < 1) as target variable (this
binary thresholding strategy was motivated by previous studies [34, 58, 227]). Each training dataset
was randomly subsampled to balance class frequencies, and model hyperparameters J , M and ν
were tuned using five-fold cross validation on this subsampled training dataset. The best model
according to the results of the cross validation was refit using the full set of training data. For the
evaluation of the trained classifiers, the model performance was measured in terms of accuracy as
defined in Chapter 4, Section 4.2.5. Additionally, the terms sensitivity and specificity are used in
this chapter. Sensitivity is the same as recall (cf. Chapter 4, Section 4.2.5), and specificity is the
true negative rate defined as the number of true negative samples divided by the sum over all true
negative and false positive samples.
5.2.5 Genomic region enrichment analysis
Region sets were analyzed for significant enrichment using the LOLA software [225]. For the
human genome, the LOLA Core region database was used. In addition, we created a custom region
set for both the human and mouse genome, comprising various sets of transcription factor binding
sites as well as histone modification peaks from the DeepBlue repository [5]. For each LOLA anal-
ysis, we filtered the results and retained enriched region sets if the support (i.e., number of regions
covered) was at least five and the multiple-testing corrected statistical significance (q-value [232])
was below 0.05. We manually selected 10–15 entries from the top ranking region sets for visu-
alization and provide the full list of LOLA enrichments in the online supplement (Appendix C.1,
Tables S2 and S3).
5.2.6 Gene age annotaࢢon
To evaluate the evolutionary age of each gene, we obtained gene age annotations for the follow-
ing species from a recent publication [142]: chicken, cow, dog, human, mouse, opossum, rat, and
rhesus macaque. UniProt identifiers were mapped to Ensembl gene identifiers using a web–based
service [195]. Since the identifiers were mapped with varying success depending on the species,
the results presented below focus on the the three species where at least 80% of all gene identifiers
could be mapped (human 97%; mouse 83%; rhesus 81%).
5.2.7 Study replicaࢢon
The code for replicating all results of this chapter is publicly available at doi.org/10.17617/1.69.
All data preprocessing and analysis pipelines have been implemented in Python/Ruffus [90]. All
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figures except for Figure 5.2 can be recreated using the respective Jupyter Notebooks5 available
in the aforementioned repository.
5.3 Results
5.3.1 Cross-species transfer of reference epigenome data using
whole-genome alignments
Our bioinformatics pipeline uses epigenome profiles for the reference species as input and
exploits whole-genome alignments to transfer these data to conserved genomic regions in the
target species. To that end, we prepared pairwise symmetric whole-genome alignments for each
pair of reference and target species (Section 5.2.2), and we used these alignments to transfer
histone signal intensities. As motivated in Section 5.1, our approach is based on the hypothesis
that sequence conservation is an indicator of regulatory conservation within a genomic region,
and that tissue-specific patterns of epigenome regulation are frequently maintained across species
in sequence-conserved regions. We tested and confirmed this hypothesis by using the transferred
epigenome data to predict tissue-specific gene expression in the target species — as described
further below.
Using alignment-based epigenome transfer, we produced genome-wide, cell-type specific
epigenome profiles for each target species. The non-zero part of the transferred histone signal
covers a substantial fraction of the overall aligned bases in the target species (ranging from human
and mouse to opossum and chicken), based on the two reference species human (Figure 5.3) and
mouse (Figure C.2). The distribution of the transferred histone signal follows patterns similar
to those of the measured histone signal in the reference species: H3K4me3 signal covers the
smallest number of bases, consistent with this mark’s prevalent occurrence in gene promoters.
The more widespread occurrence of H3K27ac and H3K36me3 is similarly consistent with the
focus of H3K27ac on a broader set of regulatory regions (including enhancer elements) compared
to H3K4me3, and H3K36me3 covers the gene body of actively transcribed genes (Chapter 2,
Section 2.1.1.4).
Further analysis of average histone signal strength in gene promoters, gene bodies, and
other genomic regions showed that, after cross-species transfer, the histone signal strength in the
target species resembles the distribution in the reference species (Figure C.3). The transferred
signal is generally strongest in gene bodies and in gene promoters, while it is weak outside of
protein-coding genes. Since we only used the histone signal in gene promoters and in gene bodies
for predictive modeling of gene expression, the low histone signal outside of these two region
types is of no concern in the prediction analysis described below.
As a validation for the cross-species transfer of epigenome data, we examined whether
5http://jupyter.org
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Figure 5.3: Coverage of transferred epigenome profiles: colored points indicate the average
number of base pairs with non-zero signal after cross-species transfer for each histone mark (error
bars denote +/- one standard deviation around the mean) between human as the reference species
and twelve target species. The number of aligned bases genome-wide (black bars), and at gene loci
(gene promoters and gene bodies combined, grey bars) are shown for comparison. Target species
are sorted by increasing evolutionary distance to the human reference (x-axis, million years since
last common ancestor indicated in parentheses).
the transferred epigenetic signals in gene promoters (for H3K4me3 and H3K27ac) and gene
bodies (for H3K36me3) retain detectable cell-type specificity. To that end, we focused on the
comparison between human and mouse, where we have reference epigenome data for both species
and most samples, and we found that correlations between transferred and measured epigenomes
are usually highest when the cell type is matched (Figure 5.4). For example, the comparison
between transferred and measured epigenomes in mouse results in a Pearson correlation of 0.75
for H3K4me3, 0.61 for H3K27ac, and 0.71 for H3K36me3 in CD4+ T cells.
Although in general epigenome data is scarce for non-model organisms, we could use the data
generated by Villar et al. [249] to corroborate the correlations observed above in one tissue (liver)
for at least two (H3K4me3, H3K27ac) of the three histone marks in several target species. We
computed the histone signal correlation in gene promoters for both marks comparing transferred
to measured epigenome data. Additionally, for the two reference species human and mouse,
we also correlated the data by Villar et al. to our DEEP and ENCODE reference epigenomes
(Figure 5.5). The data by Villar et al. show strong agreement with the DEEP and ENCODE
reference epigenomes in human and mouse, with the lowest median correlation at 0.89 for the
human H3K27ac signal. The correlations are slightly lower when comparing the data measured
by Villar et al. to the transferred epigenome data in the respective target species. However,
the median correlation is still high at approximately 0.7 or higher in most cases. Transferred
epigenomes having pig as target species show the lowest correlations of around 0.6 to 0.65 for
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both histone marks and for both reference species.
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Figure 5.4: Tissue-specific correlation of measured and transferred epigenomes: heatmaps
show pairwise Pearson correlations of measured and transferred histone signals for H3K4me3 and
H3K27ac at gene promoters (top panel) and for H3K36me3 in gene bodies (bottom panel), using
human as reference species and mouse as target species.
To substantiate these findings, we performed region set enrichment using the LOLA soft-
ware [225] on the top 5% gene promoters with the highest average transferred signal for H3K4me3,
and on the top 5% gene bodies with highest average signal for H3K36me3. We consistently ob-
served cell-type specific enrichment (Appendix C.1, Table S2), as illustrated by the LOLA en-
richment for CD4+ T cells using mouse as reference and human as target species (Figure 5.6A/B)
and by the LOLA enrichment for liver/hepatocytes using human as reference and mouse as target
species (Figure 5.6C/D). In both cases, the LOLA results show the expected enrichment for tissue-
specific histone marks associated with active promoters (H3K4me3) and actively transcribed genes
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Figure 5.5: Correlation of measured and transferred liver epigenome data: box plots show
Spearman correlation of measured and transferred histone signals for H3K4me3 and H3K27ac at
gene promoters using human (A) and mouse (B) as a reference for the cross-species epigenome
transfer. Measured liver epigenome data were obtained from the study by Villar et al. [249]. In the
case of human-to-human and mouse-to-mouse, the validation data by Villar et al. were correlated to
the DEEP and ENCODE reference epigenome data used in our study. Box plots depict correlation
values together for all individual chromosome in the target species.
(H3K36me3), respectively. The annotated cell type of the enriched region sets is the same as (or
closely related to) the cell type of the transferred epigenomes, supporting that our cross-species
epigenome transfer method retained the characteristic cell-type specificity of epigenome data.
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Figure 5.6: Genomic region enrichment analysis for transferred epigenomes: selected results
of LOLA analyses for gene promoters (panel A and C) and gene bodies (panel B and D) that were
ranked among the top 5% based on transferred epigenome signal intensities for H3K4me3 (gene
promoters) and H3K36me3 (gene bodies). Top panels show region set enrichment for CD4+ T cell
epigenomes transferred from mouse to human (panel A and B); and bottom panels show region set
enrichment for hepatocyte/liver epigenomes transferred from human to mouse (panel C and D).
Effect size (log2 of the odds ratio) is indicated on the x-axis. The false discovery rate estimate
(q-value [232]) is smaller than 10−12 in all cases.
5.3.2 Predicࢢon of gene expression using epigenome data transferred
across species
To assess the biological information carried by the transferred epigenomes in a larger number
of species (namely in those species for which hardly any epigenome data are available for
validation), we tested whether we could predict gene expression in the target species based on
the transferred epigenomes. It is well-established that gene expression can be predicted from
epigenome data [25, 115, 227]. We would expect to observe better-than-random accuracies when
predicting gene expression using transferred epigenome profiles if these profiles indeed captured
relevant regulatory biology. Moreover, to make the validation more stringent, we can exploit the
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cell-type specific character of epigenome data and try to predict cell-type specific patterns of gene
expression.
We used the uniformly processed transcriptome dataset described in Section 5.2.3 as our exper-
imental reference dataset against which we evaluated the epigenome-based predictions. In this
transcriptome dataset, we observed consistent clustering by cell type rather than by species, both
for 1-to-1 gene orthologs [133] between each pair of species (Figure 5.7) and for those genes
that were conserved across all 13 species (Figure C.4). It should be noted that there is some
controversy concerning the conservation of gene expression in orthologous genes, and different
studies reported either clustering by tissue or clustering by species [31, 144, 270].
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Figure 5.7: Transcriptome data cluster by tissue of origin: hierarchical clustering of pairwise
Pearson correlation coefficients between transcriptome profiles of 13 species used for gene expres-
sion prediction and model validation. Correlations were calculated across all 1-to-1 orthologous
genes for each species pair. Color bars at the top indicate tissue of origin. Columns are labeled with
species of origin, and row labels indicate data source (project name or “SRA” for data downloaded
from SRA/ENA).
We implemented a machine learning approach to predict gene expression profiles in the target
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species based on epigenome data in the reference species (see Figure 5.2 for an overview). Using
only data from the reference species, binary classifiers were trained to predict gene expression as
either on/high or off/low (Section 5.2.4). The prediction attributes were obtained by averaging
histone signals for H3K4me3/H3K27ac in gene promoters and for H3K36me3 within the gene
body, restricted to those subregions that were covered by the cross-species alignment used for
epigenome transfer. A threshold of one transcript per million (1 TPM; see Section 5.2.4) was ap-
plied to label genes as on/high or off/low. We observed consistently high prediction performance
for the two reference species, with cross-validated, test-set only, area under the receiver operating
characteristic curve (AUC-ROC; in the following: AUC) values of 0.89 (human to mouse) and
0.90 (mouse to human), resulting in a sensitivity of 78% (human) and 76% (mouse) at a specificity
of 90% (Figure 5.8).
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Figure 5.8: Gene expression prediction performance for human/mouse: ROC curves show
the cross-validated test-set performance predicting gene expression status in mouse based on trans-
ferred epigenome data from human (panel A) and vice versa (panel B), averaged across all included
samples and cell types in both the reference and the target species. The dashed diagonal line rep-
resents the expected performance of a random classifier (AUC = 0.5).
Having validated the epigenome-based classifiers in the reference species, we applied the
classifiers to all target species, using the transferred epigenome data as input. We predicted gene
expression in each target species independent of cell type, averaging across transferred epigenome
profiles and transcriptomes in each target species. We observed high prediction accuracies for
all target species, with AUC values ranging from 0.87 to 0.81 when using human as reference
(Figure 5.9, left), and from 0.89 to 0.83 when using mouse as reference (Figure 5.9, right). The
average sensitivity is 67% (human reference) and 73% (mouse reference) at a specificity of 90%.
As an additional evaluation, we tested if our gene expression predictions are cell-type specific,
i.e., they should show the highest accuracy for the matched cell type between reference and target
species. When comparing AUC values of tissue-matched prediction to AUC values obtained by
cross-tissue prediction, the tissue-specific predictions consistently outperform the tissue-agnostic
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Figure 5.9: Gene expression prediction performance for all species: ROC curves show
the cross-validated test-set performance predicting gene expression status based on transferred
epigenomes from human (left panel) or mouse (right panel) as reference species and the remaining
twelve species as target species. Epigenomes and transcriptomes were averaged across all included
samples and cell types in both the reference and the target species. Shaded areas represents +/- 1
standard deviation around the mean ROC curve. The dashed diagonal line represents the expected
performance of a random classifier (AUC = 0.5).
predictions across all investigated target species and for both human (Figure 5.10, top panel) and
mouse (Figure 5.10, bottom panel) as our reference species. Aggregating AUC values across
species, the difference between the mean AUC values for the tissue-matched tests and the cross-
tissue controls is highly statistically significant (one-sided Mann-Whitney-U, p-value < 10−9).
5.3.3 Comparison of epigenome-based and orthology-based predicࢢon of
ࢢssue-speciﬁc expression
To benchmark our epigenome-based predictions of gene expression, we compared their per-
formance to that of an alternative (and complementary) approach that is based on gene orthology.
Specifically, for all 1-to-1 gene orthologs between each pair of species, the orthology-based
method predicts a gene to be expressed in a certain cell type of the target species if — and only if
— it is expressed in the corresponding cell type of the reference species. This method can predict
expression only for genes that have an annotated 1-to-1 ortholog in the reference species, which
limits its scope and applicability to a subset of genes (Figure C.5).
For a systematic comparison between the epigenome-based and orthology-based methods, we
evaluated their performance on various subsets of genes. These subsets were constructed using
the following approach: we ordered all genes in the target species by increasing levels of DNA
sequence conservation in the gene body, and we used all the genes above a certain threshold as our
evaluation set. We then plotted the performance gain of the epigenome-based method (calculated
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Figure 5.10: Tissue-specific gene expression prediction performance: AUC values (calcu-
lated as in Figure 5.9) comparing the performance of gene expression prediction based on tissue-
specific (dark grey) and on average (light grey) transferred epigenomes, using human (top panel)
or mouse (bottom panel) as reference species and the remaining twelve species as target species.
The first bar shows the aggregation of mean AUC values across all species. The difference in mean
AUC for these aggregated values is statistically significant for both reference species (one-sided
Mann-Whitney-U, “***” indicates significance at p < 10−9).
as the surplus of correct predictions over the orthology-based method across all target species)
for human and mouse as our reference. In this analysis, the epigenome-based method results in
approximately 20% more correct predictions than the orthology-based method (Figure 5.11, left
panel).
Both methods display stable prediction accuracy over a broad range of gene conservation
values (Figure 5.11, right panel). Although the performance gain of epigenome-based prediction is
higher for stringent thresholds on gene body conservation (Figure 5.11, left panel), only relatively
few genes pass these stringent thresholds, and a more inclusive threshold may increase the scope
and utility of our predictions. For example, lowering the threshold on gene body conservation
to 10–15% makes it possible for the epigenome-based method to predict the expression status
for approximately 90% of all genes in the target species, compared to approximately 80% for
the orthology-based method. Given that both methods have similar median accuracies of 75.1%
and 79.9% (human reference) and of 71.5% and 78.1% (mouse reference), the epigenome-based
method offers an advantage over the orthology-based method by providing a substantially larger
number of accurate predictions.
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Figure 5.11: Comparison of epigenome-based and orthology-based approach: (left) perfor-
mance gain of epigenome-based prediction of gene expression over the orthology-based approach
using human (blue) or mouse (orange) as reference species, plotted for different thresholds on the
gene body conservation (x-axis). The number of selected genes for each threshold is also indicated
(black and gray lines). Performance is measured as the number of correct predictions (true positives
and true negatives), and the surplus of correct predictions of the epigenome-based prediction mod-
els over the orthology-based approach is transformed into a percentage value that is comparable
across species. (right) prediction accuracy of epigenome-based (solid lines) and orthology-based
(dashed lines) prediction of gene expression (solid lines) and the corresponding orthology-based
predictions (dashed lines) using human (blue) or mouse (orange) as reference species, plotted for
different thresholds on the gene body conservation (x-axis). All curves (left and right panel) rep-
resent median values of all gene expression predictions aggregated per reference species over all
target species and over all cell types. Genes in the target species are sorted by increasing gene
body conservation along the x-axis.
Finally, we evaluated the tradeoff between sensitivity and specificity in more detail for the
epigenome-based method. We interpreted the class probabilities of the classifier as a measure of
prediction confidence. We observed that the advantage of the epigenome-based method over the
orthology-based method is strongest for lenient thresholds on the class probability of around 0.5,
at the cost of a slightly reduced accuracy (Figures 5.12 and C.6). For the most stringent thresh-
olds (> 0.9), the epigenome-based method consistently makes a higher number of correct predic-
tions than the orthology-based method, while the difference in accuracy between both methods
approaches zero. Based on the shape of the curves, a relatively stringent threshold of 0.75 is likely
to constitute a suitable and broadly applicable tradeoff between sensitivity and specificity.
5.3.4 Limitaࢢons of cross-species epigenome data transfer and predicࢢon
of gene expression
Despite these promising results using cross-species epigenome transfer and epigenome-based
prediction of gene expression, the approach has certain limitations. Most importantly, whole-
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Figure 5.12: Effect of thresholding on classifier class probability estimates: prediction perfor-
mance of the epigenome-based approach (dark gray lines) and the orthology-based approach (light
gray lines), as measured by the number of correct predictions (true positives and true negatives,
left y-axis) and percent accuracy (right y-axis) for increasingly stringent cutoffs on the class prob-
ability estimates of the epigenome-based approach (x-axis, range from 0.5 to 0.95). The number
of genes selected at each threshold is indicated as dotted line. Results are shown for human as
reference and mouse as target species.
genome alignments cover only those genomic regions for which there is discernible conservation
of the DNA sequence. For example, roughly 1 giga base pairs (Gbp) of DNA sequence are
aligned between the human and mouse genome (90 million years since last common ancestor),
which corresponds to approximately a third of the human genome. At a threshold of at least
100 conserved base pairs for both the gene promoter and gene body, 92.2% (mouse) and 97.2%
(human) of genes can be target for cross-species transfer of reference epigenome data. These
values remain high across larger evolutionary time (Figures 5.13 and C.7), for example amounting
to 98.8% in the comparison between human and opossum (160 million years) and 90.7% between
human and chicken (312 million years).
We investigated the 487 human and 1,435 mouse genes that failed to meet our minimum
alignment thresholds and which we therefore cannot predict using the epigenome-based method.
Functionally characterization of these gene sets using the enrichR web service [41, 134] identified
an enrichment for Gene Ontology categories related to olfactory reception (Appendix C.1, Table
S4), which is consistent with large species-specific differences in the repertoire of olfactory
receptor genes between human and mouse [173]. We also analyzed the corresponding promoter
regions for region set enrichment using the LOLA software [225], and we found an enrichment
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Figure 5.13: Epigenome-based prediction of gene expression using the human reference: for
each species, bar plots show the total number of genes in the genome, the number of unaligned
or weakly aligned genes relative to the reference species, and the average number of genes being
correctly predicted by the epigenome-based approach in total, and after setting a threshold on the
predicted class probability of > 0.75. Target species are sorted by evolutionary distance to the
human reference along the x-axis (million years since last common ancestor indicated in parenthe-
ses).
of repetitive DNA elements (genomic duplications, satellite repeats, long terminal repeats, LINE
repeats) as well as regions characterized by the heterochromatin mark H3K9me3 (Appendix C.1,
Table S3). These results indicate that cross-species epigenome transfer is not well suited for
analyzing species-specific gene families and repetitive heterochromatin regions.
Finally, we investigated whether the evolutionary age of individual genes may be associated
with the accuracy of the epigenome-based predictions. Using a recently published dataset of gene
age annotations [142], we found that genes whose expression status was predicted incorrectly
tend to have a younger evolutionary age than those for which the expression status was predicted
correctly (Figures 5.14 and C.8). For example, the group of genes specific to mammals contains
52% more incorrectly predicted genes than would be expected based on the background distribu-
tion of gene ages; in contrast, the much larger group of genes shared across eukaryotes contains
7% more correctly predicted genes compared to expectation.
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Figure 5.14: Association between gene age and epigenome-based prediction performance:
genes were stratified by their tendency to be predicted correctly or incorrectly by the epigenome–
based approach and labeled with their annotated age. Predictions were made in human using mouse
as reference species. Bar heights indicate relative difference to the expected number of genes in
each age group (percent values are shown for comparability across species). One standard devi-
ation estimated by 1,000 bootstrap iterations is indicated as error bars. Numbers in parentheses
indicate divergence time in million years relative to the family of Hominidae (great apes includ-
ing human). Because of horizontal gene transfer, no divergence time estimates are given for the
archaea and the bacteria group. The number of expected genes in each group is derived from the
prior distribution for the gene age label.
5.4 Discussion
Epigenome profiling in the wet lab is costly and labor-intensive, and comprehensive tissue-
specific epigenome resources are currently available for only a few species. Here we explored
cross-species extrapolation of epigenome data as a new approach that utilizes the large catalogs of
human and mouse reference epigenomes to support research in non-model organisms.
We have implemented a basic method for transferring epigenomes across species based on
whole-genome alignments, which we applied and evaluated in two complementary ways. First,
by comparing transferred to measured epigenome data for matched cell types between human and
mouse, we collected evidence indicating that the cell-type specific nature of the epigenome is
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still detectable after cross-species transfer. Moreover, by correlating our transferred epigenome
data to the external validation data by Villar et al., we gathered more evidence suggesting that
a considerable portion of the epigenetic signal is successfully transferable between species, and
could be put to use in subsequent computational analyses. Second, as a proof of concept example
for such an analysis, we combined our cross-species epigenome transfer with epigenome-based
prediction of gene expression. We could validate our gene expression predictions in a range
of target species and observed generally high prediction accuracies. Since the cross-species
epigenome transfer retained the cell-type specific regulatory pattern in the data, we could show
that the predicted gene expression profiles were likewise tissue-specific. This is an important
aspect in the cross-species analysis of gene regulation.
We observed broadly consistent results across twelve mammalian and one avian species
included in our study, which span a spectrum of 20 million (mouse–rat) to 312 million (human–
chicken and mouse–chicken) years since the last common ancestor. While it may be surprising
that there is not a more pronounced decrease in prediction performance as evolutionary distances
increase, all of the species included in our study share highly conserved epigenetic machinery,
and, apparently, there is sufficient conservation in gene promoters and gene bodies to exploit this
fact. Moreover, we found that evolutionarily old genes were predicted with higher accuracy than
more recently evolved genes, which seems to be in line with the literature [189]. We assume that
this factor is likely to contribute to the robustness of predictions across a wide evolutionary range.
Our method does not have major limitations that would hinder its broad application, except
that it requires a reference genome for all included species. The more complete and more accurate
the reference genome assemblies of the target species, the higher will be the quality of whole
genome alignments, and, presumably, the performance of our method. Nevertheless, because our
method transfers epigenome data between locally aligned regions, it is not restricted to high-quality
genomes and might also cope reasonably well with initial, more fragmented genome assemblies.
If this is successfully tested, cross-species epigenome transfer could indeed hint at new ways of
investigating previously understudied non-model organisms.
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CHAPTER 6
Conclusion and Perspecࢢves
Modern biological research in the field of epigenomics is advancing at a fast pace, driven
by technological progress in areas such as single-cell sequencing [45, 83, 222], and by setting
ambitious goals such as creating the first complete atlas of all cell types in the human body [202].
The way to far-reaching goals is nevertheless studded with numerous individual studies, where
each new generation of scientists builds upon the accomplishments of the previous one — or
dismantles them in light of new evidence.
The scrutiny required to corroborate new scientific hypothesis is particularly laborious in
emerging fields such as epigenomics. The work presented in Chapter 3 focused on reducing
this workload for bioinformaticians, and on developing dissemination strategies for documented
computational pipelines. To that end, a metadata model has been developed and published in
Oxford Database [64] that is tailored to the needs of collaborative research consortia. This
metadata model aims at limiting the amount of required manual work and at automating other
tasks such as detecting errors and validating metadata records. The entire setup was successfully
tested as part of the daily work routines in the DEEP consortium and, due to secondary features
integrated over time, could actually provide more than the initially planned services. The resource
created at doi.org/10.17617/1.2W provides the documentation of the DEEP pipelines in an online
accessible, shareable and citable manner and is referenced on the official IHEC data portal [36].
After discussing standardized and presumably reproducible procedures for epigenome data
processing (Chapter 3), an important next step is to enable scientists to compare biological
samples in a meaningful way, e.g., to investigate healthy or disease cellular phenotypes. To that
end, Chapter 4 introduced SCIDDO [65], a versatile and fast tool for the differential analysis
of chromatin state segmentation maps. SCIDDO uses quantitative scores to measure chromatin
state (dis-) similarity, an approach new to differential chromatin analysis. This new approach
provides a potential advantage over competing methods, as it permits to explore varying notions
of chromatin state similarity depending on the research question at hand. Moreover, SCIDDO
does not require a large number of samples for the statistical evaluation, making it a suitable tool
for the comparative analysis of small sample groups. In an exemplary study on a selected set of
DEEP samples, SCIDDO’s usefulness in identifying differential chromatin domains between even
closely related cell types could be demonstrated. The identified differential chromatin domains
are located in functionally plausible regions, e.g., in differentially expressed genes or in various
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regulatory elements, and we thus concluded that SCIDDO is a valid addition to existing software
solutions for the analysis of chromatin data.
The principle of expanding biological knowledge by performing comparative analyses is
pushed beyond intraspecies comparisons in Chapter 5. This chapter presented an exploratory study
that crosses the species boundary between well-characterized model and understudied non-model
species purely in silico. Our results show that cross-species transfer of epigenome data is possible
among mammalian (and avian) species, and that the transferred epigenomes not only retain tis-
sue specificity but also enable tissue-specific prediction of gene expression. We thus concluded
that the tissue-specific links between epigenome profiles and gene expression are well conserved
across the analyzed species. Although cross-species transfer of epigenome data is not meant to
replace experimental data, our initial results suggest that in silico approaches could complement
experimental analysis by providing access to a larger number of (non-model) species and tissues
at essentially no additional cost. Hence, bioinformatic approaches for cross-species epigenome
analysis suggest new use cases for chromatin data in comparative studies.
Perspecࢢves
Issues arising from a lack of standardized data handling and processing procedures are still
prevalent in the field of epigenomics. These issues manifest themselves, e.g., in the course of
ongoing collaborative efforts such as the IHEC “EpiMAP”1 project. The “EpiMAP” project
aims at an integrative analysis of all reference epigenomes produced by the initiatives organized
under the IHEC umbrella (DEEP, BLUEPRINT etc.), and faces many challenges related to data
wrangling and metadata processing2. Although it is undoubtedly too early, and presumably
generally unrealistic, to expect a seamless integration of data from a considerable number of
different sources, projects such as “EpiMAP” highlight the importance of consistent metadata
models, and of replicable analysis setups to reduce the workload during later data integration tasks.
IHEC members continue their efforts to increase standardization, e.g., concerning the definition of
quality control metrics for wet lab experiments3, or the use of uniform data processing pipelines4
at all collaborating partner institutions. The latter point implies that some of the work for the
design and setup of computational analysis pipelines in DEEP has now been superseded, but this is
a positive development indicating that the field is moving toward common grounds. Such gradual
improvements can be considered the necessary steps to establish a solid basis for reproducible
research in epigenomics.
For SCIDDO, a direct comparison with a competing method could not be realized due to the
methodological differences and the dataset we used for our study (see Chapter 4, Sections 4.1
1Working title defined and used in the IHEC Integrative Analysis work group.
2Personal communication within the context of the regular IHEC Integrative Analysis work group conference calls.
3github.com/IHEC/ihec-assay-standards: IHEC Assay Standards work group code repository hosting reference
scripts that implement computational steps to derive quality control metrics for experiments such as ChIP-seq.
4For example, at the time of writing, the ENCODE ChIP-seq pipeline v2 is considered the IHEC reference:
github.com/ENCODE-DCC/chip-seq-pipeline2
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and 4.3.9). Hence, future work may evaluate the differences arising from using a binary
“match/mismatch” chromatin state scoring as opposed to the default quantitative scoring available
in SCIDDO. However, drawing general conclusions from such a comparison may not be trivial
because the lack of a genome-wide gold standard defining true regions of differential chromatin
presents a challenge to deciding on the appropriateness of the respective chromatin state scoring
in all genomic contexts. Similarly, reproducing the reported results using a different chromatin
state segmentation tool to generate the input data, e.g., EpiCSeg [154], could be easily realized
but differences in the output may be hard to interpret since different software builds on different
ChIP-seq modeling assumptions (Chapter 2, Section 2.4.2). Consequently, it would be surprising
to see virtually identical results, but general trends such as a formation of differential chromatin
domains in gene bodies of differentially expressed genes should hold nevertheless.
Apart from consolidating work, exploring different notions of chromatin state (dis-) similarity
by developing more, potentially data-derived, scoring schemes is an intriguing possibility.
Specifically, it is an open question if, for a given state segmentation model, generally applicable
scoring schemes could be created that are sensitive to the degree of cellular relatedness (in some
sense analogous to scoring matrices for biological sequence analysis [182]). In the affirmative
case, this could enable a more precise analysis of closely related cell types, which could be
relevant for examining chromatin changes during subsequent steps of cellular differentiation.
Similar considerations may be relevant when different types of (regulatory) genomic regions are
in the focus of the differential chromatin analysis. By and large, the results presented in Chapter 4
have a gene-centric view, probably covering a substantial number of regions with pronounced
differences on the chromatin level between cell types. However, fine-grained enhancer dynamics
are still poorly understood on the global scale [35, 37, 185], and it is certainly worthwhile to test if
a suitable combination of chromatin state segmentation model and scoring scheme can be devised
to investigate (smaller-scale) chromatin changes in enhancer regions.
In the narrow context of this thesis, the appropriate handling of the so-called background
chromatin state is of lesser relevance, because none of the work presented here could explicitly
help dealing with technical artifacts that may cause the lack of a signal in certain genomic regions.
From a more general perspective, a presumably context-dependent scoring of the background
state is likely required to comprehensively characterize chromatin dynamics between cellular
phenotypes within a species.
Knowledge about common patterns of chromatin state changes within one species could prove
useful for improving cross-species studies that rely on epigenome transfer as in Chapter 5. Such
additional information may help to broaden the applicability of epigenome transfer beyond coding
genes; in particular, this will be a challenge for regulatory elements such as enhancers that show
a limited sequence conservation. Nevertheless, it seems feasible that cross-species epigenome
transfer and prediction can help address the current scarcity of epigenome data for non-model
organisms. A more in-depth comparison of predicted and experimentally measured epigenome
data, ideally across a large panel of histone marks, cell types and species, would be interesting for
locating genomic regions in which the measurement deviates from the prediction. Such regions
would be strong candidates for species-specific epigenome regulation and promising targets for
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in-depth biological investigation. Species-specific properties of the epigenome are not only rele-
vant for the endeavor of understanding epigenome evolution [149], but can reveal intriguing, and
potentially medically relevant insights; a recent example is the discovered resistance to cellular
reprogramming of the naked mole rat’s epigenome, which may contribute to this species’ excep-
tional resistance to cancer [236].
On the more computational side, it would be interesting to test if the epigenetic information from
several reference species could be combined during epigenome transfer or machine learning to
increase the robustness of the approach. However, this would probably require larger and more
biologically consistent datasets; a non-trivial task given that characteristics such as (sample) age
or feeding status are difficult to match across species. Moreover, it would be desirable to perform
more in-depth work on a dataset restricted to purified cell types, i.e., to exclude whole-tissue sam-
ples that likely contain a mix of different cells and thus a mix of biological signals.
Additionally, one could consider explicitly modeling confounding factors. For example, the esti-
mated gene age seems to be a potential candidate to perform a preliminary analysis along those
lines. However, such extensions bear the risk of limiting the applicability of the computational ap-
proach if they introduce too strong dependencies on genomic annotations that have to be available
for all species considered.
At this early stage, it seems unlikely that pure bioinformatic approaches to cross-species epige-
nomics will be sufficient to derive general principles of epigenome evolution — if there are any at
all. On the other hand, a deeper understanding of epigenome dynamics within a species may al-
low for dropping the proxy of “sequence conservation suggests epigenome conservation” at some
point, which could then motivate entirely different bioinformatic approaches to in silico cross-
species epigenomics.
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Appendix: Reproducibility in
Computaࢢonal Research
A.1 Addiࢢonal Material
A.1.1 Example of a Galaxy workﬂow speciﬁcaࢢon
The following example of a published Galaxy workflow document1 represents a ChIP-seq
analysis pipeline that implements the main steps of read mapping and peak calling, and is roughly
comparable to the respective DEEP pipelines. The JSON document is structured similar to DEEP
process documents beginning with a header containing information such as the workflow name
(Listing A.1), followed by the specification of the input dataset (Listing A.2) and the individual
analysis steps of the pipeline. The example step presented in Listing A.3 is the peak calling using
the MACS [268] software. Noteworthy differences between DEEP process documents and Galaxy
workflows are, e.g., the inclusion of layout information for proper rendering in the Galaxy software
(see keyword “position” in lines 18 and 59 in Listings A.2 and A.3); the explicit specification of
software repositories (tool sheds in Galaxy lingo, see lines 64ff in Listing A.3) and the specification
of input data as extra pipeline step instead of a separate section (see Listing A.2).
Listing A.1: Lines 1 to 5 of a Galaxy ChIP–seq workflow: document header
1 {
2 ” a_ga laxy_work f low ” : ” t r u e ” ,
3 ” a n n o t a t i o n ” : ” ” ,
4 ” format−v e r s i o n ” : ” 0 . 1 ” ,
5 ”name ” : ” ChIP ( H e l i n )−2nd s t e p ” ,
1Source: usegalaxy.org/workflows/list_published, downloaded on 2018-05-13. The workflow was last updated on
2015-04-28 and has the universally unique identifier (UUID) “447c66c4-a965-4a17-a230-95fef65788de”. For layout
reasons, white space and indentation have been adapted to fit the page width.
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Listing A.2: Lines 6 to 33 of a Galaxy ChIP–seq workflow: input dataset
1 ” s t e p s ” : {
2 ” 0 ” : {
3 ” a n n o t a t i o n ” : ” ” ,
4 ” c o n t e n t _ i d ” : n u l l ,
5 ” e r r o r s ” : n u l l ,
6 ” i d ” : 0 ,
7 ” i n p u t _ c o n n e c t i o n s ” : {} ,
8 ” i n p u t s ” : [
9 {
10 ” d e s c r i p t i o n ” : ” ” ,
11 ”name ” : ” ChIP−seq a g a i n s t
12 p r o t e i n o f i n t e r e s t ”
13 }
14 ] ,
15 ” l a b e l ” : n u l l ,
16 ”name ” : ” I n p u t d a t a s e t ” ,
17 ” o u t p u t s ” : [ ] ,
18 ” p o s i t i o n ” : {
19 ” l e f t ” : 211 ,
20 ” t o p ” : 200
21 } ,
22 ” t o o l _ i d ” : n u l l ,
23 ” t o o l _ s t a t e ” : ” { \ ” name \ ” : \ ” ChIP−seq a g a i n s t
24 p r o t e i n o f i n t e r e s t \ ” } ” ,
25 ” t o o l _ v e r s i o n ” : n u l l ,
26 ” t y p e ” : ” d a t a _ i n p u t ” ,
27 ” uu id ” : ”None ” ,
28 ” w o r k f l o w _ o u t p u t s ” : [ ]
29 } ,
Listing A.3: Lines 234 to 345 of a Galaxy ChIP–seq workflow: peak calling
1 ” 6 ” : {
2 ” a n n o t a t i o n ” : ” ” ,
3 ” c o n t e n t _ i d ” : ” t o o l s h e d . g2 . bx . psu . edu / r e p o s /
4 devteam / macs /
5 p e a k c a l l i n g _ m a c s / 1 . 0 . 1 ” ,
6 ” e r r o r s ” : n u l l ,
7 ” i d ” : 6 ,
8 ” i n p u t _ c o n n e c t i o n s ” : {
9 ” i n p u t _ t y p e | i n p u t _ c h i p s e q _ f i l e 1 ” : {
10 ” i d ” : 4 ,
11 ” ou tpu t_name ” : ” o u t p u t 1 ”
12 } ,
13 ” i n p u t _ t y p e | i n p u t _ c o n t r o l _ f i l e 1 ” : {
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14 ” i d ” : 1 ,
15 ” ou tpu t_name ” : ” o u t p u t ”
16 }
17 } ,
18 ” i n p u t s ” : [
19 {
20 ” d e s c r i p t i o n ” : ” r u n t i m e p a r a m e t e r
21 f o r t o o l MACS” ,
22 ”name ” : ” g s i z e ”
23 } ,
24 {
25 ” d e s c r i p t i o n ” : ” r u n t i m e p a r a m e t e r
26 f o r t o o l MACS” ,
27 ”name ” : ” p v a l u e ”
28 }
29 ] ,
30 ” l a b e l ” : n u l l ,
31 ”name ” : ”MACS” ,
32 ” o u t p u t s ” : [
33 {
34 ” name ” : ” o u t p u t _ b e d _ f i l e ” ,
35 ” t y p e ” : ” bed ”
36 } ,
37 {
38 ” name ” : ” o u t p u t _ x l s _ t o _ i n t e r v a l _ p e a k s _ f i l e ” ,
39 ” t y p e ” : ” i n t e r v a l ”
40 } ,
41 {
42 ” name ” : ” o u t p u t _ x l s _ t o _ i n t e r v a l _ n e g a t i v e
43 _ p e a k s _ f i l e ” ,
44 ” t y p e ” : ” i n t e r v a l ”
45 } ,
46 {
47 ” name ” : ” o u t p u t _ t r e a t m e n t _ w i g _ f i l e ” ,
48 ” t y p e ” : ” wig ”
49 } ,
50 {
51 ” name ” : ” o u t p u t _ c o n t r o l _ w i g _ f i l e ” ,
52 ” t y p e ” : ” wig ”
53 } ,
54 {
55 ” name ” : ” o u t p u t _ e x t r a _ f i l e s ” ,
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56 ” t y p e ” : ” h tml ”
57 }
58 ] ,
59 ” p o s i t i o n ” : {
60 ” l e f t ” : 1228 ,
61 ” t o p ” : 452
62 } ,
63 ” p o s t _ j o b _ a c t i o n s ” : {} ,
64 ” t o o l _ i d ” : ” t o o l s h e d . g2 . bx . psu . edu / r e p o s / devteam /
65 macs / p e a k c a l l i n g _ m a c s / 1 . 0 . 1 ” ,
66 ” t o o l _ s h e d _ r e p o s i t o r y ” : {
67 ” c h a n g e s e t _ r e v i s i o n ” : ” ae2ec275332a ” ,
68 ” name ” : ” macs ” ,
69 ” owner ” : ” devteam ” ,
70 ” t o o l _ s h e d ” : ” t o o l s h e d . g2 . bx . psu . edu ”
71 } ,
72 ” t o o l _ s t a t e ” :
73 ” { \ ” g s i z e \ ” : \ ” { \ \ \ ” _ _ c l a s s _ _ \ \ \ ” :
74 \ \ \ ” Runt imeValue \ \ \ ” } \ ” ,
75 \ ” t s i z e \ ” : \ ” \ \ \ ” 4 2 \ \ \ ” \ ” ,
76 \ ” nolambda \ ” : \ ” \ \ \ ” f a l s e \ \ \ ” \ ” ,
77 \ ” __page__ \ ” : n u l l ,
78 \ ” i n p u t _ t y p e \ ” :
79 \ ” { \ \ \ ” i n p u t _ c o n t r o l _ f i l e 1 \ \ \ ” : n u l l ,
80 \ \ \ ” i n p u t _ c h i p s e q _ f i l e 1 \ \ \ ” : n u l l ,
81 \ \ \ ” _ _ c u r r e n t _ c a s e _ _ \ \ \ ” : 1 ,
82 \ \ \ ” i n p u t _ t y p e _ s e l e c t o r \ \ \ ” :
83 \ \ \ ” s i n g l e _ e n d \ \ \ ” } \ ” ,
84 \ ” _ _ r e r u n _ r e m a p _ j o b _ i d _ _ \ ” : n u l l ,
85 \ ” d i a g _ t y p e \ ” :
86 \ ” { \ \ \ ” _ _ c u r r e n t _ c a s e _ _ \ \ \ ” : 1 ,
87 \ \ \ ” d i a g _ t y p e _ s e l e c t o r \ \ \ ” :
88 \ \ \ ” no_d iag \ \ \ ” } \ ” ,
89 \ ” wig_ type \ ” :
90 \ ” { \ \ \ ” w i g _ t y p e _ s e l e c t o r \ \ \ ” :
91 \ \ \ ” wig \ \ \ ” ,
92 \ \ \ ” w igex t end \ \ \ ” : \ \ \ ” 2 0 0 \ \ \ ” ,
93 \ \ \ ” _ _ c u r r e n t _ c a s e _ _ \ \ \ ” : 0 ,
94 \ \ \ ” s p a c e \ \ \ ” : \ \ \ ” 1 0 \ \ \ ” } \ ” ,
95 \ ” x l s _ t o _ i n t e r v a l \ ” : \ ” \ \ \ ” t r u e \ \ \ ” \ ” ,
96 \ ” exper iment_name \ ” :
97 \ ” \ \ \ ” MACS i n Galaxy \ \ \ ” \ ” ,
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98 \ ” bw \ ” : \ ” \ \ \ ” 3 0 0 \ \ \ ” \ ” ,
99 \ ” f u t u r e f d r \ ” : \ ” \ \ \ ” f a l s e \ \ \ ” \ ” ,
100 \ ” nomodel_ type \ ” :
101 \ ” { \ \ \ ” n o m o d e l _ t y p e _ s e l e c t o r \ \ \ ” :
102 \ \ \ ” c r e a t e _ m o d e l \ \ \ ” ,
103 \ \ \ ” _ _ c u r r e n t _ c a s e _ _ \ \ \ ” : 1 } \ ” ,
104 \ ” mfold \ ” : \ ” \ \ \ ” 3 2 \ \ \ ” \ ” ,
105 \ ” l a m b d a s e t \ ” : \ ” \ \ \ ” 1 0 0 0 , 5 0 0 0 , 1 0 0 0 0 \ \ \ ” \ ” ,
106 \ ” p v a l u e \ ” : \ ” { \ \ \ ” _ _ c l a s s _ _ \ \ \ ” :
107 \ \ \ ” Runt imeValue \ \ \ ” } \ ” } ” ,
108 ” t o o l _ v e r s i o n ” : ” 1 . 0 . 1 ” ,
109 ” t y p e ” : ” t o o l ” ,
110 ” uu id ” : ”None ” ,
111 ” w o r k f l o w _ o u t p u t s ” : [ ]
112 } ,
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A.2 Addiࢢonal Figures
Figure A.1: Github changelog of the deepTools software suite: screenshot of the Github
changelog entries for the deepTools releases 1.5.8.2, 1.5.9 and 1.5.9.1 that followed on release
1.5.7. Source: github.com/deeptools/deepTools
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Appendix: Fast Detecࢢon of
Diﬀerenࢢal Chromaࢢn Domains
with SCIDDO
B.1 Addiࢢonal Figures
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Figure B.1: CMM18 state mnemonics and colors: mnemonics and colors for the 18 chromatin
states of the ChromHMM CMM18 model provided by the REMC. See Table B.1 for more detailed
state descriptions.
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Figure B.2: Clustering of samples based on chromatin state identity: fraction of identi-
cally assigned chromatin state bins was computed for all sample pairs based on the segmentation
produced by the CMM18 model. The resulting similarity matrix was used for a hierarchical
clustering of the samples with average linkage and Euclidean distance. Donors were arbitrarily
labeled A–G (x-axis) based on the DEEP sample metadata (the given labels are otherwise not
informative).
St
at
e 
as
sig
nm
en
t
0.5 1.0
KL Divergence
Cost: 4.97
LP solution
0.5 1.5 2.5
KL Divergence
S1
S5
S10
S15
S18
Le
ar
ne
d 
st
at
es
Cost: 6.29
Greedy solution
Figure B.3: Matching of newly learned and predefined chromatin states: the 18 chromatin
states S1, . . . , S18 of the NEW18 model are arranged in sorted order from bottom to top (right-
most y-axis) and the matched states of the CMM18 model are shown as colored blocks (see
Figure B.1) for the LP (left) and the greedy (right) solution of the assignment problem defined
in Section 4.2.3. The Kullback-Leibler divergence between the matched states is depicted on the
x-axis. Note that the color of the CMM18 states 2–4 has been changed to “salmon” to make the
TSS flanking states distinguishable from the active TSS state (bright red).
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Figure B.4: DCD length distribution: length distribution for the lower 97.5% (truncated for
visualization) of all identified differential chromatin domains for the six sample group compar-
isons. The vertical line (dashed) marks the 75th percentile of the data. The DCD length is given in
genomic bins à 200 bp (x-axis). N: total number of identified DCDs in the respective comparison.
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Figure B.5: DCDs overlapping gene bodies and enhancers affect gene expression: (left pan-
els) genes were stratified by the amount of DCD overlap either covering more than 50% of
the body (body; orange curve) or less than 50% of the body or the promoter region (partial;
blue curve). Expression fold change of the genes in the respective groups is plotted along the
x-axis within a restricted window for improved readability. Statistical significance of the differ-
ence in mean fold change of the groups relative to the no overlap group (“none”, gray dashed
line) was computed separately for negative and positive fold change genes using a two-sided
Mann-Whitney-U test (“*” significant at p < 0.01, “-” not significant otherwise; “//” not enough
data to compute statistic). (middle and right panels) the same analysis as for the gene body was
performed, but here counting the number of intra- and intergenic enhancers (anywhere, middle)
or only intergenic enhancers (right) per gene that overlap a DCD. Expression fold changes plotted
within a restricted window for improved readability. Statistical significance assessed as before.
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Figure B.6: E-value distribution in DEGs by gene body length: genes were stratified into four
groups based on expression behavior (stable or differential) and their gene body length (shortest
40%, middle 40% and longest 20% of DEGs according to gene body length). Bottom: boxplots
show distribution of E-values of all DCDs overlapping gene bodies in the respective groups ag-
gregated over all sample comparisons. The no overlap group contains all E-values of DCDs not
overlapping any gene. Middle: boxplots show distinct DCD overlaps per gene. Top: boxplots
show gene body length distribution of all genes in the respective group. Differences in magnitude
of E-values were assessed with a two-sided Mann-Whitney-U test and considered significant (*)
at p < 0.01.
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Figure B.7: Potential differences in post–transcriptional regulation of genes overlapping
DCDs: DEGs w/o a DCD in their gene body were compared to the stably expressed genes with
an overlapping DCD (N=760) in their gene body for the monocyte to macrophage comparison.
Top: boxplots show distribution of 3p UTR length as annotated in Ensembl v78 for the genes in
the respective groups. Bottom: boxplots show distribution of number of annotated miRNA tar-
gets per genes in the respective groups (TargetScan v7.2). Differences in magnitude between the
two groups were assessed with a one-sided Mann-Whitney-U test (alternative less or greater as
indicated) and considered significant (*) at p < 0.01.
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Figure B.8: SCIDDO showsmore stable performance at detectingDEGs (G2): boxplots depict
SCIDDO’s and PePr’s (light grey) performance of detecting DEGs quantified as F1 score (left) and
as accuracy (right). Performance values are summarized over all sample group comparisons and
for different thresholds on gene expression fold change (0.5, 1, 2 and 4) and on adjusted p-values
(0.1, 0.05, 0.01 and 0.001) computed with DESeq2 to call DEGs. At least one DCD/differential
H3K36me3 peak (PePr) in the gene body and at least three DCDs/differential H3K27ac peaks
(PePr) in gene-associated enhancers were required for a DEG to be considered detected on the
chromatin level. Differences in performance were assessed with a one-sided Mann-Whitney-U
test and considered significant “*” at p < 0.01
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B.2 Addiࢢonal Tables
Table B.1: State numbers, mnemonics and concise descriptions of the chromatin states of the
ChromHMM CMM18 model as provided by the REMC under egg2.wustl.edu/roadmap/web_por-
tal/chr_state_learning.html
Number Mnemonic Description
1 TssA Active TSS
2 TssFlnk Flanking TSS
3 TssFlnkU Flanking TSS upstream
4 TssFlnkD Flanking TSS downstream
5 Tx Strong transcription
6 TxWk Weak transcription
7 EnhG1 Genic enhancer1
8 EnhG2 Genic enhancer2
9 EnhA1 Active enhancer 1
10 EnhA2 Active enhancer 2
11 EnhWk Weak enhancer
12 ZNF/Rpts ZNF genes & repeats
13 Het Heterochromatin
14 TssBiv Bivalent/Poised TSS
15 EnhBiv Bivalent enhancer
16 ReprPC Repressed PolyComb
17 WkReprPC Weak repressed PolyComb
18 Quies Quiescent/Low
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Table B.2: Runtime (in minutes of wall clock time) of individual SCIDDO commands executed in
order from top to bottom to perform the differential analysis presented in Chapter 4. The runtime
for the scan command refers to a single comparison of two versus two samples. The last scan
command is provided as an example of the scaling behavior of SCIDDO (scanning for differential
chromatin domains between the four liver and the five blood samples in the dataset). Note that the
runtime includes I/O.
Command CPU cores Samples Runtime (min)
convert 7 9 < 3
stats 7 9 < 1
score 1 n/a < 1
scan 15 2 v 2 < 4
scan 15 4 v 5 < 7
Table B.3: Average Spearman correlation of E-values of all overlapping candidate regions iden-
tified in individual replicate comparisons. Rightmost column indicates the average percentage of
unique candidate regions per comparison. Values in parentheses give ± 1 standard deviation for
the respective statistic.
Group 1 Group 2 Spearman’s ρ Unique regions %
HG He 0.67 (0.06) 10.85 (3.14)
HG Ma 0.7 (0.04) 7.51 (3.6)
HG Mo 0.73 (0.04) 3.92 (1.68)
He Ma 0.68 (0.04) 5.99 (1.35)
He Mo 0.7 (0.03) 3.27 (0.39)
Mo Ma 0.7 (0.04) 17.68 (3.17)
Table B.4: Online supplementary files are hosted in the source repository of this thesis under
“Supplement/diffchrom” at github.molgen.mpg.de/pebert/dissertation
Table Filename Timestamp
S1 supp_table_S1_dataset.tsv 2018–10
S2 supp_table_S2_expression.tsv 2018–10
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CHAPTER C
Appendix: Epigenome-based
Predicࢢon of Gene Expression
across Species
C.1 Addiࢢonal Figures
Figure C.1: Overview of species included in the cross-species study: phylogenetic tree show-
ing evolutionary relationships among twelve mammalian and one avian species investigated in
chapter 5. The tree was generated using the TimeTree web service [99]. Estimated time since last
common ancestor between any two species is given in million years.
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Figure C.2: Coverage of transferred epigenome profiles: colored points indicate the average
number of base pairs with non-zero signal after cross-species transfer for each histone mark (error
bars denote ± 1 standard deviation around the mean) between mouse as the reference species and
twelve target species. The number of aligned bases genome-wide (black bars) and at gene loci
(gene promoters and gene bodies combined, grey bars) are shown for comparison. Target species
are sorted by increasing evolutionary distance to the mouse reference (x-axis, million years since
last common ancestor indicated in parentheses).
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Figure C.3: Strength of the transferred epigenetic signal: target species are sorted by increasing
evolutionary distance (a) to the human reference and (b) to the mouse reference (x-axis, million
years since last common ancestor). The average strength of the transferred histone signal in aligned
regions in gene promoters, gene bodies and outside of genes (“other”) is depicted as aggregation
over all cell types (y-axis).
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Figure C.4: Transcriptome data cluster by tissue of origin: hierarchical clustering of Pearson
correlation coefficients between transcriptome profiles of 13 species used for gene expression pre-
diction and model validation. Correlations were calculated across all 1-to-1 orthologous genes
shared by all species in the dataset. Color bars at the top indicate tissue of origin. Columns are
labeled with species of origin, and row labels indicate data source (project name or “SRA” for data
downloaded from SRA/ENA; see Table C.1: Online Table S1).
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Figure C.5: Number of annotated protein-coding and 1-to-1 orthologous genes: target species
are sorted by increasing evolutionary distance (a) to the human and (b) to the mouse reference (x-
axis, million years since last common ancestor). The number of annotated protein-coding genes
located on autosomes and the number of 1-to-1 orthologs is depicted as height of the bars.
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Figure C.6: Effect of thresholding on classifier class probability estimates: prediction per-
formance of the epigenome-based approach (dark gray lines) and the orthology-based approach
(light gray lines), as measured by the number of correct predictions (true positives and true neg-
atives, left y-axis) and percent accuracy (right y-axis) for increasingly stringent cutoffs on the
class probability estimates of the epigenome-based approach (x-axis, range from 0.5 to 0.95).
The number of genes selected at each threshold is shown as dotted line. Results are shown for
mouse as reference and human as target species.
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Figure C.7: Epigenome-based prediction of gene expression using the mouse reference:
bar plots showing for each species the total number of genes in the genome, the number of
unaligned or weakly aligned genes relative to the reference species, and the average number of
genes correctly predicted by the epigenome-based approach in total and after setting a threshold
on the predicted class probability of > 0.75. Target species are sorted by evolutionary distance
to the mouse reference along the x-axis (million years since last common ancestor indicated in
parentheses).
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Figure C.8: Association between gene age and epigenome-based prediction performance:
genes were stratified by their tendency to be predicted correctly or incorrectly by the epigenome-
based approach and labeled with their annotated age. Predictions were made (a) in mouse using
human as reference and (b) in rhesus monkey using human and mouse as reference species. Bar
heights indicate relative difference to the expected number of genes in each age group (percent
values are shown for comparability across species). One standard deviation estimated by 1,000
bootstrap iterations is indicated as error bars. Numbers in parentheses indicate divergence time
in million years relative to the family of Hominidae (great apes including human). Because of
horizontal gene transfer, no divergence time estimates are given for the archaea and the bacteria
group. The expected number of genes in each group is derived from the prior distribution for the
gene age label.
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C.2 Addiࢢonal Tables
Table C.1: Online supplementary files are hosted in the source repository of this thesis under
“Supplement/crossspecies” at github.molgen.mpg.de/pebert/dissertation
Table Filename Timestamp
S1 Supp_Table_S1_data-sources.tsv 2018–07
S2 Supp_Tables_S2_LOLA_transfer.zip 2018–07
S3 Supp_Tables_S3_LOLA_wkalign.zip 2018–07
S4 Supp_Tables_S4_enrichR_wkalign.zip 2018–07
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Appendix: License and Copyright
Informaࢢon
E.1 Manuscripts
If applicable, license and copyright information for material reused for Chapters 3, 4 and 5 is
listed below.
E.1.1 Reproducibility in Computaࢢonal Research
The manuscript Ebert et al. [64] was published in Oxford Database. The article was published
under a Creative Commons license. This license grants the following rights:
“This is an open access article distributed under the terms of the Creative Commons
CC BY license, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article.”
(See link “Permissions” in the online version of the article: doi.org/10.1093/database/bav050.)
Author contributions: none specified in the manuscript.
The author contributions for this project including the extensions presented in this thesis are as
follows: all authors contributed to conceptualizing the published metadata specification. P.E. im-
plemented the XSD process specification, the corresponding XML process templates, the CSS
design, and the Python process/metadata validation script. Figures 1 and 3 in the publication were
created by Fabian Müller; Figure 1 was reused in Chapter 3 (Figure 3.1). All versions of the “CHP”
process were developed by P.E. and Andreas Richter (acknowledged in the publication) and im-
plemented by P.E. The DEEP file tracking database including the Python SOAP client, the Python
XML-RPC server, and the DEEP status website were conceptualized by P.E. with technical sup-
port by Joachim Büch and Georg Friedrich. The DEEP file tracking database was implemented by
P.E. with assistance by Anna Hildebrandt (née Dehof). The Java file synchronization tool was im-
plemented by Georg Friedrich. All implementation work for the Python SOAP client, the Python
XML-RPC server, and the DEEP status website was carried out by P.E. with technical support by
Joachim Büch and Georg Friedrich.
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E.1.2 Fast Detecࢢon of Diﬀerenࢢal Chromaࢢn Domains with SCIDDO
The manuscript Ebert and Schulz [63] is in preparation for a second submission (2018-11)
and is publicly available as a preprint at bioRxiv: doi.org/10.1101/441766.
Author contributions as stated in the manuscript: “P.E. and M.H.S. conceptualized the project;
P.E. carried out the implementation work, analyzed the data, and wrote the first draft of the
manuscript; all authors contributed to the writing of the manuscript. All authors read and approved
the final manuscript.”
E.1.3 Epigenome-based Predicࢢon of Gene Expression across Species
The manuscript Ebert et al. [65] has been submitted (submission: 2018-07; under re-
vision at the time of writing: 2018-11) and is publicly available as a preprint at bioRxiv:
doi.org/10.1101/371146.
Author contributions as stated in the manuscript: “P.E. and C.B. conceptualized the project
with input from T.L.; P.E. analyzed the data and wrote the first draft of the manuscript; all authors
contributed to the writing of the manuscript.”
E.2 Figure Reprints
Table E.1: Licensing information for figure reprints
Figure License Publisher Source
1.1 #4432540824975 Nature Publishing Group Wagner [253]
2.1 #4407631152362 Nature Publishing Group Felsenfeld and Groudine [77]
2.2 #4407621492444 Nature Publishing Group Luger et al. [151]
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Acronyms and Abbreviaࢢons
BAM binary alignment map 48, 61
BLUEPRINT European Hematopoietic Epigenome Project [1] 31, 58, 89, 108
bp base pairs 9, 11, 13, 18, 22, 23, 62, 73, 89
CGI CpG island 17, 85
ChIP-seq chromatin immunoprecipitation followed by high-throughput sequencing 19–25, 32,
50, 54, 61, 69, 85, 108, 109, 111
CSS Cascading Style Sheets 39, 42, 136
CSV comma-separated value 48
CWL Common Workflow Language 34
DAC Data Analysis Center 31, 37–39, 44, 47, 48, 50
DCC Data Collection Center 37, 39, 47, 48, 50, 56
DCD differential chromatin domain 60, 63, 69–75, 77–83, 120
DEEP Deutsches Epigenom Programm [48] 5, 18–20, 25, 27, 31, 32, 35–40, 42, 43, 45, 47, 48,
50–53, 55, 56, 58, 60, 61, 89, 94, 96, 107, 108, 111, 136
DEG differentially expressed gene 60, 62, 63, 74–79, 81–83
DNA deoxyribonucleic acid 8–13, 15–20, 23, 59, 85, 100, 103, 104
ENA European Nucleotide Archive 89, 98, 128
ENCODE Encyclopedia of DNA Elements [49, 231, 241] 31, 58, 63, 89, 94, 96, 108
FAANG Functional Annotation of Animal Genomes 35
Gbp giga base pairs 103
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HBDE histone-binding domain enzyme 14, 17
HDAC histone deacetylase 14
HME histone-modifying enzyme 14, 16, 17
HTS high-throughput sequencing 3, 18, 19
IHEC International Human Epigenome Consortium [233] 14, 22, 32, 47, 50, 52, 58, 61, 107, 108
INSDC International Nucleotide Sequence Database Collaboration 55, 56
ISA-tab Investigation-Study-Assay tab-separated data 35, 36
IST Information Services and Technology 31, 44
JSON JavaScript Object Notation 33, 52, 111
KAT lysine acetyltransferase 14, 17
KDM lysine demethylase 14
KMT lysine methyltransferase 14
LUCA last universal common ancestor 2
MIBBI Minimum Reporting Guidelines for Biological and Biomedical Investigations 35
MINSEQE Minimum Information about a high-throughput Nucleotide Sequencing Experiment
35
MNase-seq micrococcal nuclease digestion followed by high-throughput sequencing 18
NGS next–generation sequencing 3, 5, 19
NIH National Institutes of Health 30
nm nanometer 10
NOMe-seq nucleosome occupancy and methylome sequencing 18
qPCR quantitative polymerase chain reaction 21
REMC NIH Roadmap Epigenomics Mapping Consortium 22, 31, 61, 69
RNA ribonucleic acid 8, 9
SCUFL2 Simple Conceptual Unified Flow Language (v2) 34
SRA Sequence Read Archive 89, 98, 128
140
TF transcription factor 12, 13, 15, 17, 19, 21, 85, 87
TFBS transcription factor binding site 85
TSS transcription start site 11, 89
TSV tab–separated value 48
UUID universally unique identifier 111
XML Extensible Markup Language 34, 39, 40, 42, 52, 136
XML-RPC Extensible Markup Language Remote Procedure Call 42, 136
XSD XML Schema Definition 39, 52, 136
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